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Summary
The post-translational modification of proteins is a fundamental means of biological 
information processing, with important functions in development, homeostasis and disease. 
Post-translational modifications (PTMs) can dynamically diversify the proteome in response 
to intracellular and extracellular signals. Since thousands of modified residues as well as 
entirely new modification types have recently been discovered in proteins, elucidating their 
biological functions and identifying the protein components of these PTM systems is a 
fundamental problem.
Chapter 1 gives an overview of the types and known biological functions of diﬀerent PTMs, 
as well as experimental methods used to detect them. Intrinsic disorder in proteins is 
introduced as a structural feature which may influence local evolutionary rates. Several 
examples of complex PTM signalling systems are then described.
Chapter 2 presents a study of the evolution of modified amino acids in human proteins. By 
analysing sequence, polymorphism and mutation data at the species, population and 
individual levels, we observed significant evolutionary constraints on all PTM types for which 
extensive data was available, as well as overrepresentation of amino acids which mimic 
modified residues at equivalent positions.
Chapter 3  applies a framework for the identification of important components of PTM 
signalling systems to lysine acetylation. The proteins of this system were found to be 
similarly conserved as essential genes. Their evolutionary histories suggested a conserved 
origin in chromatin regulation, followed by functional diversification.
Chapter 4 extends the scope to signalling via transcriptional regulation, and presents a 
comprehensive overview of the interactome of the stem cell transcription factor Oct4. The 
results presented here facilitated characterisation of a novel post-translational modifier of 
Oct4, the glycosyltransferase Ogt.
Chapter 5 highlights my key findings from applying evolutionary and data integration 
approaches to signalling networks, and outlines their implications for the study of novel 
signalling systems and for their engineering in synthetic biology.
This dissertation therefore illuminates evolutionary, structural and functional principles of 
cellular signalling networks across species and within populations.
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Acronyms and terminology
ASA Accessible surface area (for solvent, in square ångströms)
ES cell Embryonic stem cell
iPS cell induced pluripotent stem cell
JSD Jensen–Shannon Divergence (conservation score)
K-ac Lysine (K) acetylation
K-me Lysine (K) methylation
LC-MS/MS Liquid chromatography followed by tandem mass spectrometry
MW Molecular weight
N-gly N-linked glycosylation (on asparagines)
PDB Protein Data Bank
PPI Protein-protein interaction
PTM Post-translational modification
PTM site One specific residue undergoing post-translational modification
rASA relative solvent-accessible surface area (fraction)
rvET real-valued Evolutionary Trace (conservation score)
S-p Serine phosphorylation
T-p Threonine phosphorylation
Y-p Tyrosine phosphorylation
1. Introduction
Cellular signalling networks function to process information and generate biological 
outcomes. They operate at multiple levels and in many diﬀerent ways: for example, 
by integrating mammalian endocrine information from outside the cell through 
nuclear hormone receptors, leading to transcriptional responses; by integrating 
information from the cell surface through receptor tyrosine kinases, leading to 
autophosphorylation and downstream signalling; and by responding to any number 
of events within the cell, for instance by continuing a phosphorylation cascade. The 
net function of their interplay is to enable cellular and organismal homeostasis.
In this dissertation, I will explore the evolutionary, structural and functional features 
of cellular signalling networks, with a particular focus on the human organism and 
signalling changes which may lead to disease. Beginning with the evolution of post-
translational signalling, the study then leads into stem cell biology and pluripotency.
In this introductory chapter, I will provide an overview of the types and known 
biological functions of post-translational protein modifications, as well as the 
methods that are used to detect them. I will then introduce intrinsic disorder as a 
structural feature of proteins which aﬀects the evolutionary rates of amino acid 
residues. To illustrate the complex signalling systems enabled by post-translational 
modifications, I will first focus on the role of the well-studied histone modifications in 
eukaryotic gene regulation, and then present further examples of complex post-
translational signalling mechanisms.
1.1. Post-translational modifications (PTMs)
Post-translational modifications (PTMs) greatly increase the diversity of amino acids 
available to the cell and enable rapid regulation of protein function. Nearly all 
proteins are post-translationally modified at some stage during their life cycle (Blom 
et al., 2004; Komander, 2009). More than 300 types of modification occur 
physiologically, ranging from the addition of small chemical moieties to entire 
peptide chains such as ubiquitin (Witze et al., 2007). These modifications greatly 
expand the diversity of the protein repertoire of an organism (Walsh et al., 2005). 
Although they also occur in prokaryotes, they are most extensively encountered in 
eukaryotes, with around 5% of the protein repertoire of higher eukaryotes being 
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dedicated to PTMs (Walsh et al., 2005). While changes in transcriptional regulation 
and alternative splicing require intervening synthesis steps before they can take 
eﬀect, post-translational modifications can rapidly relay messages in the cell by 
acting on existing proteins in a matter of minutes or seconds (Lissanu Deribe et al., 
2010).
To diﬀerentiate PTM types, at least three broad distinctions can be made: covalent 
vs. proteolytic, enzyme-catalysed vs. autocatalytic, and reversible vs. permanent 
modifications (Walsh et al., 2005; Bischoﬀ and Schlüter, 2012). Limited proteolysis is 
a common mechanism for the functional maturation of many eukaryotic proteins. 
One example is the enzymatic removal of two C-terminal amino acids from α-tubulin 
in the assembly of microtubules, with relevance in processes such as axon 
regeneration (Ghosh-Roy et al., 2012). Other examples of limited proteolysis include 
the subcellular targeting of newly translated proteins to the endoplasmic reticulum 
and mitochondria. This cleavage may be carried out by specialised proteases, such 
as signal peptidases, or through autoproteolysis, as in the β  subunits of 
proteasomes, and it is generally irreversible (Walsh et al., 2005). One example of a 
spontaneously occurring non-proteolytic PTM is asparagine deamidation (Robinson 
and Robinson, 2001). In contrast, most PTMs which involve the covalent addition of 
a chemical moiety to an amino acid side chain are reversible and enzyme-catalysed 
(Bischoﬀ and Schlüter, 2012). These features together enable them to function as 
dynamic and informative signals. For covalent modifications, two additional 
classifications of can be made according to the substrate amino acid and the 
reaction type (Table 1.1). Notably, 14 of the 20 most commonly occurring, genetically 
encoded amino acids are substrates for one or more enzyme-catalysed PTM types 
(Mittal et al., 2006; Mukherjee et al., 2007; Bischoﬀ and Schlüter, 2012). The 
common mechanistic scheme in these enzyme-catalysed modification reactions is 
the covalent addition of an electrophilic chemical group to a nucleophilic amino acid 
side chain containing either a carboxyl, hydroxyl, amino or thiol group (Bischoﬀ and 
Schlüter, 2012).
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Table 1.1: Overview of known enzyme-catalysed PTMs by amino acid and reaction type.
Cys Asp Glu His Lys Met Asn Pro Gln Arg Ser Thr Trp Tyr
C D E H K M N P Q R S T W Y
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ADP-ribosylation
Carboxylation
+PZ\SÄKLMVYTH[PVU
Glycosylation
/`KYV_`SH[PVU
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6_PKH[PVU
Prenylation
Phosphorylation
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x x x x x x
x
x
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x
x
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x x
x
x x
x
x x x x x x
x
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In addition to their diversity, PTMs have been shown to aﬀect a large number of 
substrates, and increasingly precise data is becoming available on their individual 
substrate residues. Taking into account the entire dataset of PTM sites which I 
assembled in Chapter 2, one or more sites have been experimentally localised to 
specific residues for nearly three quarters of the human proteome (Gnad et al., 2007; 
Pang et al., 2010; Wang et al., 2010; Zhao et al., 2010; Gnad et al., 2010b; Dinkel et 
al., 2011; Hornbeck et al., 2012; UniProt Consortium, 2012). The functional 
characterisation of these PTM sites is an ongoing long-term challenge (Lissanu 
Deribe et al., 2010), and it is expected that the majority of PTM sites still remains to 
be discovered (Minguez et al., 2012). In many in vitro and structural studies, the use 
of a bacterial expression system may prevent the physiological post-translational 
modification of the protein being investigated (Sellick et al., 2011), and the functional 
significance of PTMs may therefore have remained unappreciated in certain cases.
In this dissertation, six of the major PTM types were chosen for study based on the 
availability of substantial residue-level data (Fig. 1.1). In descending order of the 
number of sites currently known in humans, these modifications are serine 
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phosphorylation, threonine phosphorylation, lysine ubiquitination, tyrosine 
phosphorylation, lysine acetylation and N-linked glycosylation on asparagines.
Lysine acetylation (K-ac)
Serine phosphorylation (S-p) Threonine phosphorylation (T-p) Tyrosine phosphorylation (Y-p)
Lysine ubiquitination (K-ub) N-linked glycosylation (N-gly)
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Figure 1.1: Structural overview of the six major PTM types studied in this dissertation. R1 and 
R2 respectively denote the N-terminal and C-terminal continuation of the peptide chain.
An overview of the precise numbers of known human sites for these modifications is 
given in Table 2.1.
1.1.1. History and methods of PTM identification
Biologically occurring derivatives of the standard amino acids, such as methylated 
histidine, were first described over 80 years ago (Ackermann et al., 1929). Although 
many of these are metabolic intermediates, some modified amino acids were later 
recognised as breakdown products from the catabolism of modified proteins 
(Baldwin and Carnegie, 1971; Cantoni, 1975). 
An overview of methods used to identify PTM sites is given in Figure 1.2. 
Historically, instances of enzyme-catalysed protein modification have been identified 
using a range of biochemical methods such as chromatography, electrophoresis and 
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spectrophotometry (Baldwin and Carnegie, 1971; L’Italien and Laursen, 1979), as 
well as through assays for the donor cofactors participating in the reaction (Cantoni, 
1975). These assays were later supplemented by antibody-based methods for the 
detection of a specific modification on a protein of interest, e.g. through a Western 
blot using a pan-methyllysine antibody. Though these methods are eﬀective and 
provide semi-quantitative information on the extent of modification at a given site 
(modification penetrance), they are also time-intensive and therefore limited to 
focused, low-throughput studies.
+ inexpensive
- low throughput
- cannot identify
  modified position
Chromatography,
Electrophoresis,
Spectrophotometry
Biochemistry
+ precise, specific
+ semi-quantitative
- low throughput
- antibody may
  introduce bias
- cannot identify
  modified position
Western blot
Antibody-based methods
+ high throughput
+ highly sensitive
+ identifies modified position
- confidence for individual sites
  is lower due to high throughput
+ allows relative quantification
  between two samples
- requires isotope labelling
Variant: SILAC
+ more accurate quantification
  of proteins than fragment-based,
  bottom-up mass spectrometry
+ gives insight into PTM combinations
  (protein modforms)
- pre-processing more diﬃcult than
  for peptides (especially separation)
Variant: Top-down (whole protein)
Mass spectrometry (e.g. LC–MS/MS)
Methods to identify PTM sites
Figure 1.2: Overview of methods used to identify PTM sites, with an indication of their 
strengths and weaknesses (marked “+” and “-” respectively).
More recently, liquid chromatography combined with tandem mass spectrometry 
(LC–MS/MS) has emerged as the standard technique for high-throughput, localised 
PTM site detection (Bischoﬀ and Schlüter, 2012), though numerous variants in 
instrumentation and methodology exist (Bogdanov and Smith, 2005; Bantscheﬀ et 
al., 2007; Yates et al., 2009; Bantscheﬀ et al., 2012). Put simply, mass spectrometry 
allows the identification of peptides by determining their mass-to-charge ratio (m/z), 
and comparing this figure to a genomically-derived search database of known or 
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predicted proteins. In tandem mass spectrometry, controlled fragmentation within 
the instrument yields further information about the identity of the peptide.
One notable application of mass spectrometry is the relative quantification of 
peptides, including modified peptides, in two samples using the SILAC method 
(stable isotope labelling by amino acids in cell culture). In this method, an unlabelled 
control sample is compared to a sample labelled with amino acids containing stable 
heavy isotopes, such as 13C6-Lys and 13C615N4-Arg. These samples can be derived 
from cell cultures, or from in vivo labelling in model organisms such as Drosophila 
melanogaster, C. elegans and R. norvegicus (Ong et al., 2002; Yates et al., 2009).
Advances in sample preparation, mass spectrometric technology, experimental 
techniques and data processing have enabled the identification of several thousand 
PTM sites within a single experiment (Choudhary et al., 2009). These experiments 
often include an antibody-based purification step to enrich the sample for modified 
peptides prior to analysis. Chemical derivatisation of certain modified amino acids 
can further facilitate their detection through mass shift (Bischoﬀ and Schlüter, 2012). 
In a similar vein, ubiquitination is generally detected as di-glycine remnants on 
lysines after trypsin digestion (Xu et al., 2010).
One disadvantage of high-throughput PTM site detection by mass spectrometry is 
that the confidence of detection at each site is lower than in a classical assay. It may 
occasionally produce false identifications of post-translational modifications due to 
factors such as spontaneous deamidation and carbamoylation occurring within a 
peptide (Stevens et al., 2008; Lin et al., 2010; Palmisano et al., 2012). In at least one 
study, results of lysine tri-methylation were discarded due to it being near-isobaric to 
lysine acetylation (Pang et al., 2010). Enrichment using PTM-specific antibodies 
helps to increase the overall number of PTMs identified in a given experiment, but 
antibodies may also introduce biases, due to their particular specificities for 
structural and sequence contexts (Levy et al., 2011). In addition, introducing the 
mass shifts caused by PTMs into the analysis pipeline complicates the peptide 
search by greatly increasing the size of the search database. This either limits the 
overall experiment to the consideration of a small number of PTM types at a time, or 
to a small number of distinct proteins in a highly pure sample (Baliban et al., 2010; 
Kersten et al., 2011; Muers, 2011; Tan et al., 2011). As a result, certain highly 
prevalent PTMs such as phosphorylation are routinely investigated, while others may 
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go undetected in standard data analysis workflows. This is further exacerbated by 
the sheer wealth of mass spectrometry data being generated, which may prevent 
researchers from performing more detailed, manual follow-up analyses of 
unexplained peaks, which may be present in as many as 50% of the good-quality 
spectra in an average experiment (Bischoﬀ and Schlüter, 2012). Additionally, 
standard mass spectrometry does not address the possibility of fractional site 
occupancy, i.e. that only a part of the proteins in a sample may be modified at a 
certain residue, which has been observed for phosphorylation (Olsen et al., 2010).
Applying mass spectrometry to intact proteins followed by controlled fragmentation 
within the instrument (“top-down” mass spectrometry) may oﬀer an alternative to 
the more conventional “bottom-up” fragmentation–identification approaches, which 
are most widely used. Bottom-up approaches are generally more successful at 
identifying proteins in complex mixtures, since peptide mixtures are easier to 
separate than intact proteins (Bogdanov and Smith, 2005; Yates et al., 2009). 
However, using intact proteins may allow more meaningful estimation of the 
absolute quantity of a given protein in a sample by alleviating biases introduced at 
the peptide level. In addition, the top-down approach may be an especially useful 
technique for the investigation of diﬀerent protein “modforms”, i.e. the combinatorial 
states of multiple PTMs within the same protein (Siuti and Kelleher, 2007; Thomson 
and Gunawardena, 2009). This type of analysis has already been applied to 
individual histones (Tweedie-Cullen et al., 2012), and appears very promising for the 
future combinatorial study of protein modifications.
1.1.2. Architecture of PTM signalling systems
Post-translational modifications can be introduced and removed by specific 
enzymes, and recognised by specialised protein domains. PTM signalling systems 
are therefore commonly described as consisting of “writer”, “reader” and “eraser” 
proteins (Jin and Pawson, 2012). For instance, tyrosine phosphorylation signalling 
involves tyrosine kinases, SH2-domain proteins and tyrosine phosphatases as writer, 
reader and eraser proteins, respectively (Seet et al., 2006; Lim and Pawson, 2010). 
In a chromatin context, reader proteins are often termed “eﬀector” proteins, since 
they may initiate chromatin remodelling based on the post-translational signals they 
encounter. These dynamic, reversible systems allow for elaborate combinatorial 
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logic and signal processing (Ruthenburg et al., 2007; Scott and Pawson, 2009; 
Lissanu Deribe et al., 2010; Cerone et al., 2011; Grabbe et al., 2011). Multiple 
modifying and erasing enzymes may compete and maintain a dynamic equilibrium 
of modified forms (Komander, 2009; Thomson and Gunawardena, 2009), and it has 
been shown conceptually that the steady-state concentration of protein “modforms” 
can be derived from the concentrations of the enzymes involved (Thomson and 
Gunawardena, 2009).
Reader domains such as SH2 domains (for tyrosine phosphorylation), 
bromodomains (for lysine acetylation) and chromo-like domains of the Royal family 
(for lysine and arginine methylation) recognise and bind one or more modified 
residues (Kasten et al., 2004; Seet et al., 2006; Shaw et al., 2007; Taverna et al., 
2007; Morinière et al., 2009; Yap and Zhou, 2010; Chen et al., 2011). Other reader 
domains include small zinc fingers, for instance the PHD zinc finger domain, which 
can recognise methylated lysines (Mellor, 2006). Histone lysine demethylases often 
contain reader domains that allow them to read out the methylation state of a lysine 
residue diﬀerent from their demethylation substrate (Upadhyay et al., 2011). At least 
20 diﬀerent reader domains for ubiquitination exist, covering the various ubiquitin 
chain types (Komander, 2009). Taken together, these modular recognition domains 
are important building blocks of eukaryotic cellular signalling.
For eraser proteins, relatively few serine/threonine phosphatases catalyse the 
dephosphorylation of thousands of substrates. Specificity is achieved here through 
regulatory subunits, which may direct the phosphatases to their targets (Shi, 2009). 
Deubiquitinases also occur in complexes that are thought to mediate their specificity 
(Sowa et al., 2009). For E2 ubiquitin ligases, specificity can be achieved by E3 
ligases that function as adaptor proteins which mediate interactions with substrates 
(Zeng et al., 2008; Komander, 2009).
It appears to be a general pattern in many PTM signalling systems that the number 
of modifying enzymes, or of modifier-adaptor complexes as in the substrate 
targeting of ubiquitination, is much greater than the number of erasing enzymes 
(Komander, 2009; Bischoﬀ and Schlüter, 2012; Liu and Nash, 2012). For 
phosphorylation, over 500 human protein kinases work alongside ~150 
phosphatases that counteract them (Komander, 2009; Bischoﬀ and Schlüter, 2012). 
In ubiquitination, one of two ubiquitin-activating enzymes (E1)  charges one of 37 
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ubiquitin-conjugating enzymes (E2) by attaching the ubiquitin C-terminus to a 
catalytic cysteine residue. One of over 600 E3 ligases then acts as an adaptor 
protein in targeting the E2-Ub complex to ubiquitination substrates, while enhancing 
transfer reactivity (Catic et al., 2004; Komander, 2009; Pruneda et al., 2012). These 
numbers compare to ~85 human deubiquitinases.
1.1.3. Biological functions of individual PTM types
Post-translational modifications have been implicated in nearly all biological 
processes (Komander, 2009; Lissanu Deribe et al., 2010; Wagner et al., 2011). They 
can induce changes in the conformation, enzymatic activity, interactions, stability 
and subcellular localisation of a protein. This includes import and export from the 
nucleus and other organelles, as well as export from the cell through the secretory 
system (Nishi et al., 2011; Nussinov et al., 2012; Zhang et al., 2012). PTMs are well-
suited for modulating interactions by creating or disrupting hydrophilicity matching 
between interaction interfaces (Hlevnjak et al., 2010). An overview of the biological 
functionality of selected PTMs is given below, as well as in Table 1.2.
Table 1.2: Overview of the biological functions of selected, common modification types.
PTM type Residue(s) Abbreviations 
used in this 
study
Biological functions
Phosphorylation S, T, Y S-p, T-p, Y-p regulation and signal transduction in nearly all cellular processes
Ubiquitination K K-ub targeting proteins for degradation, as well as the regulation of 
many other processes, with different polyubiquitin chain types 
having different functions which remain to be explored
Acetylation K, rarely: 
S, T
K-ac regulation of metabolic enzymes via activation, inactivation and 
destabilisation, as well as many other processes
N-linked glycosylation N N-gly stabilisation of secreted proteins, often required for proper folding, 
introduced as part of the secretory pathway in the ER and Golgi
O-linked glycosylation S, T regulation of some cellular processes, particularly development
Methylation K, R, 
rarely: E, H
regulation of several biological processes, including circadian 
rhythm, splicing and translation
SUMOylation K broad range of functions, including regulation of the cell cycle, 
heat shock response, and the folding and degradation of proteins
Prenylation (lipidation) C membrane localisation
Phosphorylation
Phosphorylation is the most prevalent post-translational modification in higher 
eukaryotes and is found in at least 7,400 substrate proteins in humans (UniProt 
Consortium, 2012). Estimates have been made that at least 70% of cellular proteins 
are phosphorylated at some stage, though the degree of fractional occupancy (the 
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fraction of protein copies that are modified) varies greatly (Olsen et al., 2010). In 
phosphorylation, a triply negatively charged phosphate group is attached to a serine 
or, more rarely, a threonine or tyrosine residue. In descending order of approximate 
frequency, protein phosphorylation can occur on serine (S), threonine (T), tyrosine 
(Y), cysteine (C), aspartate (D) and histidine (H) residues (Table 1.1).
Phosphorylation is introduced by kinases and removed by phosphatases. Many 
kinases phosphorylate both serines and threonines, and are termed Ser/Thr kinases. 
Most Ser/Thr kinases prefer to phosphorylate serines, while most phosphatases 
prefer to dephosphorylate threonines. This may account for the smaller number of 
observed threonine phosphorylation sites compared to serine. Most of these serine/
threonine kinases choose their substrates based on a ±4 amino acid motif around 
the substrate serine or threonine. Although the majority of kinases cannot 
accommodate a proline in the +1 position, around a quarter of serine/threonine 
phosphorylation sites are flanked by a +1 proline. This suggests that a small number 
of kinases may be generating a large number of phosphorylated residues, while 
others may have a smaller, more specialised set of substrates (Ubersax and Ferrell, 
2007). Tyrosine phosphorylation is the rarest type of phosphorylation, and eukaryotic 
tyrosine phosphorylation appears to be an evolutionary innovation which underwent 
expansion in the common ancestor of choanoflagellates and metazoans. It has 
distinct kinases, phosphatases and recognition domains, and is considered 
promising for creating ectopic signalling circuits in species which do not have these 
enzymes and proteins endogenously (Lim and Pawson, 2010). The abundance of 
tyrosine phosphorylation appears to increase with organismal complexity, along with 
a decrease in proteomic tyrosine content, which may have evolved to avoid 
excessive nonspecific phosphorylation of tyrosines (Tan et al., 2009b; Lim and 
Pawson, 2010). Prokaryotes appear to have independently evolved tyrosine kinases, 
though prokaryotic tyrosine phosphorylation occurs very rarely (Grangeasse et al., 
2012).
Relatively low conservation of phosphorylation sites has been reported between 
bacterial species (Soufi et al., 2008). This may either point to a high degree of 
plasticity, or to a low degree of experimental coverage of these bacterial 
phosphoproteomes. More generally, changes in phosphorylation are thought to be a 
large contributor to phenotypic divergence, which indicates that information on 
kinase-substrate associations cannot be transferred confidently between species 
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(Beltrao et al., 2009; Moses and Landry, 2010). This is likely to be the case for 
certain other PTMs as well.
Ubiquitination
Ubiquitination is involved in almost every cellular process (Komander and Rape, 
2012). Most typically, it targets proteins for degradation by the proteasome, through 
the addition of a chain of at least four K48-linked copies of ubiquitin, which is a 
highly conserved small protein of ~8 kDa. Ubiquitination is catalysed by a cascade 
of E1 (activating), E2 (conjugating) and E3 (ligating) ubiquitin ligases (Lu et al., 2008). 
HECT domain E3 ligases participate directly in the ubiquitination reaction, while 
RING/U-box domain E3 ligases serve purely as specificity-mediating adaptor 
proteins (Lu et al., 2008). The functional investigation of ubiquitination is 
complicated by several factors. In proteasomal degradation, polyubiquitination and 
the subsequent degradation of the substrate have been reported to follow rapidly 
(Pierce et al., 2009). Furthermore, the understanding of diﬀerent ubiquitin chain 
types (which diﬀer in their functions)  is still not fully worked out (Komander, 2009; 
Ikeda et al., 2010). Ubiquitin can also form mixed chains with other ubiquitin-like 
modifiers such as SUMO (Danielsen et al., 2010). In addition to targeting substrates 
to the proteasome for degradation, ubiquitin can also directly mediate 
destabilisation and unfolding of proteins (Hagai and Levy, 2010).
Acetylation
Acetylation is part of a larger group of post-translational modifications referred to as 
acylation reactions. In these reactions, an acylating enzyme uses an acyl-CoA donor 
to transfer the acyl group to a substrate residue. Donors include acetyl-CoA, 
succinyl-CoA, malonyl-CoA, palmitoyl-CoA and a large number of others (Lin et al., 
2012). Acylation can occur on lysines (K) and cysteines (C), and acetylation has also 
been described on serines (S) and threonines (T)  (Table 1.1). Many of the donor 
molecules used, such as acetyl-CoA and succinyl-CoA, are highly common 
metabolic intermediates, and it has been found that many metabolic enzymes seem 
to be regulated by acetylation (Lin et al., 2012). Succinylation and malonylation also 
frequently occur on metabolic enzymes (Lin et al., 2012). The eﬀects of lysine 
acetylation have been described as leading to either activation, inactivation or 
destabilisation of metabolic enzymes, which illustrates a similarly broad functional 
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range for acetylation as for phosphorylation (Yu et al., 2008; Zhao et al., 2010; Jiang 
et al., 2011; Lin et al., 2012). Acetylation occurs in both eukaryotes and prokaryotes. 
For instance, the half-life of the RNase R exoribonuclease in E. coli is increased by 
enzymatic acetylation at one lysine residue, thereby increasing its concentration 3- 
to 10-fold under stress conditions (Liang et al., 2011). A more in-depth description of 
lysine acetylation is given in the introduction to Chapter 3, which investigates the 
human lysine acetylation signalling system.
Glycosylation
Glycosylation is introduced in the endoplasmic reticulum or Golgi apparatus as part 
of the secretory pathway, and it can occur as N-linked, O-linked or C-linked 
glycosylation. N-glycosylation occurs on asparagines, O-glycosylation occurs on 
serines and threonines, and C-glycosylation occurs very rarely on tryptophan. The 
most common type is N-glycosylation of the highly predictive N-X-S motif, where X 
is any amino acid, and it is estimated that between one third and one half of 
eukaryotic secreted proteins are N-glycosylated in the ER (Walsh et al., 2005; Hart 
and Copeland, 2010). A more recent proteomic study described the primary motif as 
“N-!P-[S|T]-!P” where !P is not proline, occurring in nearly all cases (Zielinska et al., 
2010). The same study found an extremely high reproducibility in biological 
replicates, indicating near-total occupancy of N-glycosylation sites across all copies 
of a protein. However, the architecture of the branched polysaccharide tree on an 
individual protein can vary greatly depending on apparently stochastic encounters 
with glycosylation enzymes (Hart and Copeland, 2010). Its general functions include 
stabilisation and ensuring the proper folding of many proteins (Walsh et al., 2005; 
Shental-Bechor and Levy, 2009). O-glycosylation by N-acetylglucosamine (O-
GlcNAc) is another common type of glycosylation which has been suggested to 
have dynamic signalling roles similar to phosphorylation (Hart et al., 2007), and has 
been shown to be important in zebrafish development (Webster et al., 2009).
Additional PTM types
Arginine methylation of spliceosomal proteins by PRMT5 has been implicated as a 
potential link between circadian rhythm and alternative splicing (Sanchez et al., 
2010), and demethylation of lysines on MYPT1 by LSD1 leads to cell cycle 
progression (Hamamoto et al., 2010). In the green alga Chlamydomonas reinhardtii, 
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arginine methylation by PRMT1 in response to phototrophic growth conditions 
activates the cytosolic translation repressor protein NAB1, thereby repressing 
translation of components of the light-harvesting complex (Blifernez et al., 2011). In 
plants, rubisco, the essential photosynthetic enzyme, is methylated by RLSMT, a 
SET-domain lysine methyltransferase (Raunser et al., 2009). A number of other plant 
proteins are also methylated (Feng et al., 2009). Although the currently known 
number of human lysine and arginine methylation sites is in the low hundreds, the 
methyl group donor S-adenosyl-L-methionine (SAM) is the most widely used 
enzyme substrate after ATP, potentially suggesting that many methylation sites may 
remain unidentified (Cantoni, 1975; Paik et al., 2007; Sprung et al., 2008). For lysine 
acetylation, the generation of antibodies of high specificity appears to remain a 
technical challenge, and the identification of acetylated proteins is complicated by 
the high concentrations of histones (Guan et al., 2010). Similar problems may exist 
for lysine and arginine methylation, both of which also occur on histones 
(Kouzarides, 2007b).
The SUMO proteins, a subfamily of ubiquitin-like modifiers, have a similarly broad 
range of functions as ubiquitin, including cell cycle regulation, heat shock response, 
the folding and degradation of proteins (Golebiowski et al., 2009; Creton and 
Jentsch, 2010).
Lipidation is a group of modifications which are often involved in localising proteins 
to membranes. S-palmitoylation, a thioester-linked fatty acid modification, can eﬀect 
this reversibly (Linder and Deschenes, 2007; Maurer-Stroh et al., 2007; Yount et al., 
2010; Hang et al., 2011).
Certain reactions can remove a PTM by irreversibly converting a modified amino 
acid side chain into an atypical derivative. For instance, arginine methylation can be 
disrupted by arginine deimination, an irreversible modification which produces the 
uncharged amino acid citrulline (Guo et al., 2011). Similarly, lysine can be irreversibly 
hydroxylated by Jmjd6 (Webby et al., 2009). Hydroxylation is an oxygen-dependent 
reaction, and proline and lysine hydroxylation have been found to regulate the 
activity and half-life of hypoxia-inducible factor alpha (HIFα) (Schofield and Ratcliﬀe, 
2004). In addition, phosphothreonine lyases can convert phosphorylated threonine 
into dehydrobutyrine (Ribet and Cossart, 2010). Taken together, these types of 
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reactions provide alternative pathways for permanently altering and inactivating a 
PTM site by introducing an uncommon amino acid.
1.1.4. Disruption of PTM signalling in infection and disease
Human diseases frequently involve defects in post-translational modifications, and 
therapeutics targeted at PTM signalling proteins, such as histone deacetylase 
inhibitors, are being developed as interventions for human diseases such as cancer 
(Bradner et al., 2010). The leukemogenicity of the oncogenic fusion protein AML1-
ETO is dependent on its site-specific lysine acetylation by p300, suggesting that 
inhibition of this acetyltransferase could be a potential therapeutic approach (Wang 
et al., 2011a). Phosphorylation and ubiquitination are also implicated in α-synuclein 
aggregation in Parkinson’s disease (Hejjaoui et al., 2010; Lu et al., 2011).
Pathogens can make use of PTMs to influence or disrupt host cell signalling 
(Broberg and Orth, 2010; Ribet and Cossart, 2010). A notable example is the 
bacterium Yersinia pestis, which caused several historic plague pandemics, 
including the Plague of Justinian, the devastating “Black Death” in medieval Europe 
and a worldwide third outbreak originating in Yunnan in the mid-19th century 
(Haensch et al., 2010). One of its toxins, YopJ, acetylates serine and threonine 
phosphosites on various host proteins which are part of the MAPKK and NF-κB 
pathways, thereby inhibiting the host inflammatory response and inducing apoptosis 
of immune cells (Mittal et al., 2006; Mukherjee et al., 2006). An acetyltransferase 
related to Yersinia YopJ, termed HopZ1a, has been found in the plant pathogen 
Pseudomonas  syringae, where it interferes with the host microtubule network, 
blocks secretion and suppresses cell wall-mediated defence (Lee et al., 2012). 
HopZ1a autoacetylates a lysine residue, and is hypothesised to acetylate α-tubulin 
K252, though its mechanism of action is still unclear. Further examples include the 
manipulation of ubiquitin and ubiquitin-like modifier signalling (Ribet and Cossart, 
2010; Perrett et al., 2011), or direct dephosphorylation of host serines, threonines 
and tyrosines (la Puerta et al., 2009; Erazo et al., 2011). The apicomplexan parasites 
Toxoplasma gondii and Plasmodium falciparum  not only have phosphoproteomes 
similar in size to multicellular eukaryotes, but also a small number of endogenous 
tyrosine phosphorylation sites (Treeck et al., 2011). At least 20 kinases of 
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Plasmodium falciparum are thought to be exported into the host cell, where they 
may interfere with host tyrosine phosphorylation signalling (Nunes et al., 2007).
During infection by Legionella pneumophila, intracellular vesicle traﬃcking is altered 
due to the phosphocholination and adenylylation of Rab proteins by virulence 
factors, which aﬀects their cycling between membrane-bound and cytosolic states. 
It has been suggested that similar mechanisms may be employed for cycling even in 
the absence of infection (Oesterlin et al., 2012). In HIV infection, two important 
coreceptors bound by HIV during cell entry, CCR5 and CXCR4, are endogenously 
sulfated on tyrosines, and this modification is required for infection (Farzan et al., 
1999; Schnur et al., 2011). Pharmacological interventions which modulate post-
translational modifications may therefore represent a promising therapeutic 
approach in a number of diseases.
1.1.5. Chromatin regulation by PTMs
The nucleosome system, which compacts and regulates chromatin structure by 
dynamically wrapping DNA around histone octamers, is one of the best examples of 
the complexity and flexibility of post-translational signalling in higher eukaryotes 
(Kouzarides, 2007a; Bannister and Kouzarides, 2011; Bartke and Kouzarides, 2011). 
The recognition of its importance in gene regulation is one of the catalysts which has 
spurred recent PTM research. Classically, chromatin has been considered divided 
into transcriptionally active euchromatin and condensed, inactive heterochromatin. It 
has more recently been suggested that the individual modification marks on 
histones may combinatorially form a “histone code”, and it has been demonstrated 
that Drosophila chromatin is structured into no less than five distinct chromatin 
types, which are characterised by a particular PTM state as well as by proteins 
which recognise specific PTMs (Filion et al., 2010). Histone PTMs regulate chromatin 
conformation and gene expression, and have extensive developmental roles 
(Campos and Reinberg, 2009; Nottke et al., 2009).
However, new histone modifications are still being discovered, and their functional 
elucidation is far from complete (Muers, 2011). Recent in-depth proteomics studies 
of nucleosomes have uncovered that modifications on the individual histone 
proteins not only include classical modifications such as serine and threonine 
phosphorylation, lysine acetylation, and lysine and arginine methylation, but also 
15
include several atypical modifications such as serine and threonine acetylation, 
tyrosine hydroxylation, as well as lysine butyrylation, crotonylation, and 
propionylation (Tan et al., 2011; Tweedie-Cullen et al., 2012). The fact that these 
modifications are still being discovered in a regulatory system as intensively studied 
as chromatin, along with indications of their dynamic regulation and functionality, 
could indicate that atypical PTMs also remain undiscovered in other important 
signalling systems.
At least one type of PTM, the lysine and arginine methylation system centred on 
histones, is thought to be of prokaryotic evolutionary origin. It most likely first 
functioned in bacterial peptide methylation, and in hydroxylation systems used in 
the production of secondary metabolites (Aravind et al., 2011). The last common 
eukaryotic ancestor most likely already had several lysine and arginine 
methyltransferases as well as chromodomain-like reader proteins in place, while 
demethylases are likely to have evolved later, along with cytosine methylation in 
DNA (Aravind et al., 2011).
As mentioned above, the combination of diﬀerent histone PTMs may form a 
combinatorial “histone code”. To illustrate this, lysine methylation can either be 
transcriptionally activating or repressive, based on the methylation state (mono-, di- 
or tri-methylation) and the residue modified (Bannister and Kouzarides, 2011). 
Histone lysine demethylases often contain reader domains that allow them to read 
out the methylation state of a lysine residue diﬀerent from their demethylation 
substrate, potentially allowing them to remove opposing signals, e.g. repressive 
methylation marks in the presence of activating methylation (Upadhyay et al., 2011).
In histones, there is extensive combinatorial “cross-talk” between PTMs at diﬀerent 
residues and of diﬀerent types, including acetylation, phosphorylation, methylation, 
sumoylation, ubiquitination and proline isomerization (Latham and Dent, 2007; 
Ruthenburg et al., 2007; Fischle, 2008; Suganuma and Workman, 2008; Shukla et 
al., 2009; Filippakopoulos et al., 2012). In addition to PTMs, certain chromatin 
complexes can integrate the methylation state of DNA, whose methylation at 
cytosines is generally transcriptionally repressive, but has been found insuﬃcient in 
predicting gene activity on its own (Filion et al., 2006; Vu et al., 2006; Bartke et al., 
2010). In non-histone proteins, cross-talk exists e.g. between ubiquitination and 
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methylation (Wu et al., 2011), and between ubiquitination and phosphorylation 
(Huang et al., 2012).
In the chromatin transcriptional regulatory system, two additional layers of 
complexity are added by the constitution of chromatin remodelling complexes, and 
by non-coding RNAs (Guttman et al., 2011). The activity of chromatin remodellers 
can be modulated through the formation of variant complexes, diﬀering in their 
components (Ho and Crabtree, 2010). This is reminiscent of the modulation of 
ubiquitin ligases by adaptor proteins, which determine substrate targeting 
(Komander, 2009). Large intergenic non-coding RNAs (lincRNAs) have additionally 
been shown to aﬀect the chromatin state by regulating chromatin-modifying 
complexes, and thereby to aﬀect gene expression (Khalil et al., 2009).
1.1.6. Additional examples of complex combinatorial PTM signalling
In addition to the fascinatingly complex regulatory system centred on eukaryotic 
chromatin, post-translational signals also mutually influence each other extensively 
on other proteins (Minguez et al., 2012). This can include cases where PTMs 
compete for the same sites, as well as more indirect associations. A recent study in 
the genome-reduced obligate parasitic bacterium Mycoplasma pneumoniae found 
extensive changes in lysine acetylation when phosphorylation was perturbed, and 
vice versa, thereby identifying cross-talk between the two PTMs in a prokaryote (van 
Noort et al., 2012). Functional interplay of lysine methylation and acetylation, where 
acetylation of one lysine obstructs the methylation of two closely adjacent lysines, 
has also been reported in the regulation of mammalian NF-κB (Yang et al., 2010).
Acetylation significantly overlaps with ubiquitination sites, with competition 
occurring at around 30% of lysine acetylation sites and around 9% of ubiquitination 
sites (Wagner et al., 2011). This represents a possible mechanism for the regulation 
of half-life by preventing addition of a K48-linked polyubiquitin chain (Grönroos et 
al., 2002; Jin et al., 2004; Caron et al., 2005; Danielsen et al., 2010; Wagner et al., 
2011). As an example of interplay between lysine methylation and phosphorylation, 
methylation of lysine residues on the retinoblastoma protein pRb prevents 
phosphorylation of adjacent residues and thereby blocks cell cycle progression (Carr 
et al., 2010). In G9a, a histone methyltransferase, methylation of one lysine residue 
creates a binding site for HP1 and inhibits phosphorylation (Sampath et al., 2007). 
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Lysine acetylation also regulates gluconeogenesis by promoting PEPCK1 
degradation via recruiting the UBR5 ubiquitin ligase (Jiang et al., 2011).
1.1.7. Structural contexts of PTM sites
Where do modified residues occur in proteins? Regulation by PTMs has been 
described as occurring either orthosterically or allosterically. Orthosteric eﬀects of 
PTMs are achieved directly at the site modification, e.g. through direct recognition 
by a reader domain or through disruption of a binding interface, while allosteric 
eﬀects are achieved through conformational changes of the protein (Nussinov et al., 
2012). PTM types may diﬀer in their eﬀects, acting either mostly electrostatically or 
sterically (Nussinov et al., 2012).
An important factor for the specificity of kinases and phosphatases is the sequence 
context they recognise (Ubersax and Ferrell, 2007). Investigations of the context of 
phosphorylated sites revealed that they most frequently occur in intrinsically 
disordered regions, which are at least partially unfolded parts of proteins 
(Iakoucheva et al., 2004).
1.2. Intrinsic disorder in proteins
Protein folding has been described as a multi-dimensional energy landscape, with 
minima signifying folded states (Hartl and Hayer-Hartl, 2009). However, many 
proteins may never reach a fully folded state, and may instead carry out their 
functions in an at least partially disordered native state (Dunker et al., 2008; Gsponer 
and Babu, 2009; Babu et al., 2012; Lobanov and Galzitskaya, 2012). These 
intrinsically disordered proteins (IDPs) are especially common in eukaryotes 
(Gsponer and Babu, 2009). They tend to display relatively short half-lives and their 
expression is tightly regulated, both of which are advantageous characteristics for 
their frequent involvement in signalling roles (Gsponer et al., 2008). One canonical 
type of intrinsically disordered region are disordered linkers, which can connect fully 
folded domains while allowing conformational flexibility of the protein. This type of 
arrangement is found in many multi-domain transcription factors, which need to 
maintain specific DNA contact while recruiting additional proteins, and particularly in 
the stem cell transcription factors investigated in Chapter 4 (Frankel and Kim, 1991; 
Xue et al., 2012). Intrinsic disorder is also frequently found at protein interaction 
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interfaces, where the disordered regions may undergo a disorder-to-order transition 
upon binding (Fong et al., 2009).
Based on their conservation, intrinsically disordered regions can be classified into 
three groups: i)  fast-evolving disordered regions whose presence is conserved (e.g. 
linker regions), ii) sequence-conserved disorder (e.g. interaction motifs that fold 
upon binding), and iii)  non-conserved disorder of unclear importance (Bellay et al., 
2011). Intrinsic disorder facilitates evolutionary processes such as alternative 
splicing, domain shuﬄing and protein modularity (Mittag et al., 2010; Buljan et al., 
2012). In these processes, intrinsic disorder may permit increased functional and 
regulatory diversity while avoiding the constraints posed by the folding of structured 
domains (Romero et al., 2006). The tissue-specific splicing of disordered protein-
protein interaction motifs is one common mechanism which benefits from this 
flexibility (Buljan et al., 2012; Ellis et al., 2012). Protein-protein interactions via 
disordered interfaces can also evolve more rapidly than structured interactions 
(Mosca et al., 2012).
It has been suggested that disordered regions can constitute functional and 
evolutionary units of similar importance to folded domains without being structured 
(Tompa et al., 2009; Babu et al., 2012). For instance, these regions may contain 
important interaction motifs, including linear motifs (LMs), short linear motifs (SLiMs) 
and molecular recognition features (MoRFs)  (Fuxreiter et al., 2007; Stein and Aloy, 
2008; Edwards et al., 2011). Importantly, SLiMs frequently contain PTM sites (Davey 
et al., 2011). In fact, most phosphorylation sites occur in intrinsically disordered 
regions of proteins, and phosphorylation is enriched outside of classical functional 
domains (Iakoucheva et al., 2004; Gnad et al., 2009; Holt et al., 2009; Landry et al., 
2009; Ba and Moses, 2010). Highlighting the functional importance of disordered 
regions, it has been suggested that the pathogenicity of disease-associated 
mutations in disordered regions may sometimes be caused by transition to structure 
(Vacic and Iakoucheva, 2012).
1.2.1. Biological functions of intrinsically disordered regions
Approximately one third of eukaryotic proteins contain extended intrinsically 
disordered regions (Ward et al., 2004), and intrinsically disordered regions are a 
feature of many eukaryotic proteins involved in protein-protein interactions and 
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regulatory and signalling processes (Xie et al., 2007b; Dunker et al., 2008; Stein and 
Aloy, 2008; Gsponer and Babu, 2009). Due to their increased conformational 
flexibility compared to structured proteins, disordered proteins are able to interact 
with a broader range of partners. They frequently constitute hubs in interaction 
networks, and may more easily be reused in multiple biological processes (Gsponer 
and Babu, 2009). These processes include cell diﬀerentiation, transcriptional 
regulation, the cell cycle, mitosis, apoptosis, mRNA processing, splicing and protein 
transport. Many developmental regulators, ribonucleoproteins, ribosomal proteins, 
hormones, growth factors, cytokines and neuropeptides are intrinsically disordered 
(Xie et al., 2007b). Disordered regions have been reported to be important in 
displaying post-translationally modified sites, such as phosphorylation sites 
(Gsponer and Babu, 2009; Mittag et al., 2010; Brown et al., 2011). PTM-site 
containing regions such as these can be acquired as regulatory modules in evolution 
(Fantini et al., 2010).
Small interaction domains such as zinc fingers frequently occur within extensively 
disordered regions (Vucetic et al., 2007). The functional importance of disordered 
regions in protein-protein interactions is further illustrated by hypoxia-inducible 
factor 1 alpha (HIF-1α), which binds p53 through a disordered interaction domain 
when inducing hypoxic p53-mediated apoptosis (Sánchez-Puig et al., 2005). In 
addition, p53 itself has disordered N- and C-termini which serve as regulatory 
domains and interaction interfaces (Römer et al., 2006; Joerger and Fersht, 2007; 
Wells et al., 2008; van Dieck et al., 2009). Phosphorylation-induced interaction of 
14-3-3 reader proteins with its C-terminus activates p53’s DNA binding activity 
(Rajagopalan et al., 2008). Lysine acetylation and phosphorylation of the C-terminal 
domain are further thought to modulate p53’s DNA aﬃnity by reduction of its overall 
positive charge, resulting in more specific DNA interactions (Melero et al., 2011). 
Disordered regions containing positive charges appear to be of general importance 
in protein-DNA interactions, where they increase search eﬃciency by maintaining 
nonspecific interactions with the phosphate backbone of DNA while allowing various 
search mechanisms such as sliding, hopping, fly-casting and brachiation (Vuzman 
and Levy, 2010; Vuzman et al., 2012).
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1.2.2. Intrinsic disorder and PTMs
Intrinsic disorder of proteins is a measure of flexibility, and has been used as a 
predictive feature in the prediction of modification sites, principally based on the 
assumption that flexible regions of proteins may be more accessible to a modifying 
enzyme (Iakoucheva et al., 2004; Daily et al., 2005; Tompa, 2005; Xie et al., 2007a; 
Dunker et al., 2008). As mentioned above, phosphorylation is statistically enriched in 
disordered regions (Iakoucheva et al., 2004; Gnad et al., 2009; Holt et al., 2009; 
Landry et al., 2009; Ba and Moses, 2010), as are most other PTMs (Xie et al., 
2007a). Disordered short linear motifs also frequently contain PTM sites (Davey et 
al., 2011). It has further been suggested that the nonspecific DNA interactions of 
disordered regions in transcription factors described above can be modulated by 
modifications such as phosphorylation and acetylation (Vuzman et al., 2012).
However, intrinsic disorder at the substrate residue does not appear to be a 
necessary requirement for PTMs to occur, although it has been described as quite 
important (Iakoucheva et al., 2004; Daily et al., 2005; Tompa, 2005; Xie et al., 2007a; 
Dunker et al., 2008). Conceptually, adaptor proteins such as E3 ubiquitin ligases 
could mediate contact between a charged E2 ligase and its substrate site without 
particular site specificity on the part of the E2 ligase. Moreover, N-glycosylation and 
lysine acetylation have been reported to show enrichment in structured regions 
(Choudhary et al., 2009; Zielinska et al., 2010), as have formylation, protein splicing, 
oxidation, and covalent attachment of quinones and organic radicals (Xie et al., 
2007a). It has further been reported that certain PTMs, including lysine methylation, 
are not primarily found on the surface of proteins, but can fall within its core (Pang et 
al., 2007). This is in accord with reports that modification events can result in large 
structural changes, including domain unfolding and allosteric transitions (Díaz-
Moreno et al., 2009; Nussinov et al., 2012; Shental-Bechor et al., 2012; Yuchi et al., 
2012). Similarly, it has been shown that mutation of a single amino acid on the 
periphery of a designed protein’s core can lead to fold switching (He et al., 2012b).
1.2.3. Evolution of disordered regions
Intrinsically disordered regions tend to display faster evolutionary divergence than 
the rest of the protein, most likely since they are under less structural constraint from 
intramolecular contacts (Brown et al., 2002; 2010; 2011). In addition, solvent-
21
exposed protein regions can accept higher rates of mutation than buried regions, 
and disordered regions tend to be more hydrophilic (Sasidharan and Chothia, 2007; 
Awile et al., 2010). It has been suggested that at least some disordered regions are 
mostly conserved for their overall charge and structural flexibility (Tompa and 
Fuxreiter, 2008; Mittag et al., 2010). Providing a connection between intrinsic 
disorder, PTM sites and evolution, it has been suggested that mutations at PTM 
sites may be significant drivers of phenotypic evolution between species (Moses 
and Landry, 2010).
1.2.4. Protein-protein interaction networks
As mentioned above, post-translational modifications can aﬀect the physical 
interactions a protein is able to make in the cell, either allosterically or by occurring 
directly within an interaction interface (Nishi et al., 2011). Interfaces which enable the 
interaction between proteins are generally hydrophobic with complementarity 
mediating specificity (Chothia and Janin, 1975; Jones and Thornton, 1996), and as 
mentioned above, certain PTMs such as phosphorylation and acetylation alter the 
charge of residues, thereby enabling the regulation of protein-protein interactions 
(PPIs) and potentially fine-tuning their specificity. Protein-protein interaction 
interfaces are especially interesting since they can be included or excluded by 
alternative splicing and alternative promoters (Weatheritt et al., 2012). Alternative 
exons are sometimes expressed in a tissue-specific manner, and have been found 
enriched in modifiable residues as well as interaction motifs (Buljan et al., 2012; 
Weatheritt et al., 2012).
Both of these mechanisms, post-translational modification and the generation of 
alternative mRNAs, can therefore contribute to the rewiring of protein-protein 
interactions. These interactions are frequently represented as large networks 
covering much of an organism’s proteome, with nodes representing proteins and 
edges their physical interactions (Levy and Pereira-Leal, 2008; Mosca et al., 2012). A 
more indirect approach is the use of genetic interaction data, which have also been 
used to arrive at similar networks and appear to be predictive of physical 
interactions (Roguev et al., 2013).
It is important to note the diﬀerence between obligate and transient protein-protein 
interactions. Strong interactions are crucial for the functioning of many obligatory 
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complexes in the cell, especially in housekeeping processes such as transcription 
and replication, while weaker transient interactions are less well conserved between 
species (Jones and Thornton, 1996; Mosca et al., 2012). Intrinsically disordered 
regions are a common characteristic of proteins involved in a large number of 
interactions, often termed “hub” proteins, and the disordered regions are thought to 
play a key role in the proteins’ ability to interact with a large variety of binding 
partners (Mosca et al., 2012). One example of these is the tumour suppressor 
protein p53, whose disordered N- and C-termini allow it to participate in a large 
number of protein-protein interactions in humans, as described above (Römer et al., 
2006; Joerger and Fersht, 2007; Wells et al., 2008; van Dieck et al., 2009). 
Similar to many biological and other networks, the number of interactions per 
protein tends to approximate a power law distribution, resulting in a small number of 
highly connected “hub” proteins, and a larger number of proteins with relatively few 
interactions (Barabási and Oltvai, 2004; Giot et al., 2003; Li et al., 2006). This type of 
architecture oﬀers resilience to random mutation since the chance of randomly 
aﬀecting a highly connected protein is relatively low (Albert et al., 2000; Li et al., 
2006). This is especially true if functional redundancy is also present, as has been 
described for p38 MAP kinases  in Drosophila (Belozerov et al., 2012).
The methods used to generate large-scale data on PPIs include aﬃnity purification 
coupled with mass spectrometry (Vermeulen et al., 2008), as employed by my 
collaborators to identify interactors of Oct4 in Chapter 4, and methods with a 
phenotypic readout such as yeast two-hybrid screens (Cusick et al., 2005), or the 
use of RNA interference against multiple targets to identify genetic interactions 
(Roguev et al., 2013). Although the question of interaction strength and functionality 
is diﬃcult to address with these high-throughput methods, projecting additional 
layers of information about e.g. gene expression, subcellular localisation, protein 
structure, sequence features and evolution onto protein-protein interaction networks 
has been found to be extremely helpful in their biological interpretation (Aloy and 
Russell, 2006; Dittrich et al., 2008; Fraser et al., 2013; Levy and Pereira-Leal, 2008; 
Szklarczyk et al., 2011). An approach of this kind was applied to the human lysine 
acetylation system in Chapter 3.
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1.3. Motivation and overview of this dissertation
As illustrated above, post-translational modifications are crucial components of 
eukaryotic signalling systems, mediating processes in development, homeostasis 
and disease. Our functional understanding of these modifications is still limited. By 
applying evolutionary approaches and a data integration framework, we aim to 
understand the evolutionary histories as well as the overall topologies of these 
signalling networks, and to highlight their most essential and potentially 
unappreciated components as candidates for future study.
The dissertation is structured into three primary chapters, preceded by the 
introduction and followed by a summary section for conclusions and implications.
Chapter 1: Introduction
This chapter presents a literature overview of the diversity of post-translational 
modifications, the experimental approaches used to identify them, their known 
biological functions and describes how they may combinatorially influence protein 
function. Since many modifications occur in fast-evolving disordered regions of 
proteins, intrinsic disorder was introduced as a structural feature of proteins. Histone 
modifications were discussed as an example of a highly complex cellular regulatory 
system mediated by PTMs.
Chapter 2: Evolution of post-translationally modified residues
This chapter was prompted by the open question of how many PTM sites are 
biologically functional. We investigated this question by quantifying selection 
pressure on post-translationally modified residues at the species, population and 
somatic levels, and by analysing conservation and substitution patterns at these 
sites. The chapter also addresses the increased occurrence of mutations which may 
either resemble the modified or unmodified state at PTM sites.
Chapter 3: The human lysine acetylation system
Due to the central importance of post-translational signalling systems in cellular 
homeostasis, we here present a generalised framework for the study of PTM 
signalling systems through data integration. This method was applied here to 
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present a concise overview of the human lysine acetylation signalling system, using 
multiple types of data. Proteins with functions in lysine acetylation were identified, 
and were then analysed based on their conservation, expression profile, protein-
protein interactions and subcellular localisation. By integrating these types of 
information, the most promising candidate proteins participating in lysine acetylation 
signalling were systematically highlighted and ranked by priority for targeted 
functional study.
Chapter 4: The interaction network of Oct4
This chapter aims to understand the downstream regulatory eﬀects of Oct4 activity, 
and it is the result of a collaboration with Dr. Jyoti Choudhary’s group at the 
Wellcome Trust Sanger Institute. Oct4 is an essential transcription factor which is 
central to stem cell identity. My collaborators identified physical interactors of Oct4, 
and this group of proteins represented an important system for analysis using similar 
methods as in Chapter 3. This chapter presents an in-depth analysis of the Oct4 
protein-protein interaction network based on conservation, transcriptional 
regulation, expression data and phenotypic data, including implication in human 
disease.
Chapter 5: Conclusions and implications
In this concluding chapter, I highlight key findings and describe their potential 
implications, including the role of disruptions of post-translational signalling in 
human disease, and implications for the engineering of signalling systems in 
synthetic biology.
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2. Evolution of post-translationally modified residues
2.1. Introduction
The post-translational modification of proteins is a fundamental means of biological 
information processing that is important in development, homeostasis and disease. 
A classical example is phosphorylation, where the interplay of kinases and 
phosphatases generates complex signalling cascades.  A number of dynamic, 
reversible types of modifications have been studied on a genomic scale in an eﬀort 
to understand the regulatory code of eukaryotic chromatin. Notably, large-scale 
mass spectrometry studies have recently identified thousands of residues which 
undergo modifications such as lysine acetylation. Our functional understanding of 
these modifications is still limited. By combining several complementary 
evolutionary approaches, we here aim to investigate the evolutionary histories as 
well as the overall functional significance of these signalling networks.
This chapter also seeks to address a fundamental problem posed by the high 
sensitivity and stochastic nature of mass spectrometry (Olsen et al., 2010): do the 
thousands of post-translationally modified residues which have been identified thus 
far truly represent biologically significant regulatory events in the cell? A useful 
indirect means of addressing this question is to determine whether the modified 
residues are conserved in evolution (Kumar et al., 2009), which is done here at three 
levels: between species, within populations, and by studying the eﬀects of somatic 
mutations at PTM sites in individuals. I will then describe intriguing evolutionary 
patterns that were found in the course of these analyses. Figure 2.1 shows an 
overview of the methods used in this chapter.
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Figure 2.1: A schematic representation of the workflow undertaken here to quantify selection 
pressure at post-translationally modified residues.
2.1.1. Initial motivation
Protein phosphorylation is one of the most common types of post-translational 
modification (PTM) studied to date. Theoretical considerations suggest that 
modification sites involved in the direct regulation of protein activity might be more 
likely to occur within conserved regions of a protein family (Nühse et al., 2004). On 
the other hand, modification of unique sites could allow distinct regulation of certain 
paralogs, isoforms and proteins in a species-specific manner. In the case of 
paralogs, these sites may still be conserved among true orthologs in related species 
(Nühse et al., 2004). In a relatively small-scale study in Arabidopsis thaliana, 
observations indicated that serine and threonine phosphorylation sites do appear to 
be evolutionarily conserved in other plant species (Nühse et al., 2004).
Surprisingly, an initial report on a large-scale phosphorylation dataset stated that 
phosphorylation sites displayed lower average conservation than the rest of the 
protein (Gnad et al., 2007). In principle, it can be considered that the cell could easily 
aﬀord extensive non-functional phosphorylation sites, since even the 
phosphorylation of a large proportion of proteins would only use up a small fraction 
of cellular ATP (Lienhard, 2008). It has been suggested that the low conservation of 
phosphorylation might be due to its eﬀect being frequently exerted through “bulk 
charge”, i.e. the addition of multiple phosphate groups within a certain region of a 
protein (Serber and Ferrell, 2007). These would exert their signalling eﬀects through 
relatively unspecific enhancement or disruption of protein interactions (Holt et al., 
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2009). This has been termed the “polyelectrostatic model” of phosphorylation (Borg 
et al., 2007). In support of this, it has been reported that the overall number of 
phosphorylation sites for a protein is more conserved than their precise positions 
(Beltrao et al., 2009; Tan et al., 2009a; Brown et al., 2011). Sites may shift position in 
rapidly evolving disordered regions (Holt et al., 2009). The conservation of the 
phosphorylated state could then be due to shared subcellular localisation or 
conserved protein-protein interactions that frequently allow these phosphorylation 
substrates to come into contact with kinases (Beltrao et al., 2009).
A case has also been made for widespread non-functional, “noisy” phosphorylation 
(Lienhard, 2008; Landry et al., 2009; Moses and Landry, 2010; Levy et al., 2012), due 
to the low substrate specificity of at least some kinases (Joughin et al., 2012). In this 
case, only 10–40% of disordered phosphorylation sites may be more conserved 
than disordered control residues (Pearlman et al., 2011), while others have 
contradicted this for both structured and disordered phosphorylation sites (Chen et 
al., 2010). More recently, it has been reported in a Saccharomyces  study that up to 
90% of phosphosites may be conserved, though this study was limited to a few 
hundred high-confidence phosphorylation sites (Ba and Moses, 2010). Another 
study covering a set of vertebrate species estimated that around 70% of 
phosphorylation and N-glycosylation sites display better conservation than controls 
(Gray and Kumar, 2011). A second study of N-glycosylation also found significant 
conservation at solvent-accessible sites (Park and Zhang, 2011). An additional 
larger-scale study found evidence of conservation of serine, threonine and tyrosine 
phosphorylation sites located in loop regions, according to secondary structure 
prediction (Gnad et al., 2010a). Contrary to expectation, one study covering four 
vertebrates found that phosphorylation sites in proteins of vertebrate-specific 
functional modules, such as signalling processes, were more conserved than those 
in basic functional modules, such as metabolic and genetic processes (Wang et al., 
2011b). A study of lysine acetylation found significant conservation from Drosophila 
to humans (Weinert et al., 2011), while studies of ubiquitination reported weak 
evolutionary conservation of sites (Danielsen et al., 2010; Hagai et al., 2012), and in 
the most recent study to date, it was estimated that only around 16–26% of PTM 
sites are more conserved than control residues, and that only these are likely to have 
significant biological functions (Minguez et al., 2012).
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Clearly, the conservation and by proxy the biological functionality of PTM sites is still 
a matter of intense debate, especially due to the diﬀerences in scope in the above 
studies and due to variations in methodology. The study presented here attempts to 
resolve this by integrating comprehensive experimental information on the PTM 
types studied to date with evolutionary data on a large, representative cross-section 
of species, and by employing multiple up-to-date, independently evaluated methods 
at each step of the analysis.
2.1.2. Methodological considerations
There are several methodological aspects which we had to consider and correct for. 
Intrinsic disorder
First, the study of residue conservation is confounded by the tendency of some 
modification types to occur predominantly in fast-evolving intrinsically disordered 
regions. We addressed these diﬀerences in structural preferences between specific 
post-translational modifications by performing separate analyses for structured and 
disordered residues.
Internal residues
Second, internal residues in the core of a protein evolve more slowly than surface 
residues, since they are likely to be under much larger structural and therefore 
evolutionary constraints (Chothia and Gough, 2009; Sasidharan and Chothia, 2007). 
To generate a control group more closely resembling to modifiable residues, which 
must be accessible to a modifying enzyme in at least one conformation of the 
protein, residues predicted to be in the interior of a protein were removed from the 
structured control. We based this on structural information from the Protein Data 
Bank (PDB) in those cases where sequence similarity existed to an entry, resulting in 
the removal of under ten percent of the structured control residues (Velankar et al., 
2012).
We also subdivided certain analyses further for core and surface residues, resulting 
in a total of four distinct structural categories (with predicted disorder being very rare 
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in the interior). However, since PDB information was only available in around a fifth 
of cases, we did not make general use of the core/surface distinction in this study.
Functional divergence of paralogs
Additionally, it has been reported in recent studies on Saccharomyces cerevisiae that 
the presence of post-translational modification sites increases the likelihood of 
retention of both copies of duplicated genes, although the modification sites appear 
to diverge quickly (Amoutzias et al., 2010; Freschi et al., 2011). This supports a 
hypothesis of rapid neo- and subfunctionalisation of paralogs, and highlights the 
importance of post-translational modifications in these processes.
Ortholog identification
Another aspect was the confident identification of orthologs. A variety of advanced 
homology detection methods exist, and a number of databases have been created 
to disseminate their results (Altenhoﬀ and Dessimoz, 2009). Ensembl Compara 
performed very well in an independent evaluation of several homology detection 
pipelines (Linard et al., 2011). Previous studies of PTM site conservation have only 
rarely made full use of advanced, duplication-aware pipelines such as Ensembl 
Compara (Landry et al., 2009; Gnad et al., 2010a; Gray and Kumar, 2011; Weinert et 
al., 2011). Of these, only the study by Gnad et al. used coding sequence data, which 
can be useful for judging evolutionary distance over shorter time scales. Only two 
studies used evolutionary rates to quantify conservation (Landry et al., 2009; Gray 
and Kumar, 2011), though the study by Gray et al. did not correct for potential 
diﬀerences in intrinsic disorder occurrence at PTM sites relative to non-modified 
control sites. Landry et al. used a relatively small set of nine vertebrate species, in 
addition to an analysis in fungi (Landry et al., 2009).
Coding sequences in phylogeny
In this study, the phylogeny-based methods (rvET and Rate4site), and especially the 
hybrid method rvET, appeared more sensitive in that they detected a larger number 
of significantly conserved PTM categories, and less cases of significantly faster 
evolution at PTM sites compared to controls. The diﬀerence in performance of the 
phylogeny-based methods might be explained by their indirect access to cDNA 
30
sequence information through Ensembl Compara, which builds its phylogenetic 
trees using cDNA information, and also reconciles them with an established species 
tree (Flicek et al., 2012). This information may be especially valuable since the 
species studied are mostly mammals and vertebrates (Baldauf, 2003). Their 
evolutionary distances are relatively small, and classical taxonomic methods 
including the fossil record can contribute to the construction of their species tree.
Mutations which mimic PTMs
Mutations of phosphorylation sites to negatively charged amino acids can 
sometimes successfully mimic the eﬀects of phosphorylation, and eﬀectively make 
the phosphorylated state permanent (Thorsness and Koshland, 1987; Tarrant and 
Cole, 2009). Vice versa, phosphorylation sites may originate in place of negatively 
charged amino acids (Kurmangaliyev et al., 2011; Pearlman et al., 2011). These 
cases illustrate that simply distinguishing between the presence and absence of the 
modifiable amino acid (e.g. serine at a phosphorylation site), as adopted in many 
previous studies, is likely to be an imperfect method for judging the functional 
significance of the phosphorylation site in question, since the mutations do not 
diminish it. This illustrates that sequence entropy- and phylogeny-based 
conservation scoring methods should be considerably more sensitive in detecting 
selection pressure at PTM sites.
Heterotachy
In a phenomenon sometimes referred to as heterotachy, evolutionary rates and 
selection pressure do not necessarily remain constant over time within a lineage 
(Lopez et al., 2002; Philippe et al., 2003; Kosiol et al., 2008; Roure and Philippe, 
2011). This has led to some skepticism about the accuracy of the “molecular clock”, 
i.e. the estimation of divergence times from sequence data (Ayala, 1999), although 
other studies have reported this method to be accurate (Subramanian and Lambert, 
2011). Another complicating factor may be that mutations in one residue might lead 
to relaxation of evolutionary pressure at other positions through change in structural 
constraints (Bridgham et al., 2009).
Heterotachy should not aﬀect the observations made in this study, since PTM sites 
and control residues were obtained from the same set of proteins. Heterotachy may 
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imply that the hybrid rvET method could be more robust than the phylogeny-based 
Rate4site method, which also considers branch lengths. Population bottlenecks and 
adaptive radiation events may violate this assumption.
Two related factors may result in the loss of branch length additivity, and therefore 
complicate the reconstruction of sequence evolution: i) extremely high evolutionary 
rates, and ii)  horizontal transfer events (Tria et al., 2010). Neither are likely to be 
significant in the species used here, which are relatively closely staggered in 
evolutionary time.
Sequence windows
The authors of the Jensen-Shannon Divergence conservation scoring method (JSD) 
reported that considering a sequence window, rather than a single residue, may give 
improved results on various benchmark datasets, including the Catalytic Site Atlas 
(Porter et al., 2004), ligand binding sites and protein-protein interaction interfaces 
(Capra and Singh, 2007). The authors of the real-valued Evolutionary Trace (rvET) 
method also recently reported that taking into account the scores of neighbouring 
residues, either adjacent structurally or in the primary sequence (±1 aa), results in an 
improvement in functional site discovery (Wilkins et al., 2010). Additionally, most 
serine/threonine kinases appear to target motifs of ±4 residues in size (Ubersax and 
Ferrell, 2007). A recent study of interactions by linear motifs found that three-
dimensional context contributes ~20% to the binding energy, and is important for 
binding specificity (Stein and Aloy, 2008). In addition, it has been noted that 
recognition modules for short linear motifs may display multiple binding specificities, 
which further increases the number of their potential binding partners (Gfeller et al., 
2011). This further suggests that neighbouring protein features may play a part in 
mediating interaction specificity. However, primary sequence adjacency as 
implemented by a sequence window can only capture part of these contributions, 
and three-dimensional structure data is unavailable especially for the disordered 
PTM sites used here. In this study, we found that the use of a sequence window did 
not strengthen the PTM site conservation signals.
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Amino acid similarity
With regard to amino acid similarity matrices, the authors of the JSD implementation 
found that incorporating similarities is not always helpful when assessing residue 
conservation (Capra and Singh, 2007). They caution that the datasets of known 
functional sites used in evaluations may generally be biased towards absolutely 
conserved residues, where similarity relationships between amino acids may not be 
essential for good performance. With the potential exception of multi-specificity 
serine/threonine kinases, PTM sites would similarly require a single specific residue 
to be conserved, rendering amino acid similarities unhelpful. This illustrates that 
conservation scoring methods should be carefully chosen, and that the most 
elaborate models may not always be the most useful for a given application.
2.2. Methods
Given the diversity of the types of post-translational modification and their potential 
disorder/structure preferences, the primary challenge in this study was to quantify 
PTM site conservation (Fig. 2.1). To achieve this, we needed to source 
experimentally-determined PTM sites, predict their structural properties, obtain 
clusters of homologous proteins, remove paralogs due to their rapid divergence, 
align the orthologous sequences, reconstruct their phylogeny, and then quantify 
conservation using several up-to-date evolutionary scoring methods. The details of 
these steps are described below.
2.2.1. Obtaining PTM sites
Amino acid sequences as well as experimentally determined post-translational 
modification sites were extracted from the curated Swiss-Prot subsection of the 
UniProt database (release 2012_01)  (UniProt Consortium, 2012). We also included 
PTM sites from PhosphoSitePlus version 110311 (Hornbeck et al., 2012), PHOSIDA 
(obtained 2012-02-03) (Gnad et al., 2010b) and Phospho.ELM version 2011-11 
(Dinkel et al., 2011). These databases also include many PTMs other than 
phosphorylation. Additional experimental lysine acetylation and N-glycosylation sites 
were obtained from individual large-scale studies (Gnad et al., 2007; Pang et al., 
2010; Wang et al., 2010; Zhao et al., 2010). The final compendium, incorporating all 
PTM site resources that previous major studies have used, consisted of 172,931 
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sites, of which 89,236 were on human proteins. This dataset comprises the following 
major PTMs: lysine acetylation (abbreviated “K-ac”), lysine ubiquitination (“K-ub”), 
N-glycosylation (“N-gly”), and serine (“S-p”), threonine (“T-p”)  and tyrosine 
phosphorylation (“Y-p”). Their structures are shown in Figure 1.1.
2.2.2. Predicting structural properties
Distinction between intrinsically disordered and structured residues
In order to address the diﬀerent evolutionary rates of intrinsically disordered and 
structured regions, disordered protein segments were predicted using six methods: 
DISOPRED2 (Ward et al., 2004), IUPred in “long” and “short” operating modes 
(Dosztányi et al., 2005), MULTICOM-REFINE, MULTICOM-REFINE with sspro4.1 
(Deng et al., 2009), and PrDOS2 (Ishida and Kinoshita, 2007). Although some 
methods provide various scores in addition to a binary disorder/structure call, only 
the binary calls per amino acid were retained. A consensus of all six methods was 
used for verification, and the experimental DISPROT database (release 5.8) 
(Sickmeier et al., 2007) served as a gold standard control.
PrDOS2 and MULTICOM-REFINE placed first and third respectively in the CASP9 
disorder prediction assessment, according to the area under their receiver operating 
characteristic (ROC) curves (Monastyrskyy et al., 2011). This measure strikes a 
compromise between the sensitivity and specificity of disorder prediction, i.e. the 
rates of false negatives and false positives. This metric is the most useful for the 
present study since both under- and overestimation of intrinsic disorder would be 
equally detrimental. The second best method, DISOPRED3C, was not yet available 
for use. The CASP9 assessment also used a highly varied set of prediction targets 
from diverse species, which should ensure the robust prediction of intrinsic disorder.
It is notable that PrDOS2 and MULTICOM-REFINE disagree quite substantially in 
their predictions (on 14% of the residues in the UniProtKB/Swiss-Prot proteome 
studied here). While MULTICOM-REFINE is a purely ab initio prediction method, 
PrDOS2 is a hybrid method which includes ab initio prediction as well as a template-
based PSI-BLAST approach (Deng et al., 2012). All methods were carried forward in 
the analysis and produced highly similar results, although MULTICOM-REFINE was 
later chosen as the primary predictor to be presented in the interest of space. The 
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proteome-wide agreement among all six disorder predictors in terming residues 
structured or disordered was 63%, and both MULTICOM-REFINE and PrDOS2 
showed agreement with DISPROT on 94% of residues. Overall, 41.7% of all 
residues were predicted to be intrinsically disordered by MULTICOM-REFINE, the 
primary predictor chosen in this chapter.
Distinction between core and surface residues
Absolute all-atom solvent-accessible surface areas (ASAs) for all 86,008 proteins 
contained in the PDBe database (the Protein Data Bank in Europe) as of 2012-11-07 
(Velankar et al., 2012) were calculated using the program “PISA”, as contained in 
version 6.3.0 of the CCP4 structural analysis software package (Krissinel and 
Henrick, 2005; 2007; Winn et al., 2011). Default parameters were used, but the 
multimer assembly analysis step was deactivated by recompiling due to failure on a 
large fraction of PDB structures. Monomeric ASA values were unaﬀected by this 
modification. Without assembly analysis, ASA values could be obtained for 76,680 
PDB structures (89.2%), the missing structures being predominantly of DNA or RNA 
or NMR-based. Relative solvent-accessible surface areas (rASAs) were then 
calculated using a reference table of all-atom ASAs for the central amino acid in Gly-
X-Gly tripeptides (Miller et al., 1987). Residues with a relative accessible surface 
area of >25% were considered to lie on the protein surface. This threshold has been 
reported to provide the best separation in terms of sequence composition between 
buried (core) and surface residues (Levy, 2010).
The per-residue core/surface calls collected from PDB were then used to determine 
likely ASA values for the human protein sequences from UniProt, which form the 
basis of this chapter. This was done via BLASTP searches with an E-value cutoﬀ 
of  1, chosen to be slightly more stringent than the default value of 10, while still 
remaining inclusive of more distant matches. This adjustment excluded only a very 
small fraction of very low-scoring BLASTP matches. Each UniProt residue’s core/
surface status was then obtained from the best-scoring PDB sequence match 
reported by BLASTP, provided that the aligned residues were identical. In an 
alternative approach, the average ASA value from identical residues across all 
BLASTP matches below the E-value cutoﬀ which still contributed more UniProt 
sequence coverage was used. Highly similar results were observed (data not 
shown). In this alternative approach, the median absolute disagreement for residues 
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where multiple overlapping and coverage-contributing BLAST matches were 
available was 5.5  Å, which was considered an indication that the structures 
generally agree well in terms of accessible surface area per residue.
Overall, despite the relatively inclusive BLASTP-based approach described above, 
using structural information from PDB to distinguish between core and surface 
residues drastically limited the number of investigable PTM sites to around 20% of 
sites (e.g. from 56,537 to 11,211 residues for the disorder predictor MULTICOM-
REFINE and the variation scoring method Rate4site). It also reduced the number of 
disordered PTM sites to be studied, with MULTICOM-REFINE predicting 41.7% of 
all residues to be intrinsically disordered, whereas the proportion of disordered 
residues with identical BLASTP matches in PDB was only 16.3%. As expected, core 
residues were largely predicted to be structured, with 90.3% of core residues falling 
into structured regions, indicating good agreement between the disorder predictors 
and the PDB-based core/surface distinction. Where PDB information was available, 
approximately half (53.9%) of all structured residues were predicted to fall into the 
protein core, with the rest lying on the surface, highlighting the general usefulness of 
the core/surface distinction in identifying residues under diﬀerent evolutionary 
constraints.
However, in order to maintain a statistically useful number of sites and to better 
address disordered residues, we made use of the PDB-based core/surface 
distinction only in some analyses (e.g. Table 2.2). The primary purpose of this 
distinction was to remove structured core residues from the control samples, since 
these residues were expected to be extremely highly conserved and would therefore 
not represent a useful, structurally equivalent type of control for PTM sites. This 
aﬀected around 8% of the structured control residues.
2.2.3. Obtaining homology clusters
Protein- and cDNA-level multiple sequence alignments and a species tree covering 
56 primarily mammalian and vertebrate species were obtained from Ensembl 
Compara (Release 65, December 2011) (Flicek et al., 2012). Using homologs from 
Ensembl oﬀers an advantage over simpler methods that have been widely used in 
previous studies of PTM site evolution. A bidirectional best hit BLAST search will 
only return a limited set of ortholog pairs (that are each other’s best hits). It might 
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therefore be too stringent and produce false negatives. A simple one-directional 
BLAST, on the other hand, makes it diﬃcult to identify a true ortholog among the 
hits, especially if many closely related paralogs score similarly or if a true ortholog is 
not present, and ultimately an arbitrary cutoﬀ would have to be chosen.
Compara addresses these problems through a more sophisticated pipeline for 
building homology clusters, involving a species-based guide tree based on well-
established taxonomies, especially for the vertebrates. The pipeline allows 
deviations from the species tree if there is very strong evidence of lateral transfer, 
but this is unexpected in the species considered here. Phylogenetic reconstruction 
becomes an important component of the analysis in evolutionary rate calculation, 
where either the dendrogram structure alone (rvET, see below) or both structure and 
branch lengths (Rate4site) are used. A simple alignment of BLAST hits, as used in 
some studies, essentially discards all knowledge on species relationships. It 
assumes that the evolutionary distances between sequences are directly 
measurable from their sequence similarity, which will not be the case if selection 
pressure has changed in diﬀerent lineages, or over long time scales. The accuracy of 
the phylogenetic tree constructed will also be lower in the absence of taxonomic 
information. Therefore, the use of Ensembl Compara as an ortholog source 
constitutes a methodological improvement.
2.2.4. Removal of paralogs
In the analysis of protein interfaces, inclusion of diverse homologs including 
paralogs has been reported to give slightly improved results (Caﬀrey et al., 2004). 
For PTM sites, however, the opposite has been observed. Duplicated genes rapidly 
lose phosphorylation sites as their sequences diverge, suggesting that substantial 
neo- and subfunctionalisation of regulation via phosphorylation is occurring 
(Amoutzias et al., 2010; Freschi et al., 2011). In order to remove all potentially 
functionally divergent proteins, we decided to exclude paralogs when calculating 
conservation scores.
One-to-one orthologs of human proteins were obtained from Ensembl Compara 
(Vilella et al., 2009; Flicek et al., 2012), and the homology clusters were filtered to 
contain only these. This approach discards inparalogs, but retains outparalogs and 
divides them into separate orthology clusters (Sonnhammer and Koonin, 2002). 
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Orthology clusters consisting of less than ten sequences were also discarded. This 
means that at a minimum, each processed orthology cluster spanned all primate 
species included in Compara, which should ensure suﬃcient evolutionary distance 
to assess evolutionary trends. 
2.2.5. Alignment of sequences
Alignment among one-to-one orthologs, without functionally divergent paralogs, 
should result in better alignment quality, and remove gaps originally introduced by 
distant homologs within a sequence family. The orthologous clusters were therefore 
aligned using MAFFT, a fast multiple sequence alignment method (Katoh and Toh, 
2008), which performs very well in independent evaluations (Ahola et al., 2006; Nuin 
et al., 2006; Golubchik et al., 2007; Liu et al., 2010a; 2010c). MAFFT is also used in 
major public homology pipelines such as Ensembl Compara (Flicek et al., 2012). Six 
variants of this method were used. MAFFT can run in either local (L-INS-i), global (G-
INS-i), or BLAST-like (E-INS-i) alignment modes. In addition, MAFFT can either 
construct a guide tree based on sequence similarity, or use the Compara species 
tree as a starting point.
L-INS-i is the default alignment mode of MAFFT, and is optimised for aligning one 
central conserved region while allowing terminal variation. This is appropriate given 
observations of preferential terminal domain acquisition over long evolutionary 
timescales (Moore et al., 2008). The Ensembl Compara pipeline first attempts the 
global-like alignment mode G-INS-i, presumably due to the relatively short distances 
between many species in Compara, and then reverts to the local L-INS-i mode if a 
consensus with other alignment programs cannot be reached (Flicek et al., 2012). 
Guide trees for MAFFT were generated from the Compara species tree, and pruned 
of any species that were no longer present in the paralog-free orthology clusters 
using Bio::Phylo (Vos et al., 2011). The alignment results from all six variations of 
MAFFT were carried forward in the analysis. Since the results produced were quite 
similar, the species tree-based L-INS-i mode was chosen for display in this chapter 
for simplicity.
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2.2.6. Phylogenetic reconstruction
Though horizontal gene transfer is not unheard of in higher eukaryotes, it is 
exceedingly rare (Dunning Hotopp, 2011), and we therefore assumed that the 
Compara species tree, as established largely through classical taxonomy, is a 
reliable blueprint for the gene trees. The known instances of lateral transfer to 
eukaryotes are thus far limited to insects and nematodes, with endosymbiotic 
bacteria or fungi as the clade of origin (Danchin et al., 2010; Moran and Jarvik, 2010; 
Acuna et al., 2012).
The phylogenetic tree and branch lengths of the alignments generated by MAFFT 
were calculated using TreeBeST (Guindon and Gascuel, 2003; Ruan et al., 2008). 
TreeBeST reconciles gene-specific phylogenetic trees with a genome-wide species 
tree, and it is a widely used method for phylogenetic inference in public homology 
detection projects (Ruan et al., 2008; Hulsen et al., 2009; Vilella et al., 2009; Flicek et 
al., 2012). PAL2NAL was used for generating codon alignments from amino acid 
alignments, which is useful for evaluating evolutionary distance over shorter time 
scales (Suyama et al., 2006). All of these steps mirror Compara’s approach. 
Alignments with branch lengths above 100 were discarded, since these only occur 
when artificially introduced by TreeBeST in order to point to violations of the 
Compara species tree, and they lead to technical problems in computing 
evolutionary rates. This aﬀects less than ten alignments. The NCBI taxonomy 
database was used to translate between taxon identifiers and species names 
(Sayers et al., 2012).
TreeBeST also incorporates both amino acid and back-translated coding sequence 
(CDS) alignments, in order to cover both long and short evolutionary distances, 
respectively. The CDS data is especially important in Compara since the 
evolutionary distances between many of the species are relatively small. At the 
codon level, synonymous mutations can accumulate without significant selection 
pressure, presenting a more finely resolved picture of evolutionary distance (Baldauf, 
2003).
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2.2.7. Assessing site conservation using variation scores
Methods for quantifying conservation can be broadly grouped into three categories: 
i)  entropy-based methods, ii) phylogeny-based methods, and iii) hybrid methods 
(Johansson and Toh, 2010). Johansson et al. performed a comparative analysis of 
25 conservation scoring methods, graded on their performance at identifying 
enzyme active site residues from the Catalytic Site Atlas (Porter et al., 2004). 
Although the various scores display diﬀerent characteristics, they largely cluster 
together according to their fundamental methodologies. With this in mind, one 
method from each category was chosen in this study, according to its performance 
in the evaluation by Johansson et al. and the availability of a software 
implementation. The three methods used are i) the Jensen-Shannon divergence 
(JSD), ii) Rate4site, and iii) real-valued Evolutionary Trace (rvET).
Symbol frequency-based approach: Jensen-Shannon divergence (JSD)
The Jensen-Shannon divergence (JSD) is a measure purely based on symbol 
frequency (Capra and Singh, 2007). It is the best-scoring method in the Johansson 
et  al. evaluation (Johansson and Toh, 2010). JSD uses the BLOSUM62 matrix to 
derive background amino acid frequencies for sites subject to no evolutionary 
pressure. Then, positions in an alignment that are found to have amino acid 
distributions very diﬀerent from this background distribution are proposed to be 
functionally important or under evolutionary constraint. It also implements a 
sequence weighting method that rewards sequences that are “surprising” (Capra 
and Singh, 2007). The authors find that JSD outperforms Rate4site, though only on 
some of the datasets tested (Capra and Singh, 2007), and another report has also 
suggested that an entropy-based approach can perform similarly well as the time-
intensive Rate4site method (Mihalek et al., 2007). Minor technical problems were 
encountered for a negligible set of nine proteins whose scores could not be 
obtained, and which were therefore removed from all analyses. By default, JSD uses 
a window of ±3 amino acids. This option was not used in the present study as it did 
not result in an increase in the observed degree of conservation when studying PTM 
sites. Alignment columns that consist of >30% gaps were discarded by JSD by 
default. The JSD score ranges between 0 and 1. For comparability with the other 
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two methods, this score was inverted by subtracting its value from 1, so that lower 
values now signify stronger conservation in accord with the other two methods.
Phylogeny-based approach: Rate4site
Rate4site is a phylogeny-based Empirical Bayesian method, which calculates 
replacement probabilities for each residue, using the JTT model of evolution 
(Mayrose et al., 2004). It is the only method incorporating branch lengths in its 
calculations. In alignments of less than 50 sequences, Rate4site appears to perform 
slightly worse than other methods on a test set for catalytic site prediction 
(Johansson and Toh, 2010). Minor technical problems were encountered for a 
negligible set of three proteins whose scores could not be obtained, and which were 
therefore removed from all analyses. Phylogenetic trees were passed to Rate4site, 
and the original tree branch lengths were retained. This ensures the information from 
the CDS alignment as used by TreeBeST is kept in the branch lengths.
Hybrid approach: Real-valued Evolutionary Trace (rvET)
Real-valued Evolutionary Trace (rvET) is a mixed score incorporating both 
phylogeny-based and sequence entropy information (Mihalek et al., 2004). It is 
defined as the sum of the information entropy within an alignment column and a 
phylogeny-based score, i.e. the number of tree nodes that need to be traversed 
from the root of the tree to reach a branch in which the alignment column is uniform. 
The rvET score ranges from a minimum of 1 to higher values, with 1 signifying 
complete conservation of a residue within an alignment. This method uses the 
simple Shannon entropy (Shannon, 1951) in combination with phylogenetic 
information. The more complex von Neumann entropy definition, which additionally 
takes amino acid similarities into account, was not found to be an improvement 
(Johansson and Toh, 2010).
Normalisation method
In addition to the raw conservation scores, we repeated our analyses using scores 
normalised per protein. This normalisation was performed by adjusting all scores in 
a protein to a mean of zero and a standard deviation of one, i.e. a residue evolving at 
the average rate of the protein received a normalised score of zero (Fig. 2.4).
41
2.2.8. Assessing evolutionary patterns at PTM sites
Comparing PTM sites to control sites
This analysis will address the central question whether post-translationally modified 
residues fall into more evolutionarily constrained regions than control residues. The 
three scoring methods described above were used to quantify conservation at PTM 
sites as compared to non-modified amino acids of the same type, within proteins 
bearing at least one PTM site of the same type, as control sites. Johansson et al. 
note that evolutionary rates should not be compared between alignments, since 
most scoring methods are dependent on the number of sequences in the alignment. 
These dependencies cannot be resolved through simple measures, such as dividing 
by alignment size (Johansson and Toh, 2010). Though all three conservation scoring 
methods selected here display this dependency, I circumvented this problem by 
selecting all control sites from the same set of proteins as the modified sites. This 
type of control also ensures that the proteins can, in principle, be modified, since at 
least one modification site of the type of interest exists on them. The correlation 
between the number of PTM sites and control sites per protein was positive 
(p <  2.2-16, r =  0.66, Pearson's product-moment correlation), and stratification by 
protein (Table 2.2) as well as normalisation of scores (Fig. 2.4)  were used to address 
potential diﬀerences in the distribution of PTM sites and control sites across 
proteins. When choosing the control sites, non-experimental PTM sites annotated as 
“probable”, “potential” or “by similarity” in UniProt were also avoided, in order to 
ensure as confidently as possible that control sites were not modified. PTM sites 
without a suitable number of control residues within the same protein, i.e. less 
control residues than PTM sites, were not considered in the analysis. This aﬀected 
less than twenty proteins.
In one previous study of serine phosphorylation conservation, the nearest 
unmodified serine was used as a control (Kurmangaliyev et al., 2011). However, this 
might result in a residue with diﬀerent structural characteristics being chosen, and it 
does not make full use of the available control sites. We decided to take the 
following approach: modified residues of a certain structural category were 
compared to all non-modified control residues of the same structural category within 
the same set of proteins. Structured residues predicted to fall into the protein core 
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(approximately 8%) were removed from the analysis. Since the control residues were 
of the same disorder/structure category, they should be under comparable structural 
constraints in evolution as the modified residues, providing an adequate background 
to detect evolutionary rate diﬀerences against.
The resulting distributions of variation scores are shown as density estimates, using 
a Gaussian kernel function, and the R package ggplot2 (Wickham, 2010). Two-tailed 
Mann-Whitney U tests as well as permutation tests were used to determine whether 
the estimated distribution function of the PTM site variation scores diﬀers 
significantly from that of the control sites. For stratified tests, this was done using 
implementations from the conditional inference R package “coin” (Hothorn et al., 
2008). In order to determine the directionality of the diﬀerences (i.e. increased or 
decreased conservation at PTM sites), the medians of the samples were compared, 
as appropriate for the Mann-Whitney U test.
To judge the extent of conservation of PTM sites with reference to known functional 
residues, a list of residues participating in confirmed protein-protein interaction 
interfaces was obtained from a recent study by Levy et al. (Levy et al., 2012), and 
known catalytic residues were obtained from the Catalytic Site Atlas (Porter et al., 
2004). To ensure comparability of these variation scores, only residues from the set 
of proteins which also contained PTM sites were included.
The nature of PTM site substitutions in evolutionary history
It has been noted that phosphorylated residues may act as a reversible mimic of 
functionally important acidic residues (Nühse et al., 2004). In order to determine 
whether such mimicry may exist for PTM types other than phosphorylation, the 
frequencies of substitution by various amino acids at PTM sites were compared to 
those at control sites using Two Sample Logo (Vacic et al., 2006). The default option 
for Student’s t-test was used instead of a binomial test due to performance reasons. 
A significance threshold of α = 0.001 was used to correct for multiple testing.
We considered better-conserved residues to be more likely to retain similar 
functions, and therefore hypothesised that amino acid substitutions at better-
conserved sites should be more functionally meaningful than at fast-evolving sites. 
Therefore, the PTM sites were split into tertiles for each PTM type and disorder 
category, and the best-conserved third was investigated in detail. Using the top third 
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strikes a balance between good conservation and a suﬃciently large sample size for 
statistical analysis. The boundaries of the PTM site tertiles were then used to select 
control sites within the same score range, i.e. residues under similar evolutionary 
pressure. The resulting control site samples displayed highly similar averages and 
standard deviations to the PTM site samples.
Tracing PTM sites across multiple species
Since modifications such as lysine acetylation exist even in bacteria (Wang et al., 
2010), and since the evolutionary origins of PTM sites have not yet been explored in 
detail, I generated plots of the conservation profiles of all human PTM sites in my 
dataset. This analysis is represented as a heatmap figure, produced using NeatMap 
(Rajaram and Oono, 2010), which shows the breakdown of the conservation 
patterns for these PTM sites (i.e. primate-specific, mammalian, jawed vertebrates, or 
even in fungi). More sporadic conservation patterns may be evidence for imprecise 
polyelectrostatic conservation of certain PTMs, or for only recent evolution of the 
site. Unmodified control residues are shown for comparison, excluding structured 
core residues.
2.2.9. Investigating the population and individual levels
Variation at post-translationally modified sites was assessed using data on non-
synonymous single-nucleotide polymorphisms (nsSNPs) in populations, and on 
somatic mutations in individuals. Only missense variants, resulting in a single amino 
acid change, were used. Neutral nsSNPs from whole-genome shotgun sequencing 
(“LOWCOV”) were obtained from the coding annotation (released July 2, 2012)  of 
the integrated phase 1 release (version 3) of the 1000 Genomes Project (Consortium 
et al., 2010). SNPs exclusively identified by exome sequencing (“EXOME”) were 
discarded from the main analysis due to their very low allele frequencies. While the 
whole-genome sequencing SNPs occurred at an average allele frequency (corrected 
for linkage disequilibrium) of ~4%, the exome-sequencing SNPs occurred at a 20-
fold lower average allele frequency of ~0.2%. This suggests that these are rare 
alleles which have not spread in the population, and in some cases they might 
possibly derive from sequencing errors.
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Confirmed disease-causing mutations (“DM”) were obtained from the 2012.2 release 
of the Human Gene Mutation Database (HGMD) (Stenson et al., 2009). Human 
somatic mutations in individuals that are causative of cancer were obtained from 
release 57 of the Catalogue Of Somatic Mutations In Cancer (COSMIC) (Dinkel et al., 
2011). To verify if the observations in humans hold true in other organisms, an 
additional analysis was performed using nsSNP data on 38 diﬀerent strains of S. 
cerevisiae (Liti et al., 2009). In this dataset, any SNPs with a quality score below 40 
were discarded, unless they were present in at least two strains.
For each of these variation datasets, the dependence between the presence of 
variants and of PTMs was assessed separately for each PTM and disorder type, 
using Fisher’s exact test. Structured core residues were excluded from the control 
group.
2.3. Results
Recent large-scale studies have identified a large number of post-translationally 
modified (PTM) sites in a variety of organisms, with humans, mice and yeast being 
by far the most intensively studied species. Since the mass spectrometry methods 
used for their identification are highly sensitive, questions have been raised as to 
what fraction of the identified sites are modified with biologically meaningful 
frequency in vivo. We approached this problem by studying conservation scores at 
PTM sites as compared to unmodified residues, while controlling for structural 
characteristics. An overview of the human PTM site dataset we obtained is shown in 
Table 2.1. Orthologs could be found for approximately two thirds of proteins in each 
category using Ensembl Compara. This was done by searching Ensembl Compara 
for Ensembl protein identifiers, which were mapped from the UniProtKB/Swiss-Prot 
identifiers used for PTM site annotation directly via mapping information from 
UniProtKB (release 2012_01) (UniProt Consortium, 2012).
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Table 2.1: Overview of human PTM types. The six PTMs highlighted in bold were chosen for 
study in this chapter due to the high availability of known sites. The number of modified 
proteins and of PTM sites for which orthologous proteins could be found in Ensembl Compara 
are given under “proteins with orthologs” and “sites with orthologs”, respectively. These 
columns show the final numbers of proteins and sites used in the conservation score-based 
analyses and conservation profiles. “n.d.” indicates that the number of orthologs was not 
determined since the modifications were not investigated in this study.
4VKPÄJH[PVU (TPUVHJPK 7YV[LPUZ 7YV[LPUZ^P[O
VY[OVSVNZ
:P[LZ :P[LZ^P[O
VY[OVSVNZ
7OVZWOVY`SH[PVU :LYPUL 7,688 5,410 39,531 25,159
7OVZWOVY`SH[PVU ;`YVZPUL 5,470 3,538 12,047 6,787
7OVZWOVY`SH[PVU ;OYLVUPUL 5,171 3,631 12,749 8,284
<IPX\P[PUH[PVU 3`ZPUL 4,821 3,374 17,434 10,870
(JL[`SH[PVU 3`ZPUL 2,903 2,033 6,505 4,183
V[OLYTVKPÄJH[PVUZ ]HYPV\Z 2,824 n.d. 6,040 n.d.
5SPURLKNS`JVZ`SH[PVU (ZWHYHNPUL 873 600 2,047 1,406
4L[O`SH[PVU (YNPUPUL 86 n.d. 239 n.d.
4L[O`SH[PVU 3`ZPUL 82 n.d. 189 n.d.
The resulting alignments of orthologous proteins were then used to calculate the 
conservation scores. The median number of orthologs (i.e. species) per alignment 
was 42 (Fig. 2.2), and a minimum threshold of ten species was used to minimise 
artefacts arising from small alignments. At minimum, an alignment of ten species 
should span all primates included in Ensembl Compara, ensuring suﬃcient 
phylogenetic distance to assess evolutionary trends.
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Figure 2.2: Size distribution of the alignments of orthologous proteins used to calculate 
conservation scores in this chapter. A minimum threshold of 10 species was used. The median 
number of orthologs (i.e. species) was 42 (see dashed line).
2.3.1. PTM sites are more conserved than structurally similar control 
residues between species
When analysing the conservation of PTM sites, we found that modification sites 
were generally significantly better conserved than a structurally equivalent 
background, as determined via Mann-Whitney U tests. Figure 2.3 shows the 
conservation of PTM sites compared to control residues according to three 
methods: i) the Jensen-Shannon divergence (JSD), a purely symbol frequency-
based approach (Fig. 2.3A)  (Capra and Singh, 2007), ii)  Rate4site, a phylogeny-
based method (Fig. 2.3B)  (Mayrose et al., 2004), and iii) the real-valued Evolutionary 
Trace score (rvET), a hybrid approach with an entropy-based component as well as 
a phylogeny-based component (Fig. 2.3C) (Mihalek et al., 2004). The control 
samples were around eleven times larger on average than the samples of PTM sites.
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Figure 2.3: Conservation density plots showing conservation of PTM sites compared to control 
sites, assessed using (A) Jensen-Shannon divergence (JSD), a symbol frequency-based 
method, (B) Rate4site, a phylogeny-based method, and (C) the real-valued Evolutionary Trace 
score (rvET), a hybrid approach with an entropy-based component as well as a phylogeny-
based component. Low variation scores indicate strong sequence conservation. Horizontally, 
the leftmost column contains all residues, while the other two show a breakdown into 
disordered and structured residues. Vertically, the diﬀerent PTM types are shown. Asterisks 
indicate the level of statistical significance (***: p<0.001, **: p<0.01, *: p<0.05), as determined by 
a two-sided Mann-Whitney U test. The dashed lines indicate the median of each sample, in 
blue for PTM sites and in grey for control residues. Where median PTM site variation is higher 
than that of controls, these asterisks are shown in round brackets. The size of the PTM site 
sample in each category is given in the top right corner. The size of the corresponding control 
sample was around eleven times larger on average.
The leftmost column in Figure 2.3A–C contains all residues, whereas the other two 
constitute a breakdown into disordered and structured residues, with internal 
residues having been removed from the structured control. Notably, when all sites 
were considered together without distinguishing between disordered and structured 
residues, the symbol frequency-based JSD and the phylogeny-based Rate4site 
scoring methods reported that sites of threonine phosphorylation (T-p) were not only 
non-conserved, but were significantly less conserved than background (Fig. 2.3A). 
However, once the distinction was made, both disordered and structured 
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phosphorylated threonines (T-p, Fig. 2.3A–B) were found to be significantly more 
conserved than controls. Similarly, when considering all sites together, tyrosine 
phosphorylation sites appeared to evolve at the same rate than unmodified residues 
for these two methods (Y-p, Fig. 2.3A–B). Once we distinguished between 
intrinsically disordered and structured residues, structured tyrosine phosphorylation 
sites were consistently found conserved, though disordered sites were not 
conserved according to JSD.
Overall, the hybrid scoring approach rvET reported the most PTM types and 
categories as significantly more conserved than controls, including both disordered 
and structured PTM sites of all types studied here (Fig. 2.3C). It also did not report 
threonine phosphorylation sites to evolve significantly faster than controls when not 
distinguishing between disordered and structured, though this remained a case 
where no significant diﬀerence could be found (T-p, Fig. 2.3C). The phylogeny-based 
Rate4site performed similarly with the disorder/structure distinction, except for 
disordered ubiquitination sites (K-ub, Fig. 2.3B), while the symbol frequency-based 
JSD method reported less cases of significant conservation.
Disordered N-glycosylation sites consistently showed the strongest conservation 
signal compared to control sites using all three methods (Fig. 2.3A–C). One factor in 
explaining strong conservation of N-glycosylation sites may be its high site 
occupancy, i.e. nearly all copies of an N-glycosylation substrate are modified, and 
the fact that glycosylation is highly important for successful transit of a substrate 
protein through the secretory pathway due to quality control mechanisms (Ellgaard 
et al., 1999; Zielinska et al., 2010). The majority of serine and threonine 
phosphorylation sites occurred in disordered regions, while tyrosine 
phosphorylation, lysine acetylation, ubiquitination and N-linked glycosylation sites 
were found to fall more frequently into structured regions. This is in line with 
previous reports for acetylation and ubiquitination (Norris et al., 2009; Xu et al., 
2010).
In order to determine whether PTM sites diﬀered from control sites in their structural 
characteristics, the fraction of disordered residues for each PTM type was also 
compared to the random samples of non-modified control sites by using Fisher’s 
exact test. No significant diﬀerences were found, indicating that PTM sites did not 
show a strong preference for either disordered or structured regions, although a 
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slight general trend towards more frequent disorder at phosphorylation and 
glycosylation sites was observed (data not shown). For acetylation and 
ubiquitination sites, the trend was towards slightly decreased disorder, though also 
not statistically significant.
Notably, the evolutionary rates reported by Rate4site in many cases displayed a 
bimodal distribution, divided into well-conserved sites on the left and rapidly 
evolving sites on the right (Fig. 2.3B). This is in contrast to the distributions reported 
by JSD and rvET, which appear largely unimodal except for a relatively small peak of 
highly conserved residues in some cases, especially for rvET (Fig. 2.3A and C). 
Normalisation of Rate4site scores (Fig. 2.4B)  removes the bimodal distributions 
observed for unnormalised Rate4site, resulting in plots more similar to the 
unnormalised symbol frequency-based and hybrid approaches. Normalisation of 
Rate4site scores also causes minor diﬀerences in statistical significance and 
introduces more significantly faster-evolving cases, such as for tyrosine 
phosphorylation and ubiquitination sites. Similarly, normalisation appeared to 
decrease the sensitivity of the symbol frequency-based and hybrid approaches and 
leads to a general decrease in the number of categories which were found 
significantly conserved compared to controls (Fig. 2.4A, C). The hybrid rvET 
approach still reported all disordered PTM sites except ubiquitination to be 
significantly more conserved than controls.
Nearly all peaks of the normalised density plots are left-shifted (below the average), 
indicating a long tail of sites evolving much faster than the average to the right (Fig. 
2.4A–C). When normalising the symbol frequency-based and hybrid scores, the 
highly conserved density peaks seen in some categories in Figure 2.3B and 2.3C 
also disappear, resulting in more homogenous plots for the three scoring methods. 
Whether the bimodality and peaks represent artefacts or meaningful diﬀerences in 
conservation between proteins is unclear. These cases may have been caused by 
relatively small alignments near the minimum alignment size of ten sequences 
(which still span at least all primates in Ensembl Compara). Since control sites were 
drawn from the same set of proteins, these smaller alignments should not skew the 
statistical tests for conservation, although they may introduce slight artefacts in the 
density plots which normalisation may help to alleviate.
51
Symbol frequency-based approach (normalised)A
All sites Disordered sites Structured sites
 *** n=4123
 (**) n=10584
 *** n=1373
n=23256
 (***) n=7765
 (***) n=6515
 ** n=1615
 (***) n=4014
 *** n=364
 *** n=19409
n=5245
n=2096
 * n=2508
n=6570
 ** n=1009
n=3847
 *** n=2520
n=4419
0.0
0.2
0.4
0.6
0.8
0.0
0.2
0.4
0.6
0.8
0.0
0.2
0.4
0.6
0.8
0.0
0.2
0.4
0.6
0.8
0.0
0.2
0.4
0.6
0.8
0.0
0.2
0.4
0.6
0.8
.ïDF
.ïXE
1ïJO\
6ïS
7ïS
<ïS
ï ï ï 0 1 2 3ï ï ï 0 1 2 3ï ï ï 0 1 2 3
Normalised varLDWLRQVFRUH-HQVHQï6KDQQRQGLvHUJHQFH
De
ns
ity
@VWURQJHUFRQVHUYDWLRQ ControlPTM
All sites Disordered sites Structured sites
 *** n=4176
 (***) n=10834
 *** n=1403
 *** n=25093
 (***) n=8257
 (***) n=6774
 *** n=1674
 (***) n=4183
 *** n=381
 *** n=21192
 *** n=5687
 * n=2271
 ** n=2502
n=6651
 *** n=1022
n=3901
 *** n=2570
n=4503
0.0
0.5
1.0
0.0
0.5
1.0
0.0
0.5
1.0
0.0
0.5
1.0
0.0
0.5
1.0
0.0
0.5
1.0
.ïDF
.ïXE
1ïJO\
6ïS
7ïS
<ïS
ï ï 0 1 2 ï ï 0 1 2 ï ï 0 1 2
NorPDOLVHGevROXWLRQDr\rDWHRDWHVLWH
'
HQ
VL
W\
@VWURQJHUFRQVHUYDWLRQ ControlPTM
B 3K\ORJHQ\EDVHGDSSURDFKQRUPDOLVHG
52
Hybrid approach (normalised)C
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Figure 2.4: Normalised conservation density plots showing conservation of PTM sites 
compared to control sites for (A) Jensen-Shannon divergence (JSD), a symbol frequency-based 
method, (B) Rate4site, a phylogeny-based method, and (C) the real-valued Evolutionary Trace 
score (rvET), a hybrid approach with an entropy-based component as well as a phylogeny-
based component. Normalising the Rate4site scores per protein here removes the bimodal 
distributions observed in Fig. 2.3C. Please see Figure 2.3 for a complete description of the plot 
content.
In order to systematically verify the usefulness of the structural and other 
classifications used in our comparisons of PTM sites to control residues above, 
Mann-Whitney U and permutation tests were carried out on all possible 
stratifications (Table 2.2). The results suggested that distinguishing simultaneously 
between diﬀerent PTM types, disordered and structured residues, as well as core 
and surface residues (where PDB data was available)  gives the clearest diﬀerence in 
conservation scores between modified and control residues, as assessed using p-
values (Table 2.2B).  Stratification by protein did not appear useful, resulting in 
insignificant p-values in some cases. Both types of tests reported very similar p-
values. The directionality was always towards stronger conservation of the modified 
residues, as assessed using one-sided Mann-Whitney U tests (data not shown).
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Table 2.2: Assessment of diﬀerent stratification methods in studying the overall conservation of 
PTM sites. Mann-Whitney U tests and permutation tests were performed using all available 
combinations of classification criteria. (A) Results with the entire dataset, prior to the PDB-
based core/surface distinction. (B) Results with the more limited dataset including the core/
surface distinction. Here, insignificant p-values are marked in underlined italic text, while the 
optimal stratification method for each conservation scoring method is highlighted in bold. 
Overall, distinguishing simultaneously between PTM types, disordered and structured residues, 
as well as core and surface residues resulted in the most significant observed diﬀerences in 
evolutionary rates between modified and control residues.
A :[YH[PÄJH[PVU
Core/surface 
distinction made? Conservation score :[YH[PÄJH[PVUTL[OVK by PTM
I`KPZVYKLYLK
Z[Y\J[\YLK
I`JVYL
Z\YMHJL I`WYV[LPU
4HUU>OP[UL`
U test
Permutation 
test
5V 1:+Z`TIVS UVUL 5( <2.2E-16 <2.2E-16
5V 1:+Z`TIVS ptm 5( <2.2E-16 <2.2E-16
5V 1:+Z`TIVS disstr 5( <2.2E-16 <2.2E-16
5V 1:+Z`TIVS WYV[ 5( 7.03E-06 0.0059
5V 1:+Z`TIVS ptm-disstr 5( <2.2E-16 <2.2E-16
5V 1:+Z`TIVS W[TWYV[ 5( 1.80E-09 4.70E-06
5V 1:+Z`TIVS KPZZ[YWYV[ 5( <2.2E-16 <2.2E-16
5V 1:+Z`TIVS W[TKPZZ[YWYV[ 5( <2.2E-16 <2.2E-16
5V 9H[LZP[LWO`SVNLU` UVUL 5( <2.2E-16 <2.2E-16
5V 9H[LZP[LWO`SVNLU` ptm 5( <2.2E-16 <2.2E-16
5V 9H[LZP[LWO`SVNLU` disstr 5( <2.2E-16 <2.2E-16
5V 9H[LZP[LWO`SVNLU` WYV[ 5( <2.2E-16 <2.2E-16
5V 9H[LZP[LWO`SVNLU` ptm-disstr 5( <2.2E-16 <2.2E-16
5V 9H[LZP[LWO`SVNLU` W[TWYV[ 5( <2.2E-16 <2.2E-16
5V 9H[LZP[LWO`SVNLU` KPZZ[YWYV[ 5( <2.2E-16 <2.2E-16
5V 9H[LZP[LWO`SVNLU` W[TKPZZ[YWYV[ 5( <2.2E-16 <2.2E-16
5V Y],;O`IYPK UVUL 5( <2.2E-16 <2.2E-16
5V Y],;O`IYPK ptm 5( <2.2E-16 <2.2E-16
5V Y],;O`IYPK disstr 5( <2.2E-16 <2.2E-16
5V Y],;O`IYPK WYV[ 5( <2.2E-16 1.11E-15
5V Y],;O`IYPK ptm-disstr 5( <2.2E-16 <2.2E-16
5V Y],;O`IYPK W[TWYV[ 5( <2.2E-16 <2.2E-16
5V Y],;O`IYPK KPZZ[YWYV[ 5( <2.2E-16 <2.2E-16
5V Y],;O`IYPK W[TKPZZ[YWYV[ 5( <2.2E-16 <2.2E-16
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B :[YH[PÄJH[PVU
Core/surface 
distinction made? Conservation score :[YH[PÄJH[PVUTL[OVK by PTM
I`KPZVYKLYLK
Z[Y\J[\YLK
I`JVYL
Z\YMHJL I`WYV[LPU
4HUU>OP[UL`
U test
Permutation 
test
@LZPL7+)VUS` 1:+Z`TIVS UVUL , ,
@LZPL7+)VUS` 1:+Z`TIVS W[T , ,
@LZPL7+)VUS` 1:+Z`TIVS disstr , ,
@LZPL7+)VUS` 1:+Z`TIVS JVYLZ\YM , ,
@LZPL7+)VUS` 1:+Z`TIVS WYV[ 0.0582 0.2475
@LZPL7+)VUS` 1:+Z`TIVS W[TKPZZ[Y   , , 
@LZPL7+)VUS` 1:+Z`TIVS W[TJVYLZ\YM , ,
@LZPL7+)VUS` 1:+Z`TIVS W[TWYV[ 0.2856 0.4967
@LZPL7+)VUS` 1:+Z`TIVS disstr-coresurf <2.2E-16 1.66E-13
@LZPL7+)VUS` 1:+Z`TIVS KPZZ[YWYV[   
@LZPL7+)VUS` 1:+Z`TIVS JVYLZ\YMWYV[  
@LZPL7+)VUS` 1:+Z`TIVS W[TKPZZ[YJVYLZ\YM , , 
@LZPL7+)VUS` 1:+Z`TIVS W[TKPZZ[YWYV[ 0.0685 0.1183
@LZPL7+)VUS` 1:+Z`TIVS W[TJVYLZ\YMWYV[ 0.1314 0.2590
@LZPL7+)VUS` 1:+Z`TIVS KPZZ[YJVYLZ\YMWYV[  
@LZPL7+)VUS` 1:+Z`TIVS W[TKPZZ[YJVYLZ\YMWYV[ 0.0624 0.1051
@LZPL7+)VUS` 9H[LZP[LWO`SVNLU` UVUL  
@LZPL7+)VUS` 9H[LZP[LWO`SVNLU` W[T   
@LZPL7+)VUS` 9H[LZP[LWO`SVNLU` disstr  ,
@LZPL7+)VUS` 9H[LZP[LWO`SVNLU` JVYLZ\YM  
@LZPL7+)VUS` 9H[LZP[LWO`SVNLU` WYV[  0.0542
@LZPL7+)VUS` 9H[LZP[LWO`SVNLU` W[TKPZZ[Y ,  ,
@LZPL7+)VUS` 9H[LZP[LWO`SVNLU` W[TJVYLZ\YM , ,
@LZPL7+)VUS` 9H[LZP[LWO`SVNLU` W[TWYV[  
@LZPL7+)VUS` 9H[LZP[LWO`SVNLU` KPZZ[YJVYLZ\YM , ,
@LZPL7+)VUS` 9H[LZP[LWO`SVNLU` KPZZ[YWYV[  
@LZPL7+)VUS` 9H[LZP[LWO`SVNLU` JVYLZ\YMWYV[   
@LZPL7+)VUS` 9H[LZP[LWO`SVNLU` ptm-disstr-coresurf 2.10E-06 3.06E-07
@LZPL7+)VUS` 9H[LZP[LWO`SVNLU` W[TKPZZ[YWYV[ , 
@LZPL7+)VUS` 9H[LZP[LWO`SVNLU` W[TJVYLZ\YMWYV[  
@LZPL7+)VUS` 9H[LZP[LWO`SVNLU` KPZZ[YJVYLZ\YMWYV[  
@LZPL7+)VUS` 9H[LZP[LWO`SVNLU` W[TKPZZ[YJVYLZ\YMWYV[ , 
@LZPL7+)VUS` Y],;O`IYPK UVUL , ,
@LZPL7+)VUS` Y],;O`IYPK W[T , ,
@LZPL7+)VUS` Y],;O`IYPK disstr #, ,
@LZPL7+)VUS` Y],;O`IYPK JVYLZ\YM ,  ,
@LZPL7+)VUS` Y],;O`IYPK WYV[ 0.2210 0.1025
@LZPL7+)VUS` Y],;O`IYPK W[TKPZZ[Y #, ,
@LZPL7+)VUS` Y],;O`IYPK W[TJVYLZ\YM #, ,
@LZPL7+)VUS` Y],;O`IYPK W[TWYV[ 0.0679  
@LZPL7+)VUS` Y],;O`IYPK KPZZ[YJVYLZ\YM #, ,
@LZPL7+)VUS` Y],;O`IYPK KPZZ[YWYV[  
@LZPL7+)VUS` Y],;O`IYPK JVYLZ\YMWYV[ 0.0525 
@LZPL7+)VUS` Y],;O`IYPK ptm-disstr-coresurf <2.2E-16 2.22E-16
@LZPL7+)VUS` Y],;O`IYPK W[TKPZZ[YWYV[   
@LZPL7+)VUS` Y],;O`IYPK W[TJVYLZ\YMWYV[  
@LZPL7+)VUS` Y],;O`IYPK KPZZ[YJVYLZ\YMWYV[  
@LZPL7+)VUS` Y],;O`IYPK W[TKPZZ[YJVYLZ\YMWYV[  
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Figure 2.5: Comparison of evolutionary rates for catalytic residues from the Catalytic Site Atlas 
(“CSA”), protein-protein interaction interfaces (“Int”) and modified residues (“PTM”). 
Conservation density plots showing conservation assessed using (A) Jensen-Shannon 
divergence (JSD), a symbol frequency-based method, (B) Rate4site, a phylogeny-based 
method, and (C) the real-valued Evolutionary Trace score (rvET), a hybrid approach with an 
entropy-based component as well as a phylogeny-based component. Low variation scores 
indicate strong sequence conservation. Asterisks indicate the level of statistical significance 
between samples (***: p<0.001, **: p<0.01, *: p<0.05), as determined by two-sided Mann-
Whitney U tests. The dashed lines indicate the median of each sample. Where the median of 
the first sample is higher than that of the second, these asterisks are shown in round brackets 
as in previous figures. The size of each sample is given in the top right corner.
Additionally, to obtain a frame of reference for the observed variation scores, we 
performed a comparison between PTM sites, residues participating in protein-
protein interaction interfaces and catalytic residues (Fig. 2.5). All three categories 
diﬀered significantly from each other, with catalytic residues being the most highly 
conserved group and interaction interfaces generally being more conserved than 
PTM sites. Although catalytic residues were the most numerous among the strongly 
conserved sites, all three categories overlapped in this area. The bimodal 
distribution observed for phylogeny-based Rate4site score (Fig. 2.5B) showed this 
most clearly, displaying an equivalent peak of highly conserved residues in all three 
categories, and indicating that certain interface residues and PTM sites may be 
conserved to an equivalent extent as catalytic residues. Similarly, the hybrid rvET 
score (Fig. 2.5C) displayed a peak of absolutely conserved residues with a score of 
1 for all three categories, which was largest for the catalytic residues.
2.3.2. Many PTM sites have ancient evolutionary origins
In addition to quantifying conservation at PTM sites using aggregate conservation 
scores, we also traced the conservation of individual modified residues across 
species. Figure 2.6 shows conservation profiles for disordered and structured 
human PTM sites in a large cross-section of other species from Ensembl Compara. 
These species are ordered according to their phylogenetic relationships in the 
Compara species tree (Flicek et al., 2012), from human on the left to yeast on the 
very right. Though there appears to be evidence of mutations being retained within 
lineages, there is also a considerable amount of variability which does not seem 
confined to a lineage. This seems to be especially the case for human N-
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glycosylated residues. In at least some cases, the absence of orthologous residues 
(white tiles in Fig. 2.6) could also point to insuﬃcient sequencing coverage.
Overall, there is a large amount of conservation of human post-translationally 
modified residues extending beyond the mammalian lineage. In many cases, there 
appears to be a boundary upon leaving the gnathostomata (from Danio rerio to 
Petromyzon marinus, which is the rightmost vertebrate), or the tetrapoda (from 
Xenopus tropicalis  to Tetraodon nigroviridis, centrally between the mammalian and 
vertebrate boundaries). Lysine acetylation, ubiquitination and tyrosine 
phosphorylation sites are relatively more conserved than the other PTMs studied, 
though this seems to stem more from the type of amino acid itself, as evidenced by 
the control residues. Tyrosines appear more conserved than serines and threonines. 
This may be due to positive selection for tyrosine loss caused by the advent of 
tyrosine phosphorylation early in the metazoan lineage, potentially resulting in 
stronger conservation of the tyrosines which were retained (Tan et al., 2009b).
For all PTMs, this analysis illustrates the low experimental coverage of post-
translational modifications in most species other than mice and humans. Due to the 
sparseness of experimental PTM site information for other species, relatively little 
experimental overlap could be detected, even in the mouse. An exception is N-
glycosylation, where large-scale analysis has been undertaken in the mouse, and a 
good overlap with human sites is clearly evident. Although S. cerevisiae, Drosophila 
melanogaster and C. elegans are relatively well-studied, surprisingly few human 
PTM sites appeared to have precisely conserved, modified orthologous residues in 
these species, in line with a previous report on yeast-human conservation (Minguez 
et al., 2012).
Interestingly, many acetylated disordered lysines which are also modified in the 
mouse appear to occur in proteins with no homologs in most mammals. A similar 
“gap” of PTM sites conserved identically in a certain lineage, but with few 
homologous proteins outside it is visible for structured threonine phosphorylation 
sites (T-p, Fig. 2.6B).
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Figure 2.6: Conservation profiles of diﬀerent human PTM types and unmodified control 
residues for (A) disordered and (B) structured sites. The figure legend is shown in panel C. 
Species are shown on the horizontal axis of each panel, and individual PTM sites or control 
residues are shown on the vertical axis. Species are arranged according to their phylogenetic 
relationships, from human on the left to yeast on the right, as obtained from the Ensembl 
Compara species tree. Green tiles indicate the presence of an identical homologous residue. 
Blue tiles further indicate that an identical, homologous residue is experimentally known to be 
modified by the same PTM type. Annotations by similarity were excluded here. In orange tiles, 
a homologous protein exists, but does not contain an identical residue, while white indicates 
that no homologous position exists in a species’s proteome. Vertically, the residues are 
arranged in descending order by the number of species with identical homologous residues 
(marked in green), and in case of ties secondarily by the number of species with a homologous 
protein (marked in orange), and additionally by the number of known modified identical 
residues (marked in blue).
2.3.3. Mutations at PTM sites may mimic or avoid the modified state
Since mimetic mutations can mirror the eﬀect of a PTM (Thorsness and Koshland, 
1987), we decided to investigate whether PTM sites diﬀer from unmodified residues 
in the types of residues that are present at orthologous positions. An enrichment in 
mimetic residues would be an additional indication that PTM sites tend to be 
functionally important. Although the directionality of substitution in other species 
cannot be determined since we have no direct knowledge of the ancestral 
sequences, we will refer to the presence of amino acids which diﬀer from the 
modifiable human residue as “mutations” or “substitutions” here as a simplification. 
We decided to use the best-conserved tertile of PTM sites to determine score 
cutoﬀs, since well-conserved sites should ensure limited functional divergence. 
Using the raw, unnormalised scores from the three diﬀerent conservation scoring 
methods, significant substitution diﬀerences generally did not appear consistently 
with all three scoring methods. Since normalisation resulted in more uniform score 
distributions in Figure 2.4, we decided to repeat this analysis with normalised 
scores.
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When the scores were normalised per protein, certain enrichments appeared 
consistently (Fig. 2.7A). The unnormalised Rate4site result resembled these 
consistent results from normalised scores slightly more closely than the other 
methods (Fig. 2.7B), and was therefore included here as the only raw score in the 
interest of space. This resemblance only existed for  structured tyrosines, disordered 
serines and perhaps lysines (Fig. 2.7B). For disordered tyrosines, the substitution 
pattern did not diﬀer significantly from control sites, while disordered threonine 
phosphorylation sites had also not shown a bimodal distribution in their raw 
Rate4site conservation scores (Fig. 2.3B), which may oﬀer an explanation for the 
absence of an enrichment in their column here.
We then decided to focus on the normalised conservation scores (Fig. 2.7A)  for the 
substitution analysis, since they were best able to recapture the significant 
conservation of modified residues which we detected previously in Figures 2.3–4. 
Despite reporting a relatively small number of PTM categories as significantly more 
conserved than controls in Fig. 2.4A, the normalised symbol frequency-based JSD 
method was well able to recapture overrepresentation of these original residues 
here. This was the case for each disordered PTM type except for lysine acetylation, 
which JSD reported to be significantly more frequently replaced by negatively-
charged glutamate (E)  compared to unmodified lysines. The good performance of 
the JSD method may be explained here by the similarity of its symbol frequency-
based approach to the symbol overrepresentation test used here, since JSD may be 
most likely to retrieve the tertile with the lowest number of substitutions out of the 
three conservation scoring methods, since it does not take phylogeny into account.
In addition to the original amino acids for each PTM type, we expected the 
substitution analysis to show an overrepresentation of negatively charged 
phosphomimics at disordered serine phosphorylation sites (Kurmangaliyev et al., 
2011; Pearlman et al., 2011). Though small compared to the enrichment for serine, 
this was indeed retrieved by all three normalised scoring methods, as well as all raw 
scores, with Rate4site showing the strongest enrichment of both aspartate (D) and 
glutamate (E).
We additionally found that aspartate substitutions (D) might be enriched at 
phosphorylated structured tyrosines, which may also constitute a previously 
unreported type of phosphomimicry. Intriguingly, acetylated disordered lysines might 
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preferentially become replaced by negatively charged glutamate (E) according to 
both the normalised symbol frequency-based JSD score and the raw phylogeny-
based Rate4site score. Structured acetylated lysines were enriched in substitutions 
by either glutamine (Q) and asparagine (N), two structurally similar amino acids with 
carboxamide side chains, which only diﬀer in their carbon chain length. Disordered 
N-glycosylated asparagines (N)  were found to be significantly enriched in glutamine 
(Q) substitutions. Since asparagine and glutamine are structurally very similar, 
mutation to glutamine (Q) could potentially abolish N-glycosylation while maintaining 
a very similar structure.
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Figure 2.7: Amino acid over- and underrepresentation at well-conserved PTM sites, using the 
best-conserved third of PTM sites according to (A) the three normalised conservation scores 
and (B) the phylogeny-based raw Rate4site scores. Amino acids which were significantly more 
or less frequently encountered at PTM sites compared to similarly conserved control residues 
are shown in colours according to their charge (blue: positive, black: neutral, red: negative). 
The analysis is broken down horizontally into disordered and structured residues, as well as 
vertically by the conservation scoring method used to determine the best-conserved PTM site 
tertile range. Within each panel, the six PTM types studied are shown left-to-right. 
Overrepresentation is shown in the upper half of each panel, while underrepresentation is 
shown in the lower half. The scaling of the one-letter amino acid codes is proportional to their 
relative degree of over- or underrepresentation within an individual panel column.
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2.3.4. PTM sites are more constrained than control residues at the 
population and somatic levels
Thus far, we have attempted to address the likely functionality of PTM sites by 
investigating conservation at modified residues between species. However, this 
approach does not confirm functional relevance of a specific site within the human 
species. Functional constraints on post-translationally modified sites in humans was 
therefore assessed by using data on non-synonymous single-nucleotide 
polymorphisms (nsSNPs) within human populations (Fig. 2.8A), and on disease-
causing variants and cancer-associated somatic mutations in individuals (Fig. 2.9). 
This analysis was further substantiated using variation data from 38 strains of S. 
cerevisiae (Fig. 2.8B) (Liti et al., 2009).
Consistently, we found PTM sites to be significantly less frequently aﬀected by 
natural variants than unmodified control residues (Fig. 2.8), and significantly more 
frequently aﬀected by disease mutations (Fig. 2.9). In most non-significant cases in 
the largest datasets (1000 Genomes and HGMD), this is still maintained as a trend. 
Notably, our analysis of this intra-species data strongly highlights the conservation 
of structured PTM sites in addition to disordered sites. While N-glycosylation and 
threonine phosphorylation were the only PTM types which were consistently 
reported as more conserved than controls at structured sites using normalised 
scores in Figure 2.4, all structured PTM types were here found to be either 
significantly depleted in natural variants (Fig. 2.8A) or enriched in disease mutations 
(Fig. 2.9A). These findings are supported by an earlier study using a smaller PTM site 
dataset, which reported that disease mutations are enriched at PTM sites (Li et al., 
2010).
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Figure 2.8: Decreased nsSNP incidence at PTM sites in natural variation, assessed using data 
from (A) the human 1000 Genomes Project and (B) yeast strain variation data. Cases where 
PTM sites are significantly less often aﬀected by non-synonymous SNPs are highlighted in blue 
and with a minus symbol. Asterisks indicate the level of statistical significance of the 
diﬀerence (***: p<0.001, **: p<0.01, *: p<0.05), as determined by Fisher’s exact test.
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Figure 2.9: Increased nsSNP incidence at PTM sites in disease, assessed using (A) disease 
mutation data from the Human Gene Mutation Database (HGMD) and (B) cancer-associated 
somatic mutations from the COSMIC database. Cases where PTM sites are significantly more 
often aﬀected by non-synonymous SNPs are highlighted in orange and with a plus symbol. 
Asterisks indicate the level of statistical significance of the diﬀerence (***: p<0.001, **: p<0.01, 
*: p<0.05), as determined by Fisher’s exact test.
2.4. Discussion
The analyses in this chapter were prompted by the open question of whether a large 
fraction of PTM sites may be biologically nonfunctional. We here investigated this 
question by quantifying selection pressure acting on post-translationally modified 
residues at the species, population and somatic levels, and by analysing 
evolutionary profiles of these sites. We also addressed the tendency of certain 
modifications to occur in fast-evolving intrinsically disordered regions, and the 
intriguing subject of mimetic and avoiding mutations at modification sites. We found 
mild, but significant evidence of increased conservation of at least a fraction of PTM 
sites at all points.
2.4.1. Quantifying PTM site conservation using conservation scores
Using three diﬀerent conservation scoring methods, we investigated the 
conservation of human PTM sites while correcting for structural characteristics 
aﬀecting evolutionary rates. Though wide ranges of variation in scores were 
observed, as reported in previous studies of evolutionary rates (Subramanian and 
Lambert, 2011), we found that disordered and structured modified residues were 
generally significantly more conserved overall than unmodified controls (Fig. 2.3–4). 
Using conservation scores normalised per protein however, structured sites for PTM 
types other than N-glycosylation and threonine phosphorylation appeared to be 
similarly conserved as control residues (Fig. 2.4).
Well-conserved PTM sites appear similarly conserved as catalytic residues
A comparison was performed between PTM sites, residues participating in protein-
protein interaction interfaces and catalytic residues (Fig. 2.5), allowing us to obtain a 
frame of reference for the observed variation scores. Though catalytic residues were 
significantly more highly conserved as a group than interaction interfaces, and these 
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respectively more than PTM sites as a group, all three distributions overlapped in the 
highly-conserved peak defined by the catalytic residues. Especially the bimodal 
distribution observed for phylogeny-based Rate4site score (Fig. 2.5B), but also the 
peak of absolutely conserved residues with a score of 1 for the hybrid rvET score 
(Fig. 2.5B) showed this most clearly, displaying an equivalent peak of highly 
conserved residues in all three categories, and indicating that certain interface 
residues and PTM sites are conserved to an equivalent extent as catalytic residues.
The observed non-conservation of structured PTM sites using normalised 
scores may be due to high background conservation at structured control 
sites
Though structured residues likely to be in the protein core were removed from the 
control samples, the discrepancy we observed between the generally significantly 
conserved disordered and the less frequently conserved structured sites may make 
sense in light of the lower background conservation of disordered regions (Brown et 
al., 2002; 2010; 2011). Against a disordered background, the conservation of 
functional residues might be much more apparent than against a background under 
stronger structural constraint. An alternative explanation could be provided for 
phosphorylation by the polyelectrostatic model, which suggests that phosphorylated 
residues in disordered regions can present themselves as diﬀuse charges, involving 
rapidly changing conformation of the disordered region (Borg et al., 2007). Recent 
advances in the structural analysis of disordered proteins support this view of 
disordered proteins as “structural ensembles” that may rapidly transition between 
conformations (Lange et al., 2008; Marsh and Forman-Kay, 2011). If polyelectrostatic 
mechanisms are generally important at phosphorylation sites, this may help to 
explain the increased conservation of disordered phosphorylation sites which we 
observed.
Overall, our results illustrate the importance of structural distinctions, since prior to 
the distinction between disordered and structured regions we were frequently 
unable to detect significant conservation (Fig. 2.3–4). This is further shown in detail 
in our experimentation with all possible stratification combinations in Table 2.2.
69
The choice of conservation scoring method is important
The real-valued Evolutionary Trace score, a hybrid method combining an entropy-
based and a phylogeny-based component, performed better than alternatives and 
detected significant conservation of disordered and structured sites for all PTM 
types studied here when using the raw score. The fact that the three methods 
performed very similarly in an independent evaluation (Johansson and Toh, 2010), 
but showed notable diﬀerences in results here suggests that the choice of 
conservation scoring method is of great importance when analysing PTM site 
conservation. It has been suggested that certain datasets of known functional sites 
which are used in the evaluation of scoring methods may generally be biased 
towards absolutely conserved residues (Capra and Singh, 2007). This seems 
relatively appropriate for PTM sites, unless mimetic mutations are taken into 
account.
The bimodality of scores observed using Rate4site may or may not be 
artifactual
Conservation density plots using unnormalised Rate4site scores generally displayed 
bimodal distributions of evolutionary rates (Fig. 2.3B). In support of multimodality of 
residue conservation, a previous report has described evolutionary rates as forming 
several peaks for the majority of proteins: slowly evolving “core” residues, fast-
evolving surface residues, and extremely evolvable residues in disordered regions 
(Tóth-Petróczy and Tawfik, 2011). Although the bimodal distributions at PTM sites 
reported by Rate4site could be artifactual, potentially due to score dependency on 
alignment size, they might then also signify that there are two evolutionary classes of 
PTM sites: i)  well-conserved residues that are functionally conserved far back in 
evolution, and ii) less conserved residues that have either only recently acquired 
importance in post-translational signalling, or are non-functional PTM sites and 
potentially only present at low occupancy, i.e. in a small fraction of protein copies 
(Beltrao et al., 2012). This view can be supported by our results in Figure 2.5C, 
where the highly-conserved component of the bimodal distribution of Rate4site 
scores appears to overlap well with the peak for catalytic residues.
Although the other scoring methods did not display clear bimodal distributions (only 
small peaks of well-conserved residues), the fact that the unnormalised Rate4site 
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score best retrieved aspartate (D) and glutamate (E) enrichments at disordered 
serine phosphorylation sites (S-p, Fig. 2.7B) might lend a small degree of support to 
the idea that the uniquely bimodal distribution of the unnormalised Rate4site scores 
could represent a meaningful diﬀerence between two populations of residues. 
Rate4site was the only method which explicitly used branch lengths for scoring 
conservation, which may potentially lend it increased sensitivity. The fact that the 
bimodality disappeared upon normalisation at the protein level (Fig. 2.4B) may be 
due to diﬀerential conservation of entire proteins, which could be influenced by the 
presence or absence of functional PTM sites.
The low conservation observed for lysine ubiquitination sites using normalised 
scores could be due to degradation-associated sites
The relatively low conservation of ubiquitination we observed using normalised 
scores could potentially be due to relatively unspecific degradation-related 
ubiquitination. It has been noted that ubiquitination mostly occurs in structured 
regions, although less frequently if the sites are associated with degradation (Hagai 
and Levy, 2010; Hagai et al., 2011). This finding, in addition to the higher 
background conservation at unmodified control residues in structured regions, may 
explain the absence of observable conservation of ubiquitination sites using 
normalised scores (Fig. 2.4A–C). Recent studies that distinguish between ubiquitin 
chain types could be used to address this, but these data are not yet available at a 
large enough scale (Sims et al., 2012).
PTM sites do not appear to show disorder or structure preference when 
compared to control residues sampled from the same proteins
Previous studies have generally reported PTM sites to fall preferentially into 
disordered regions (Iakoucheva et al., 2004; Xie et al., 2007a; Gnad et al., 2009; Holt 
et al., 2009; Landry et al., 2009; Ba and Moses, 2010). In our analyses, though some 
PTM types were indeed observed to fall more frequently into either disordered or 
structured regions, these structural preferences were not significantly diﬀerent from 
unmodified control residues of the same amino acid type within the same set of 
proteins, indicating that PTM sites did not show a significant preference for either 
disordered or structured regions, although a general trend towards more frequent 
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disorder at phosphorylation and glycosylation sites was indeed observed. Lysine 
acetylation and ubiquitination sites were instead found to be slightly, but 
insignificantly, more frequently structured than their unmodified counterparts. 
Potentially, then, intrinsic disorder might not be a generally required feature of an 
accessible, modifiable residue, and this would indicate that intrinsic disorder may 
not always be a useful characteristic for predicting PTM sites.
2.4.2. Analysis of PTM site evolution using conservation profiles
Evidence of lineage-specific and sporadic conservation of PTM sites
In the conservation profiles of human post-translationally modified residues (Fig. 
2.6), there appeared to be a considerable amount of variability which did not seem 
confined to a lineage. Aside from non-functionality of some PTM sites at least in 
species other than human, possible explanations for these noisy patterns could 
include post-translational regulatory divergence in individual species, potentially 
including mutations which mimic or avoid the modified state (Fig. 2.7), and which 
may hypothetically underlie phenotypic diﬀerences between species. However, 
many control residues showed similar patterns. Human N-glycosylation sites had 
especially few orthologous residues in non-mammalian and in non-vertebrate 
species. This may point to extensive diﬀerences in the types of glycoproteins these 
species generate, which have been reported to be a major factor in speciation (Varki 
and Altheide, 2005; Varki and Nelson, 2007; Varki et al., 2008; Varki, 2010; Varki et 
al., 2011). Conversely, human structured acetylated lysines appeared to be 
conserved in a relatively large number of species, though not drastically more often 
than control lysines.
Invertebrates, vertebrates and primates appear divergent in PTM signalling
The observation that Drosophila melanogaster, C. elegans  and S. cerevisiae, despite 
being relatively well-studied in terms of PTM sites, have surprisingly few modified 
residues orthologous to human PTM sites could either be due to non-position 
specific conservation as in the polyelectrostatic model (Borg et al., 2007), or due to 
divergence of these post-translational signalling systems at many sites. It has been 
suggested that the majority of phosphorylation events on both sides may have 
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evolved after the divergence of higher eukaryotes, C. elegans  and yeast (Zielinska et 
al., 2009; Gnad et al., 2010a). This would indicate that more closely related model 
organisms should be used in the study of human PTM signalling. Corroborating this, 
a relatively large fraction of disordered serine and threonine phosphorylation sites 
appears to be specific to primates (Fig. 2.6). This might indicate extensive changes 
in serine and threonine phosphorylation signalling in the early divergence of the 
primate lineage.
2.4.3. Analysis of substitution patterns at PTM sites
Mutations at PTM sites tend to resemble either the modified or unmodified 
state
Substitutions by negatively charged amino acids can successfully mimic the 
phenotype of phosphorylated residues (Thorsness and Koshland, 1987; Tarrant and 
Cole, 2009), and vice versa some phosphorylation sites appear to have originated 
from negatively charged amino acids. These amino acids may have been part of an 
ancestral salt bridge, which phosphorylation can conditionally restore (Nühse et al., 
2004; Kurmangaliyev et al., 2011; Pearlman et al., 2011). Conversely, mutation to a 
negatively charged residue would eﬀectively make the modified state of a 
phosphorylation site permanent. It should be briefly noted at this point that 
phosphomimics such as glutamate and aspartate are not always functionally 
equivalent to phosphorylation, as illustrated by a study of the diﬀerent aggregation 
kinetics of α-synuclein mutants, which aggregate as Lewy bodies in Parkinson’s 
disease (Paleologou et al., 2008). Nonetheless, successful PTM mimicry is not 
limited to phosphorylation. Mutations to glutamine can reconstitute the eﬀects of 
lysine acetylation (Yang et al., 2010; Liu et al., 2011; Nagaraj et al., 2012; Yu et al., 
2012), and leucine and methionine can be used to successfully mimic lysine 
methylation (Hyland et al., 2011). The importance of PTM mimicry is further 
illustrated by the fact that PTMs often appear to modulate protein-protein 
interactions by improving or disrupting hydrophilicity matching, which highlights the 
importance of charges and electrostatic interactions (Hlevnjak et al., 2010).
We observed a number of interesting overrepresented substitutions at PTM sites 
(Fig. 2.7). Depending on the scoring method used, substitutions by glutamine (Q) 
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and asparagine (N)  were overrepresented at structured lysine acetylation sites. We 
hypothesise that either their carbonyl oxygens or their primary amines may at least 
partially be able to mimic the steric and electrostatic interactions made by 
acetyllysine at structured sites (Figure 1.1). We also observed overrepresentation of 
glutamate (E) and aspartate (D)  at disordered serine phosphorylation sites (in line 
with earlier reports), of aspartate (D) at tyrosine phosphorylation sites, and of 
glutamine (Q) at disordered N-glycosylated asparagines. Substitution of 
glycosylatable asparagine by glutamine, which only diﬀers in carbon chain length, 
may be an eﬃcient way of abolishing N-glycosylation while minimally aﬀecting 
structure otherwise, thereby representing an “avoiding” type of PTM site mutation. 
At disordered lysine acetylation sites, an overrepresentation of substitutions by 
glutamate (E) was observed using two scoring methods, and this is discussed in 
more detail below.
Negatively charged succinylation or malonylation modifications might 
potentially occur as alternatives at lysine acetylation sites
The enrichment of negative charges at lysine acetylation sites, though inconsistently 
reported, was a surprising finding to us since lysine itself is positively charged, and 
acetylated lysine is neutral. In at least one instance, however, a mutation of a lysine 
acetylation site to glutamate (E)  has been reported to mimic the eﬀect of acetylation 
(Erkmann and Kaufman, 2009). In this case, it has been suggested that the key 
factor is the removal of the positive charge of lysine by any means.
An alternative hypothetical explanation for the enrichment could be the presence of 
competing lysine succinylation or malonylation at lysine acetylation sites, at a 
frequency extensive enough to significantly aﬀect substitution patterns. Both 
succinyl- and malonyllysine are negatively charged, and like acetylation, these 
modifications use a CoA-containing metabolic intermediate as the donor molecule 
(Tan et al., 2011; Lin et al., 2012). Succinyl-CoA is an intermediate of the citric acid 
cycle, while malonyl-CoA is formed from acetyl-CoA by acetyl-CoA carboxylase and 
is central in the synthesis of long-chain fatty acids (Ellis and Wolfgang, 2012)(Lin et 
al., 2012). Lysine succinylation and malonylation can be specifically reversed by 
erasing enzymes (Zhang et al., 2010c; Du et al., 2011). While sirtuins tend to act as 
protein deacetylases, Sirt5 was found to be a lysine desuccinylase and 
demalonylase, and the reactions involved are mechanistically equivalent to those 
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involved in lysine deacetylation by class I sirtuins (Du et al., 2011; Peng et al., 2011). 
In this light, it is interesting that Sirt5 can also still act as a very weak deacetylase, 
further highlighting the similarity of the modification reactions by showing cross-
reactivity (Olsen, 2012). Sirt5 is found in mitochondria as well as the cytoplasm 
(Olsen, 2012; He et al., 2012a), although nuclear sites of lysine succinylation and 
malonylation have also been found on human, mouse, Drosophila and yeast 
histones (Xie et al., 2012). It has been suggested that lysine succinylation may be 
very abundant in human cells (Du et al., 2011). A useful way to follow up on these 
findings would be proteomic studies using specific antibody-based enrichment for 
succinylated or malonylated lysines.
Serine and threonine phosphomimicry may require multiple mutational steps
One prerequisite for mimetic mutations at a functionally important PTM site is that 
the mimetic residue should be reached in one mutational step. This is not the case 
for serine and threonine phosphorylation, which indicates that selection pressure 
may need to be relaxed through gene duplication (Diss et al., 2012). When not under 
constraint due to phosphorylation, serine has been described as a highly 
mutationally active residue (Creixell et al., 2012). Interestingly, multinucleotide 
substitutions have been reported to occur more frequently than would be expected 
from the random coincidence of individual neutral nucleotide substitutions (Averof et 
al., 2000; Hodgkinson and Eyre-Walker, 2010; Schrider et al., 2011). Though certain 
types of multinucleotide substitutions are more likely to occur than others, for 
instance due to environmental influences such as ultraviolet light leading to 
dipyrimidine lesions, it can be concluded in principle that any amino acid could be 
substituted by any other without an intervening fitness gap. Possible mechanisms 
include homologous recombination and gene conversion, especially over long 
evolutionary distances (Miyazawa, 2011b), as well as others (Hodgkinson and Eyre-
Walker, 2010). Within the primate lineage, multinucleotide substitutions have been 
reported to be rare (Smith et al., 2003), though in general, allowing them in 
substitution models leads to a maximum likelihood improvement (Whelan and 
Goldman, 2004; Miyazawa, 2011a). A more recent study has reported a general 
enrichment in eukaryotes, including humans (Schrider et al., 2011). Nonetheless, the 
diﬃculty of reaching negatively charged phosphomimics through point mutations of 
serine and threonine phosphosites indicates that these mutations may be limited to 
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rare duplication events at the root of a lineage. The large number of serine 
phosphorylation sites (Table 2.1) may have aided in the identification of significant 
overrepresentation of negative charges at disordered positions in ours and other 
studies, despite the complex mutational steps required (Fig. 2.7).
The other types of PTM mimicry we observed can proceed through single 
point mutations
In this study, findings were also made with regard to the feasibility of mimicry for 
other PTM types. The enrichment of potential aspartate (D) phosphomimics which 
we observed at structured tyrosine (Y) phosphorylation sites (Fig. 2.7A) can be 
reached by a single point mutation (UAU to GAU or UAC to GAC), as opposed to 
glutamate (E), which would require two base changes and was not significantly 
overrepresented (Watanabe and Yokobori, 2011). It is intriguing to speculate that 
part of the depletion of tyrosines in higher eukaryotes (Tan et al., 2009b) may be due 
to phosphomimetic mutations. Additionally, the mutation of disordered lysine 
acetylation sites (K) to glutamate (E) and of structured lysines to glutamine (Q)  both 
require only one point mutation. This indicates that these hypothetically mimetic 
mutations may occur first in evolution, and could then be followed by an additional 
single point mutation leading to transition to either aspartate (D) or asparagine (N), 
respectively. Similarly, the potential PTM-avoiding mutation of N-glycosylated 
asparagine (N) to glutamine (Q) can occur through a single point mutation.
2.4.4. Constraints on PTM sites at the population and somatic levels
Structured sites appear under clear selection pressure within populations and 
under functional constraint in individuals
Our results on PTM site conservation using data on natural variation and on disease 
mutations indicated that structured PTM sites are in fact also under strong 
constraint (Fig. 2.8–9), despite the observed absence of significant conservation 
when using a conservation scoring approach across species (Fig. 2.3–4). However, it 
should be noted that both the natural variant nsSNPs and the mutations associated 
with genetic disease from HGMD used here are limited to mutations which are at 
least non-lethal in early development. This is opposed to the situation across 
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species, where selection pressure even on essential positions may be relieved by 
strong functional divergence potentially aided by prior gene duplication. Our 
interpretation therefore is that these nsSNP datasets will be limited to mutations at 
structured sites which do not majorly interfere with protein folding, as potentially 
opposed to the conservation scores. Compared to these control sites, PTM sites 
then appeared significantly conserved. This indicates that it may be crucial in the 
analysis of structured PTM site conservation to distinguish between peripheral and 
core residues, which should be feasible for the majority of the human proteins 
investigated here through the use of homology modelling (Chothia, 2003; Eswar et 
al., 2007; Krieger et al., 2009; Braberg et al., 2012).
Ubiquitination and protein half-life may be aﬀected by rare polymorphisms
Additionally, although the low-frequency natural variation nsSNPs identified by the 
1000 Genomes Project exclusively through exome sequencing were discarded from 
this analysis due to their rarity, an investigation of these variants uncovered one 
significant enrichment of nsSNPs at lysine ubiquitination sites. Aside from this, the 
rare variants showed no significant preferences with regard to PTMs. It is tempting 
to speculate that these polymorphisms may modulate protein half-life by preventing 
polyubiquitination at certain sites, or modulate other types of ubiquitin signalling.
2.4.5. Summary of key points and perspective
In our analyses of the conservation of PTM sites compared to structurally similar 
background residues, we consistently found mild, but significant evidence of 
increased conservation of at least a fraction of PTM sites. Some sites were highly 
conserved, on par with catalytic residues (Fig. 2.5). The distributions of conservation 
scores at PTM sites, however, also included many residues which evolved rapidly. In 
addition to non-functionality, rapid divergence and lineage specificity, another 
explanation for the observed low conservation of a notable fraction of PTM sites 
may be the occurrence of specific types of mutations, which leave open the 
possibility of the site being functionally important in a given species.
Mimetic mutations, which resemble the modified amino acid and essentially fix the 
modified state, and PTM-avoiding mutations, which resemble its unmodified state 
and thereby disable the modification, may both decrease the apparent conservation 
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of a functionally important PTM site. Alternatively, a PTM site may arise at a residue 
which was previously already functional, and allow its function to be regulated 
(Pearlman et al., 2011). This is partially, but not completely alleviated by using a 
conservation scoring method which goes beyond determining the simple presence 
or absence of a modifiable residue, as has been done in this study. Ideally, a 
conservation scoring method that strongly rewards structural and biochemical 
similarity between residues should be developed for PTM sites.
Taken together, our results indicate that independently of structural characteristics, 
human PTM sites are mildly, but significantly more conserved overall than control 
residues at multiple evolutionary timescales for the six major PTM types studied.
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3. The human lysine acetylation system
3.1. Introduction
Lysine acetylation is a common post-translational modification conserved from 
prokaryotes to humans (van Noort et al., 2012), and aﬀects several thousand 
proteins in humans (Table 2.1). While the elucidation of its functions has not yet 
progressed as far as that of phosphorylation signalling, it has generated a large 
amount of interest due to its implication in transcriptional regulation and epigenetics, 
as well as in many other cellular processes, including metabolic regulation 
(Choudhary et al., 2009; Wang et al., 2010; Zhao et al., 2010). In this chapter, we 
applied a systematic data integration approach in order to identify lysine acetylation 
signalling proteins with interesting functional properties. In addition to presenting a 
concise overview of the human lysine acetylation signalling system using multiple 
types of data, we envision that this integrative approach may serve to highlight 
potentially under-appreciated candidates for detailed functional investigation.
3.1.1. Mechanisms and functional domains
Post-translational signalling systems are commonly described as being composed 
of “writer”, “reader” and “eraser” proteins (Seet et al., 2006; Lim and Pawson, 2010). 
Lysine acetylation is introduced by acetyltransferases, recognised by bromodomain 
proteins, and removed by deacetylases, which are described here in detail.
Acetyltransferases (Writers)
Acetylation of lysines is catalysed by lysine acetyltransferases (KATs), which were 
previously also termed histone acetyltransferases (HATs). These enzymes use acetyl-
CoA as an acetyl group donor, which is a metabolic intermediate connecting 
glycolysis to the citric acid cycle. Several domains with acetyltransferase activity 
have been described: in terms of Pfam domain families, these are MOZ/SAS 
(PF01853), KAT11 (PF08214) and GNAT (PF00583) (Punta et al., 2012). 
Mechanistically, all of these domains can catalyse the transfer of the acetyl group of 
acetyl-CoA to the ε-amino group of lysine by a sequential catalytic mechanism of ε-
amino group deprotonation followed by nucleophilic attack on the cofactor 
(Mischerikow and Heck, 2011). In addition to the internal acetylation of proteins on 
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lysine side chains, several enzymes in these families alternatively acetylate a 
protein’s N-terminal α-amino group, which can aﬀect protein half-life (Hwang et al., 
2010; Soppa, 2010; Wildes and Wells, 2010).
Bromodomain proteins (Readers)
The canonical reader domain for lysine acetylation is the bromodomain (Pfam: 
PF00439) (Sanchez and Zhou, 2009; Zhang et al., 2010b; Punta et al., 2012), which 
appears to be limited to nuclear proteins (Zeng and Zhou, 2002; Mujtaba et al., 
2007; Norris et al., 2009), though not all bromodomain proteins display binding to 
the core histones (Zhang et al., 2010b). Individual bromodomain proteins may 
display diﬀerent sequence specificities based on the residues neighbouring the 
acetylated lysine (Hudson et al., 2000). This has been more recently investigated in 
detail for 14 bromodomain-containing proteins from S. cerevisiae (Zhang et al., 
2010b). In certain proteins it occurs as two tandem bromodomains, resulting in the 
potential for combinatorial recognition of multiple acetylated lysines (Nakamura et 
al., 2007). Whether equivalently specialised reader domains exist in other 
compartments, as in the cytoplasm or mitochondria, remains to be determined 
(Norris et al., 2009). Alternatively, lysine acetylation might function primarily through 
conformational and electrostatic changes in its substrates outside the nucleus. 
Another type of domain, the PHD zinc fingers, has been found to very rarely bind 
acetylated lysine, for instance at H3K14 (Suganuma and Workman, 2011). However, 
as this domain is much more commonly involved in binding methylated lysine 
(Mellor, 2006), it was not included as a reader domain here.
Deacetylases (Erasers)
Reversal of lysine acetylation is catalysed by lysine deacetylases (KDACs), which are 
frequently also termed histone deacetylases (HDACs). At least two subgroups of 
these enzymes exist, though additional subdivisions have been described 
(Mischerikow and Heck, 2011). According to Pfam, these two sub-groups are the 
histone deacetylases (Pfam: PF00850) and sirtuins (Pfam: PF02146)  (Punta et al., 
2012). Histone deacetylases are Zn2+-dependent enzymes which hydrolyse the 
acetyllysine amide bond, yielding acetate and the deacetylated lysine-containing 
substrate protein. Sirtuins, named for their homology to the yeast protein Sir2, are 
NAD+-dependent enzymes. Sirtuins couple protein deacetylation to NAD+ hydrolysis, 
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yielding acetyl-ADP-ribose, nicotinamide and the deacetylated lysine-containing 
substrate. Alternatively, sirtuins have been reported to transfer the ADP-ribosyl 
moiety of NAD+ to the substrate, yielding a mono-ADP-ribosylated substrate protein 
and nicotinamide (Mischerikow and Heck, 2011).
3.1.2. Biological functions
Chromatin regulation
Lysine acetylation was first identified as a transcriptionally activating post-
translational modification of histones (Ogryzko et al., 1996; Spange et al., 2009). A 
simplified yet relevant model of this activity is that it can neutralise positive charges 
on histones, leading to a decrease in aﬃnity for the negatively charged phosphate 
backbone of DNA, thereby mediating an open chromatin conformation. For instance, 
H4K16 acetylation acts according to the above model by decreasing the aﬃnity 
between the disordered histone H4 N-terminus and the linker DNA between two 
nucleosomes, thereby decompacting chromatin fibres (Shahbazian and Grunstein, 
2007). Similarly, H3K9 acetylation is observed in transcriptionally active regions. 
However, the function of lysine acetylation on histones also depend on the specific 
residue which is acetylated. H3K4 acetylation acts as a repressive signal by 
decreasing the aﬃnity of certain activating chromodomain-containing proteins for 
methylated H3K9, thereby leading to heterochromatin formation and transcriptional 
repression (Xhemalce and Kouzarides, 2010). Other lysines such as acetylated 
H3K14 may act as a signal bound by reader proteins, while H3K56 acetylation 
appears to act as an identification mark for newly synthesised histones during S-
phase (Suganuma and Workman, 2011).
Connection with metabolism
In addition to many other cellular processes, especially those involving large protein 
complexes (Choudhary et al., 2009), lysine acetylation was shown to regulate 
metabolic enzymes in both humans and prokaryotes (Wang et al., 2010; Zhao et al., 
2010). This is interesting since the cofactor used in acetylation, acetyl-CoA, is a 
common metabolic intermediate. It has been found in both humans and in 
Salmonella that many metabolic enzymes seem to be regulated by acetylation 
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(Wang et al., 2010; Zhao et al., 2010; Lin et al., 2012). The eﬀects of lysine 
acetylation on the functions of these enzymes are diverse, and have been described 
as leading to either their activation, inactivation or destabilisation (Yu et al., 2008; 
Lammers et al., 2010; Zhao et al., 2010; Jiang et al., 2011; Lin et al., 2012). This 
illustrates a broad range of eﬀects for acetylation, similar to that of phosphorylation. 
As an additional example, the half-life of the RNase R exoribonuclease in E. coli is 
increased by enzymatic acetylation at one lysine residue, thereby increasing its 
concentration 3- to 10-fold under stress conditions (Liang et al., 2011).
In Salmonella, a positive correlation has been observed between the activity of 
glucose metabolism and the acetylation of various enzymes. Here, acetylation of 
certain enzymes has been described as favouring the metabolism of glucose by 
increasing enzyme activity in glycolysis and the citric acid cycle. In contrast, a 
decrease in acetylation of certain enzymes was described to favour the glyoxylate 
pathway and gluconeogenesis (Lin et al., 2012). A correlation between deacetylation 
state of certain metabolic enzymes and the concentration of acetyl-CoA has also 
been reported (Wang et al., 2010; Cai et al., 2011). Caloric restriction is associated 
with deacetylation of mitochondrial proteins (Schwer et al., 2009; Bao and Sack, 
2010), which appears to be catalysed by mitochondrial sirtuins, and redox stress 
also aﬀects lysine acetylation (Bao and Sack, 2010). These connections suggest that 
lysine acetylation signalling may be relevant to the study of human diseases 
including diabetes, obesity and cancer. Concordantly, histone deacetylase inhibitors 
have been developed for use as anti-cancer and anti-inflammatory treatments 
(Bantscheﬀ et al., 2011).
Additional functions
Since lysine acetylation removes a positive charge, its eﬀects could potentially be 
similar to those of phosphorylation, where negative charges are introduced 
(Kouzarides, 2000; Norris et al., 2009). Similarly to phosphorylation, lysine 
acetylation has been found to exert a wide range of eﬀects. Eﬀects on enzymatic 
activity, protein-protein interactions, DNA binding, protein stability and subcellular 
localisation have been documented (Glozak et al., 2005; Scroggins et al., 2007; Sun 
et al., 2007; Sadoul et al., 2008; Fantini et al., 2010; Liarzi et al., 2010; Xiong et al., 
2010). As in the charge-based mechanism described above for chromatin 
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decompaction, lysine acetylation can also decrease the DNA aﬃnity of transcription 
factors (Aran-Guiu et al., 2010).
Proteins can be acetylated at the α-amino group of the N-terminal amino acid, or at 
the ε-amino group of internal lysines. N-terminal acetylation seems to occur co-
translationally, and is very common in eukaryotes (Wildes and Wells, 2010)  and 
certain archaea, but extremely rare in bacteria (Soppa, 2010). N-terminal acetylation 
is thought to be a factor in determining protein half-life (Hwang et al., 2010). In 
biotechnology, acetylation has been used to create highly negatively charged 
enzymes that are less prone to aggregation and display increased stability (Shaw et 
al., 2008). Overall protein charge has also been implicated as a determinant of 
protein aggregation in neurodegenerative diseases (Shaw et al., 2010).
Lysine acetylation has also been implicated in neurological roles, including 
neurodegenerative disease. Inhibiting the deacetylase Sirt2 has been reported to 
counteract neurodegeneration in a model of Parkinson’s disease, and acetylation 
has similarly been reported to target mutant huntingtin for degradation in 
Huntington’s disease (Outeiro et al., 2007; Jeong et al., 2009). It has also been 
reported that neurotransmission aﬀects lysine acetylation of a number of proteins, 
as well as of histones in distinct brain regions (Sen and Snyder, 2010).
Lysine acetylation is additionally important in the endogenous regulation of 
microtubule assembly, which an acetyltransferase of the plant pathogen 
Pseudomonas  syringae has been shown to disrupt (Lee et al., 2012). Other 
pathogens also use acetyltransferases as virulence factors (Mittal et al., 2006; 
Mukherjee et al., 2006; Tasset et al., 2010).
3.1.3. Motivation and analysis outline
Due to the central importance of post-translational signalling systems such as lysine 
acetylation in cellular homeostasis, we were prompted to develop and refine a 
general framework for the study of PTM signalling systems by data integration. This 
method is applied here to lysine acetylation, a highly common PTM which displays a 
wide range of functions in higher eukaryotes as well as prokaryotes. Proteins with 
functions in lysine acetylation were identified, and were then systematically analysed 
based on their conservation, expression profile, protein-protein interactions and 
subcellular localisation. By integrating these types of information, the most 
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promising candidate proteins participating in lysine acetylation signalling were 
systematically highlighted and ranked by priority for targeted followup studies.
3.2. Methods
3.2.1. Identification of proteins with functions in lysine acetylation
Human proteins containing one or more lysine acetylation writer, reader and eraser 
Pfam domains were retrieved from UniProtKB/Swiss-Prot (release 2012_01), which 
provides Pfam domain annotation for its proteins (Punta et al., 2012; UniProt 
Consortium, 2012). For writers, domains used were: “MOZ/SAS” (PF01853), “KAT11 
family” (PF08214)  and “Acetyltransferase (GNAT) family” (PF00583). For readers, the 
domain was the “Bromodomain” (PF00439). For erasers, these were 
“Hist_deacetyl” (PF00850)  and “Sir2 family” (PF02146). Since it has been noted that 
some acetyltransferases are quite divergent and cannot be easily grouped by 
sequence homology (Mischerikow and Heck, 2011), we additionally performed a 
manual search of UniProtKB/Swiss-Prot for proteins with annotation relating to 
acetylation. In this search, we retrieved additional confirmed acetyltransferases, as 
well as proteins which were annotated to contain bromodomains, but not according 
to Pfam. This may potentially be due to a relatively strict, limited definition of the 
Pfam bromodomain Hidden Markov Model (HMM). We therefore additionally 
included all proteins with a match to the bromodomain superfamily definition (SCOP 
ID 47370)  in the SUPERFAMILY database (Gough et al., 2001; Wilson et al., 2007; 
2009). This resulted in the addition of three additional reader proteins with significant 
matches to SUPERFAMILY’s definition of the bromodomain family.
3.2.2. Analysis of evolutionary conservation
Two complementary analyses of evolutionary conservation of the lysine acetylation-
related candidate proteins were performed, at diﬀerent evolutionary distances. For 
an analysis largely focused on vertebrates and shorter evolutionary distances, 
aligned protein homology clusters were obtained from Ensembl Compara (Release 
65, December 2011) (Flicek et al., 2012). In order to retrieve the best-matching 
ortholog for each human protein, the global pairwise sequence identity percentage 
of the best-matching pair of sequences corresponding to the human Ensembl gene 
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identifiers (as mapped to by the original UniProtKB/Swiss-Prot identifiers) was used 
to generate the protein conservation profile figure. A complementary analysis of 
more distantly related species was performed analogously using ortholog pairs from 
InParanoid 7 (Ostlund et al., 2010). Since InParanoid does not provide alignments, 
sequence identities of pairs were calculated using global pairwise Needleman-
Wunsch alignments. For comparison of the average conservation of the lysine 
acetylation-related proteins to other groups of interest, a list of human transcription 
factors was obtained (Vaquerizas et al., 2009), and human essential genes were 
obtained from version 6.8 of the DEG database (Zhang and Lin, 2009). Missing 
orthologs were considered to have a sequence identity of zero when calculating 
average conservation. The matrices were visualised using Genesis 1.7.6 (Sturn et al., 
2002), and complete-linkage hierarchical clustering was used to cluster the genes in 
the conservation profile figures.
3.2.3. Subcellular localisation
Subcellular localisation information was obtained from UniProtKB/Swiss-Prot 
2012_01, and terms were manually simplified to “Nuclear” or “Cytoplasmic”. 
Proteins which were annotated as both were termed “Shuttling” proteins, since they 
are presumably able to change their localisation between the nucleus and 
cytoplasm. Proteins without subcellular localisation annotation in UniProt were 
labelled “Unknown”.
3.2.4. Protein-protein interaction network
Known protein-protein interactions were obtained from STRING 9.0.5 (Szklarczyk et 
al., 2011). Only experimental and “knowledge-based” interactions from external 
databases were used, with the default “medium confidence” of 0.4 as the threshold. 
Cytoscape 2.8.3 was used to generate the network figure using an edge-weighted 
force-directed layout (“BioLayout”), weighted using STRING’s combined confidence 
score (Smoot et al., 2011). Statistical assessment of the number of proteins in a 
given category which interact with at least one lysine acetylation substrate, 
compared to the proteome-wide figure, was done using Fisher’s exact test.
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3.2.5. Expression profiles and co-expression network
Human expression data was obtained from the BioGPS “U133A/GNF1H Gene 
Atlas” (Su et al., 2004) and log2-transformed to achieve a more Gaussian-like value 
distribution, which is required for assessing correlations using the Pearson product-
moment correlation coeﬃcient (Ballman, 2008). Up-to-date mappings of probe sets 
to transcripts were obtained for the AﬀyMetrix U133A chip from Ensembl (release 
65, December 2011) (Flicek et al., 2012). Since recent probe set mappings were not 
available for the custom GNF1H chip, its expression values were not used. We 
chose this expression dataset due to its high reported reproducibility and linear 
relationship between abundance at the transcript and protein levels (Lage et al., 
2008). Six of the 84 samples were from human cancer cell lines, rather than healthy 
human tissues. While these are shown in the expression matrix figure, only healthy 
tissues were considered when quantifying co-expression for the co-expression 
network. The Pearson product-moment correlation coeﬃcient was used for 
detecting significant co-expression via Student’s t-distribution, with Bonferroni 
correction for multiple testing. Cytoscape 2.8.3 was used to generate the network 
figure using an edge-weighted force-directed layout (“BioLayout”), weighted using 
the correlation coeﬃcients, with minor manual adjustments to reduce overlap 
(Smoot et al., 2011). We also quantified the expression breadth of genes as 1-τ, 
where τ is the tissue specificity index
τ =
N
i= 1 (1 − xi )
N − 1  
and where N is the number of tissues and xi is the expression profile component 
normalised by the maximal component value (Yanai et al., 2005).
3.2.6. Candidate ranking
The candidate score is a rank-based measure which takes into account a protein’s 
average conservation according to the Compara-based approach, its number of 
protein-protein interactions, number of co-expressed genes and its expression 
breadth across tissues, all with equal weight. It was calculated as follows: for each 
gene in each column, the fraction of lower- or equal-ranking genes in a given column 
was calculated, and the final score is composed of the average of these column 
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scores. Genes which had no information available in a column were not considered 
for its scoring. The final score thus ranges between 0 (for a protein ranking lowest or 
unranked in all categories) and 1 (for a protein ranking highest in all categories). 
When generating the ranked summary table, information on genetic disease 
mutations from HGMD (Stenson et al., 2009) and OMIM (Amberger et al., 2009) as 
well as cancer-causing mutations from the Cancer Gene Census (Futreal et al., 
2004) were also integrated as an additional metric of the functional importance of 
genes. Additionally, significant up- or down-regulation of the mouse orthologs 
(identified using Ensembl Compara) in the diﬀerentiation of embryonic stem cells as 
determined using expression data from StemBase (Sandie et al., 2009) is shown. 
This methodology is described in detail in Chapter 4, section 4.2.3.
3.3. Results
3.3.1. Identification of 100 lysine acetylation-related candidate proteins
By searching for functional Pfam domains as well as manually for proteins either 
confirmed or likely to be functionally involved in lysine acetylation (as either writer, 
reader or eraser proteins), we were able to identify a set of 100 human candidate 
proteins (Fig. 3.1). Notably, four proteins fell into both the writer and reader 
categories, indicating that they might be able to integrate the modification state of 
an adjacent lysine in the substrate targeting of their acetyltransferase activity. This 
writer-reader overlap and the size of the functional categories is reiterated as a Venn 
diagram in Figure 3.2. Acetyltransferases and bromodomain reader proteins made 
up the largest groups, consisting of 43 proteins each, with an overlap of 4 proteins 
containing both types of domain. The smallest group were the deacetylases, 
consisting of 18 proteins and showing no overlaps.
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NCOA1, NCOA2, NCOA3,
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CREBBP, EP300,
KAT2A, KAT2B
ASH1L, ATAD2, ATAD2B,
BAZ1A, BAZ1B, BAZ2A,
BAZ2B, BPTF, BRD1, BRD2,
BRD3, BRD4, BRD7, BRD8,
BRD9, BRDT, BRPF1,
BRPF3, BRWD1, BRWD3,
CECR2, KIAA2026, MLL,
PBRM1, PHIP, SMARCA2,
SMARCA4, SP100, SP110,
SP140, SP140L, TAF1,
TAF1L, TRIM24, TRIM28,
TRIM33, TRIM66,
ZMYND8, ZMYND11
HDAC1, HDAC2, HDAC3,
HDAC4, HDAC5, HDAC6,
HDAC7, HDAC8, HDAC9,
HDAC10, HDAC11,
SIRT1, SIRT2, SIRT3,
SIRT4, SIRT5, SIRT6,
SIRT7
 MOZ/SAS family
Acetyltransf_1 / GNAT
KAT11 family
Hist_deacetyl
Sir2 family (sirtuins)
Bromodomain
Human genes
acetyltransferases bromodomain proteins deacetylases
ReadersWriters Erasers
Protein domains
Acetyltransf_1 / GNAT
 MOZ/SAS family
CREBBP, EP300,
KAT2A, KAT2B
Figure 3.1: Functional classes, Pfam domains and gene symbols for putative components of 
the human lysine acetylation system. Four genes fall into both the writer and reader 
categories.
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39
39
18
4
acetyltransferases (W)
bromodomain proteins (R)
deacetylases (E)
Figure 3.2: Venn diagram showing the number of human proteins for lysine acetylation-related 
functional classes.
3.3.2. Nearly all candidate proteins are highly conserved in vertebrates
Figure 3.3 shows the conservation of the human lysine acetylation proteins, as 
determined using homology information from Ensembl Compara. A strikingly high 
degree of conservation is apparent, with the large majority of proteins having 
orthologs in all vertebrates. Interestingly, the potentially combinatorial writer-reader 
proteins (WR) were the best-conserved category overall, despite their potentially 
more complex architecture of at least two distinct domains. Erasers and readers 
showed similarly strong conservation to each other, with the notable exception of 
the bromodomain reader proteins KIAA2026, SP100, SP110, SP140 and SP140L. 
SP110 and SP140 are components of nuclear bodies, which are also referred to as 
nuclear dots or PML bodies (UniProt Consortium, 2012). Although orthologs of these 
proteins apparently exist in all mammals, they are highly divergent outside the 
primate lineage (Fig. 3.3). This suggests that lysine acetylation signalling 
mechanisms linked to nuclear bodies, which might use these five proteins as 
readers, may have evolved at the base of the primate lineage. Writers as a group 
displayed the most cases where orthologs were absent in species, often in patterns 
not constricted to a lineage, though many writers were also highly conserved even in 
non-vertebrates.
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Figure 3.3: Conservation of human lysine acetylation proteins, based on Ensembl Compara. 
Columns represent species, while rows represent genes. Rows are coloured according to the 
gene’s functional category, and shaded according to the sequence identity between the human 
protein and its best-matching ortholog in a species. Missing orthologs are shown in white.
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Figure 3.4: Conservation of human lysine acetylation enzymes, based on InParanoid. Fewer 
species were covered, but with longer evolutionary distances. For a complete description of 
the plot content please see Figure 3.3.
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Across the species in Ensembl Compara, the lysine acetylation-related proteins were 
significantly better conserved than the human proteome-wide average (p = 8.7-137, 
Mann-Whitney U test), at an average sequence identity of 63.4% compared to the 
human average of 51.2%. Their conservation is on par with that of essential genes 
at 64.0% (though lower, p = 6.2-5, Mann-Whitney U test). This also makes them 
significantly more conserved than the average for human transcription factors of 
53.3% (p = 6.7-86, Mann-Whitney U test), which have been shown to display a 
relatively high degree of evolutionary plasticity in the human lineage (De et al., 2008; 
López-Bigas et al., 2008). In both transcription factors and in the lysine acetylation 
signalling proteins studied here, there appears to be substantial variation between 
highly conserved factors likely to be essential on the one hand, and less conserved, 
dynamically evolving proteins on the other, as evidenced by their respective 
standard deviations in sequence identity of 34.6% and 30.3%, as well as the gaps in 
their conservation profiles (Fig. 3.3, Fig. 3.4). As a category, the bromodomain 
proteins (readers) displayed the lowest conservation at an average of 61.2%, and 
high variation at a standard deviation of 30.5%, followed by the acetyltransferases 
(writers) with 63% average sequence identity.
A complementary approach based on a resource containing a much larger number 
of non-vertebrate species, InParanoid, is shown in Figure 3.4. Both here and in 
Figure 3.3, the conservation of the best putative ortholog is indicated based on 
global sequence identity, which means that large changes such as domain 
acquisitions, a common mechanism in the evolution of phosphorylation signalling 
systems and proteins in general (Chothia and Gough, 2009; Jin and Pawson, 2012), 
should be clearly visible as decreased sequence identity.
In the alternative InParanoid approach, the human lysine acetylation candidate 
proteins are also well-conserved within the vertebrates. In addition, since InParanoid 
covers a much wider phylogenetic range, divisions become apparent between those 
candidates which are conserved across very long evolutionary distances, and others 
which appear to have arisen more recently, most likely by expansion of protein 
families through gene duplication. The most evolutionary ancient proteins include 
the acetyltransferase and elongator complex component ELP3 as well as the 
histone deacetylases HDAC1 and HDAC2. These appeared to have orthologs in all 
eukaryotes, and they were only non-conserved in E. coli (the rightmost column).
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In three cases (KIAA2026, HDAC7 and TAF1L), the InParanoid approach reported 
that no orthologs were present outside of humans, though Compara did find a 
number of orthologs comparable to other candidates. These were artefacts caused 
by identifier mapping problems to the relatively old InParanoid release, and they did 
not aﬀect any of the other genes.
3.3.3. Many substrates are exclusively located in the cytoplasm
More than half of the writer and eraser candidates are observed in the cytoplasm at 
least some of the time (cytoplasmic or “shuttling”). Their substrates are most 
frequently observed exclusively in the cytoplasm (Figure 3.5). Conversely, 
bromodomain reader proteins appear absent from the cytoplasmic environment 
(unless shuttling, 15% of proteins), perhaps hinting at the existence of other 
specialised cytoplasmic reader domains yet to be identified in this part of the cell.
21%
15% 64%
ERWRW
Nuclear Shuttling Cytoplasmic Unknown
20%
41%
20%
20%
Substrates
13%
28%
31%
28%
50% 50%
22%
44%
33%
Figure 3.5: Subcellular localisation of lysine acetylation-related proteins and of lysine 
acetylation substrates.
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3.3.4. Functional classes tend to share physical interactions
Writer
Writer/Reader
Reader
Eraser
Physical
interaction
Cytoplasmic
(incl. partially)
Figure 3.6: Protein-protein interaction network, showing known physical interactions among 
human lysine acetylation-related proteins. Node colours indicate functional category (blue: 
writers, brown: writer-readers, orange: readers, green: erasers). Dark blue node borders 
indicate either cytoplasmic or “shuttling” subcellular localisation.
Analysing the protein-protein interaction network of the lysine acetylation-related 
candidates revealed that functional classes (writers, readers and erasers) tend to 
cluster together in a force-directed layout (Fig. 3.6). This could either be due to a 
similar set of interaction partners, or due to mutual interactions. For histone 
deacetylase-family erasers (HDAC1 to HDAC11), both seem to be the case. 
Acetyltransferases seem to cluster together due to shared interactors, which may 
either be specificity-mediating adaptor proteins reminiscent of E3 ubiquitin ligases, 
or they might also be acetylation substrates. Readers tend to interact with one 
another, suggesting that they might form part of larger complexes which might be 
performing combinatorial readout of multiple acetylation sites. SMARCA4 interacted 
with the largest number of other reader proteins, and is one of the most highly 
conserved reader proteins (Fig. 3.3). Additionally, we found that around half of the 
candidate proteins were not known to physically interact with any other lysine 
acetylation-related proteins.
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Table 3.1: Percentage of proteins in diﬀerent functional categories which physically interact 
with lysine acetylation substrates. Fisher’s exact test was used to compare the number of 
proteins which interact with at least one acetylated substrate to that across the entire human 
proteome.
Category Interacting with 
K-ac substrates
Not interacting with 
K-ac substrates
Percentage 
interacting
p-value
All K-ac-related proteins 66 34 66% 2E-06
W 23 16 59% 0.04
WR 4 0 100% 0.03
R 23 16 59% 0.04
E 16 2 88.9% 5.4E-05
K-ac substrates 2099 804 72.3% 9.8E-205
Other human proteins 7270 10019 42%
All Nuclear 1628 1222 57.1%
All Shuttling 1381 496 73.6%
All Cytoplasmic 4951 5470 47.5%
All Unknown 1437 3657 28.2%
In an analysis of the known physical interactions of the diﬀerent functional 
categories of lysine acetylation-related proteins with acetylation substrates, it was 
found that especially eraser proteins were highly likely to interact with acetylated 
proteins (Table 3.1). Nearly 89% of eraser proteins, as well as all of the combinatorial 
writer-reader proteins displayed at least one such substrate interaction. In total, 66% 
of all lysine acetylation-related candidate proteins studied here were known to 
interact with acetylation substrates, significantly higher than the proteome-wide 
percentage of 42% (p = 2-6, Fisher’s exact test). Acetylation substrates also 
frequently made interactions with other acetylated proteins, at a percentage of 
72.3% (p = 9.8-205, Fisher’s exact test). These numbers may indicate strong 
functional links between diﬀerent acetylation-related proteins and substrates, as well 
as among the acetylated substrates themselves.
In terms of subcellular localisation, “shuttling” proteins, which can be found both in 
the nucleus and the cytoplasm, were among the most frequent interactors with 
acetylation substrates, at 73.6%. Conversely, only 28.2% of proteins with unknown 
localisation interacted with acetylated proteins.
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3.3.5. Many candidates show significantly similar expression profiles
Co-expression analysis can be used to identify functionally related genes (Mason et 
al., 2009; Nayak et al., 2009). This type of analysis further allows us to highlight 
functionally related proteins within the lysine acetylation system which are not 
necessarily physical interactors, but which may be active in concert in similar sets of 
tissues (Fig. 3.7). This figure also shows that the candidate proteins varied widely 
both in their average expression and in their expression between individual tissues. 
Some proteins were very highly expressed in some tissues, but were otherwise 
generally inactive, indicating specialised rather than universal roles. We quantified 
this aspect by calculating the expression breadth for each gene, which allowed us to 
highlight candidates which were expressed across a large number of tissues.
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Figure 3.7: Expression profiles of lysine acetylation-related proteins in human tissues. Columns 
correspond to diﬀerent tissues, while rows show individual genes. The colour gradient 
proceeds from blue for low expression (1.5 standard deviations below the chip-wide average) 
through black (chip-wide average expression) to yellow for high expression (up to 1.5 standard 
deviations above the chip-wide average). Complete-linkage hierarchical clustering was 
performed to arrive at the final layout.
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Writer/Reader
Reader
Eraser
Cytoplasmic
(incl. partially)
r = 0.9
r = 0.75
r = 0.6
r = 0.45
r = -0.6
Expression correlation
(Pearson’s r)
Figure 3.8: Co-expression network of lysine acetylation-related proteins in healthy human 
tissues. Genes are represented as nodes, while edges represent significant co-expression 
between two genes. The line thickness and shading of the edges represent the strength of co-
expression, with blue representing inverse correlation.
Figure 3.8 shows significant expression correlations between the candidate proteins, 
including between candidates belonging to separate functional classes. Notably, this 
analysis revealed a larger number of links between proteins than their physical 
interaction network (Fig. 3.6), with fewer candidates appearing isolated. Here, 
candidates were frequently co-expressed across functional categories, indicating 
significant functional associations between e.g. acetyltransferases and readers. This 
makes mechanistic sense, since certain reader proteins may only need to be 
expressed if a corresponding writer enzyme is present. In a similar potential 
mechanistic connection, expression of the histone deacetylase SIRT2 was found to 
be significantly anti-correlated with the acetyltransferase HAT1 (as well as HDAC1). 
Both SIRT2 and HAT1 act in histone H4 acetylation, respectively deacetylating 
H4K16 and acetylating H4K5/H4K12 (Kouzarides, 2007), which lends support to the 
functional significance of their anti-correlated expression patterns.
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3.3.6. Candidate ranking
In addition to presenting a concise overview of the human lysine acetylation 
signalling system using multiple types of data, one primary motivation of this 
chapter was to integrate this information in order to highlight the most promising 
candidate proteins participating in lysine acetylation signalling, and to systematically 
prioritise them for targeted followup studies. This is done here by presenting an 
informative summary table of information on all candidates, as well as by ranking 
them using a scoring function (Table 3.2). The scoring function takes into account a 
candidate protein’s average conservation according to the Compara analysis, its 
number of protein-protein interactions, the number of co-expressed genes, and the 
expression breadth (fraction of tissues where a gene is expressed) of the candidate.
99
Table 3.2: Candidate list ranked by candidate score. This table lists human lysine acetylation-
related proteins according to their apparent functional importance. The candidate score is a 
rank-based measure, which takes into account the four central columns (conservation 
according to the Compara analysis, protein-protein interactions, co-expression and expression 
breadth) with equal weight.
Gene Class Subcellular 
localisation
Disease 
implications
Conservation 
(Average 
sequence 
identity)
Known 
protein-
protein 
interactions
Degree of 
co-
expression
Expression 
breadth
Expression 
trend in ESC 
differentiation
Candidate  
score
Candidate 
rank
HDAC3 E Nucleus 87% 18 41 0.66 0.87 1
HDAC1 E Nucleus 87% 24 34 0.66 0.85 2
HDAC2 E Nucleus 86% 19 15 0.73 0.76 3
BAZ2A R Nucleus 61% 6 46 0.87 0.73 4
BRPF1 R Both 81% 4 35 0.69 0.73 5
KAT6A W Nucleus 68% 7 30 0.75 0.71 6
TAF1 R Nucleus HGMD/OMIM 69% 3 38 0.72 0.68 7
EP300 WR Both CGC/HGMD/OMIM 74% 19 12 0.70 Down 0.67 8
BAZ1B R Nucleus 67% 6 38 0.67 0.67 9
SMARCA4 R Nucleus CGC/HGMD/OMIM 74% 17 20 0.64 0.67 10
ELP3 W Both 81% 1 25 0.78 0.66 11
HDAC11 E Nucleus 68% 9 19 0.79 0.65 12
CREBBP WR Both CGC/HGMD/OMIM 74% 18 11 0.66 0.64 13
TRIM33 R Nucleus CGC/OMIM 68% 7 29 0.65 0.63 14
NCOA1 W Nucleus CGC/HGMD 68% 7 24 0.68 0.63 15
BRD3 R Nucleus CGC 74% 2 34 0.67 0.63 16
KAT8 W Nucleus 69% 5 15 0.82 Down 0.62 17
SMARCA2 R Nucleus HGMD/OMIM 76% 11 8 0.64 Up 0.60 18
BRD7 R Nucleus 66% 4 37 0.66 0.60 19
HDAC6 E Both 52% 11 16 0.86 Down 0.59 20
ZMYND11 R Nucleus HGMD 80% 3 11 0.74 Up 0.59 21
BRD4 R Nucleus CGC 60% 8 21 0.74 0.59 22
BRD2 R Nucleus 73% 1 29 0.70 0.58 23
SIRT1 E Both HGMD 62% 14 33 0.53 Down 0.57 24
TRIM28 R Nucleus 53% 7 22 0.73 Down 0.57 25
CLOCK W Both HGMD 76% 6 5 0.71 0.56 26
NAT10 W Nucleus 77% 1 29 0.61 0.56 27
NAA10 W Both HGMD/OMIM 68% 27 0.82 0.55 28
NAA50 W Cytoplasm 82% 21 0.71 0.55 29
MLL R Nucleus CGC 69% 5 26 0.61 0.55 30
NCOA3 W Both HGMD 68% 7 29 0.43 Down 0.55 31
NCOA2 W Nucleus CGC 73% 8 19 0.54 0.54 32
KAT5 W Both 72% 6 19 0.63 Down 0.54 33
BRD1 R Nucleus HGMD 64% 4 34 0.61 0.54 34
NAA40 W Unknown 77% 40 0.55 0.53 35
KAT6B W Nucleus HGMD/OMIM 66% 4 18 0.73 Down 0.53 36
KAT2B WR Nucleus 75% 15 8 0.47 0.53 37
HDAC5 E Both 69% 10 16 0.54 0.52 38
KAT2A WR Nucleus 76% 6 5 0.64 Down 0.51 39
ASH1L R Both 67% 22 0.79 Up 0.50 40
TRIM66 R Nucleus 52% 37 0.79 0.50 41
HDAC7 E Both 61% 9 0.76 0.49 42
NAT9 W Unknown 62% 25 0.80 0.48 43
SIRT2 E Cytoplasm 60% 7 3 0.79 Up 0.48 44
HAT1 W Both 77% 27 0.56 Down 0.48 45
ZMYND8 R Unknown 72% 1 21 0.62 0.47 46
CDYL W Nucleus 73% 3 20 0.52 Down 0.46 47
PHIP R Nucleus HGMD 71% 31 0.55 0.44 48
MGEA5 W Both HGMD 80% 17 0.63 0.44 49
NAA60 W Unknown 70% 15 0.71 0.43 50
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Gene Class Subcellular 
localisation
Disease 
implications
Conservation 
(Average 
sequence 
identity)
Known 
protein-
protein 
interactions
Degree of 
co-
expression
Expression 
breadth
Expression 
trend in ESC 
differentiation
Candidate  
score
Candidate 
rank
HDAC4 E Both HGMD/OMIM 68% 12 5 0.43 0.42 51
CDY1 W Nucleus 49% 22 0.81 0.42 52
CDY2A W Nucleus 50% 22 0.80 0.42 53
HDAC8 E Both 76% 9 0.40 54
SIRT4 E Cytoplasm 66% 1 8 0.71 0.40 55
BPTF R Both 61% 36 0.57 0.38 56
ATAD2B R Unknown 63% 38 0.48 0.38 57
TRIM24 R Both OMIM 65% 5 8 0.59 0.38 58
SIRT3 E Cytoplasm HGMD 51% 2 4 0.83 0.38 59
HDAC9 E Nucleus HGMD 70% 11 0.38 60
SIRT6 E Nucleus 59% 14 0.81 Down 0.38 61
SIRT5 E Cytoplasm HGMD 68% 2 13 0.55 0.37 62
BAZ1A R Nucleus 66% 2 20 0.51 0.37 63
KAT7 W Nucleus 80% 6 0.59 0.36 64
SAT1 W Cytoplasm HGMD/OMIM 65% 1 1 0.73 0.36 65
SIRT7 E Both 58% 38 0.44 Up 0.34 66
NAA11 W Both 61% 20 0.65 0.33 67
CSRP2BP W Both 78% 2 0.30 68
BRPF3 R Unknown 73% 4 Down 0.30 69
PBRM1 R Nucleus CGC 75% 2 Up 0.28 70
HDAC10 E Both 54% 13 0.27 71
GTF3C4 W Nucleus 63% 2 0.67 0.25 72
ATAD2 R Nucleus 65% 1 9 0.43 0.25 73
BAZ2B R Nucleus 67% 8 0.54 0.25 74
GNPNAT1 W Cytoplasm 81% Down 0.24 75
SP100 R Nucleus 27% 20 0.59 Up 0.23 76
SP140 R Both 28% 1 21 0.39 0.23 77
SP110 R Nucleus HGMD/OMIM 27% 26 0.45 0.22 78
SP140L R Unknown 26% 30 0.27 0.21 79
NAA20 W Both 75% 0.20 80
BRD8 R Nucleus 61% 1 5 0.24 0.17 81
ESCO2 W Both HGMD/OMIM 56% 3 Down 0.15 82
ESCO1 W Both 59% 2 0.15 83
BRD9 R Unknown 62% 1 0.15 84
BRWD1 R Both HGMD 60% 1 0.12 85
BRWD3 R Unknown HGMD/OMIM 65% 0.11 86
TAF1L R Nucleus HGMD 64% 0.10 87
NAT6 W Cytoplasm 35% 8 0.43 Up 0.10 88
AANAT W Cytoplasm HGMD/OMIM 48% 8 0.22 0.09 89
SAT2 W Cytoplasm 51% 1 0.09 90
BRDT R Nucleus 54% 3 0.33 0.09 91
NAA30 W Cytoplasm 58% 0.06 92
NAT8 W Cytoplasm 46% 2 0.28 0.05 93
CECR2 R Unknown 52% Down 0.05 94
NAT14 W Cytoplasm 46% 0.03 95
NAT8L W Cytoplasm HGMD/OMIM 40% 0.02 96
NAT16 W Unknown 30% 0.02 97
KIAA2026 R Unknown 27% 0.01 98
SATL1 W Unknown HGMD 17% 0.00 99
NAT8B W Cytoplasm 0.00 100
The three very highly conserved deacetylases HDAC1–3, the widely expressed 
reader proteins BAZ2A, BRPF1 and TAF1, and the acetyltransferases ELP3 and 
KAT6A appear to be the most universally important components of the human lysine 
acetylation signalling system across tissues and species, according to the criteria 
used here. Strangely, both TAF1 and ELP3 are reported by Compara as absent in 
some species, such as Ornithorhynchus anatinus  (platypus), Felis  catus  (cat) and 
Sus scrofa (pig). InParanoid reports full conservation of these genes within its set of 
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species, which does not contain these three species. These might therefore be false 
negatives due to insuﬃcient sequencing coverage.
The genetic disease associations from HGMD and OMIM are spread relatively evenly 
across the table, while the nearly exclusively somatic cancer-causative mutations 
from CGC appear more frequently at the head of the list. This could be explained by 
the consideration that essential genes, where any mutations are likely to be 
embryonically lethal, should not tend to appear in the genetic disease databases 
(HGMD and OMIM), although these essential genes are of the highest functional 
importance.
Several of the lysine acetylation-related genes were either significantly up- or down-
regulated in diﬀerentiated cell types, as compared to embryonic stem cells (ESCs). 
This could be explained in light of the extensive chromatin remodelling that takes 
place during diﬀerentiation, and in which changes in histone acetylation play an 
important role (Rasmussen, 2003; Azuara et al., 2006; Meshorer and Misteli, 2006).
3.4. Discussion
Several potentially interesting aspects of the human lysine acetylation system were 
found during the above analyses. The proportions of the writer and eraser 
categories (Fig. 3.1, Fig. 3.2) were similar to the constitution of the phosphorylation 
and ubiquitination signalling systems, which contain a much smaller number of 
erasing enzymes compared to the number of modifying enzymes (for 
phosphorylation), or compared to the number of distinct modifying complexes (for 
ubiquitination) (Komander, 2009; Bischoﬀ and Schlüter, 2012). Potentially, this might 
indicate that erasers are primarily responsible for maintaining a dynamic equilibrium 
of acetylation and deacetylation at a large number of substrate sites, while the 
writers may have primary signalling roles at a more specific set of sites. Alternatively, 
it may indicate that a portion of lysine acetylation sites are not reversible. 
In addition, some writer enzymes displayed higher divergence than readers or 
erasers, indicating that they may potentially be the most evolvable part of the 
system among the vertebrates (Fig. 3.3). The conservation profiles also highlighted 
several strikingly conserved genes, including the acetyltransferases ELP3, NAT10 
and NAA20, the writer-reader proteins CREBBP, EP300, KAT2A, and KAT2B, the 
reader proteins SMARCA2 and SMARCA4, and the deacetylases HDAC1, HDAC2 
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and HDAC3. All of these except NAA20 also scored in the top third of the ranked 
table, potentially indicating that conservation is well-correlated with the other 
features included in the ranking method.
The conservation profiles generated using InParanoid, which covers many non-
vertebrate species, appeared to show interesting evidence of family expansions by 
gene duplication. Similar lineage-specific expansions have been described in the 
evolution of the lysine methylation system (Aravind et al., 2011).
With only two exceptions, the more highly-ranked half of the candidates are located 
at least partially in the nucleus, or their localisation was still unknown. Lower-ranked 
candidates more frequently occurred in the cytoplasm. This suggests that the most 
essential functions of lysine acetylation tend to be carried out within the nucleus. 
Since the higher-ranked half also display higher conservation, a remote speculation 
might be that lysine acetylation first fulfilled essential roles in the nucleus before 
diversifying into cytoplasmic roles over evolutionary time, perhaps accompanying 
the family expansions observed in Figure 3.4.
The results on the interaction network are in accordance with the consideration that 
the functional interactions between writers, readers and erasers can be separated in 
time and space, since they may take place on a substrate (Fig. 3.8). Aside from such 
indirect functional interactions, it is conceivable that some of the relative sparsity of 
the experimentally-determined protein-protein interaction network (Fig. 3.7) 
compared to the co-expression network (Fig. 3.8) may be due to physical 
interactions which remain unidentified. Though expression data is not an ideal 
predictor of protein concentration, studies in human cell lines and on the expression 
dataset used here have reported good correlations between mRNA and protein 
concentrations (Ballman, 2008; Lundberg et al., 2010; Vogel et al., 2010; Nagaraj et 
al., 2011). This indicates that the co-expressed genes might form stoichiometric 
complexes, and that co-expression could potentially point to direct physical 
interactions.
The writer, reader and eraser proteins as well as acetylation substrates frequently 
made physical interactions with other acetylated proteins (Table 3.2). This may 
indicate strong functional links between diﬀerent acetylation-related proteins and 
substrates, as well as among the acetylated substrates themselves. In addition, 
“shuttling” proteins, which can be found both in the nucleus and the cytoplasm, 
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were among the most frequent interactors with acetylation substrates (73.6%). 
Certain shuttling proteins might therefore take part in acetylation-dependent signal 
transduction mechanisms across the nuclear membrane.
In summary, this chapter has given an overview of the writer, reader and eraser 
proteins involved in the human lysine acetylation signalling system by using multiple 
types of data, including the conservation, expression patterns, protein-protein 
interactions and subcellular localisations of its components. This information was 
then integrated into a ranked summary table order to systematically highlight 
promising candidate proteins for detailed further investigation (Table 3.2). The 
approach we used here can be thought of as a generalised framework which can be 
applied to the study of PTM signalling systems, and which makes use of pre-
existing large-scale datasets.
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4. The interaction network of Oct4
This chapter is the result of a collaboration with Dr. Jyoti Choudhary’s group at the 
Wellcome Trust Sanger Institute, published in Pardo et al. (Pardo et al., 2010), an 
article of which I am a joint first author. My collaborators identified physical 
interactors of Oct4, a transcription factor with a central role in the establishment and 
maintenance of stem cell identity. Using similar methods to those presented in 
Chapter 3, I performed an analysis of its potential signalling functions. Here, I will 
present an in-depth analysis of the Oct4 interactome based on transcriptional 
regulation, expression data, sequence conservation and phenotypic data, including 
human disease phenotypes and cancers.
4.1. Introduction
Embryonic stem cells hold great promise in regenerative medicine due to their ability 
to diﬀerentiate into all three germ layers (endo-, meso- and ectoderm), and therefore 
to form all cell types of an adult organism. This property is termed pluripotency 
(Evans and Kaufman, 1981; Martin, 1981; Barberi et al., 2005). Their envisioned uses 
include the regeneration of tissues damaged by injury or degenerative diseases, 
growing autologous patient tissues for drug tolerance and eﬃcacy tests, and even 
the regeneration of complex organs through tissue engineering (Park et al., 2008; 
Yamzon et al., 2008; Zhou et al., 2008; Macarthur et al., 2009). They may also find 
applications in the generation of well-defined cell populations as models, which 
could be derived from them using defined combinations of factors (Enver et al., 
2009; Hyman and Simons, 2011; Spence et al., 2011). A continuing challenge, 
however, is the discovery of a safe and ethically acceptable means of obtaining cells 
with pluripotent capabilities. Induced pluripotent stem cells (iPS cells), which can be 
generated by reprogramming adult cells using specific combinations of transcription 
factors, are one viable option, though embryonic stem cells are still considered 
superior in their homogeneity and therapeutic safety (Belmonte et al., 2009). 
Diﬀerences in gene expression can exist between iPS cells and embryonic stem 
cells (Chin et al., 2009), and some iPS cells may carry chromosomal aberrations 
(Mayshar et al., 2010), though gene expression noise may also be a normal feature 
of ES cells which has been associated with the maintenance of pluripotency (Trott et 
al., 2012).
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Induced pluripotent cells capable of diﬀerentiating into all three germ layers were 
first generated from mouse fibroblasts by ectopic expression of four transcription 
factors: Oct4, Sox2, Klf4 and c-Myc (Takahashi and Yamanaka, 2006). This feat was 
then repeated with human fibroblasts (Takahashi et al., 2007). One of these four 
transcription factors, c-Myc, is an oncogene which was later shown to be 
expendable in iPS cell generation, though at the cost of reduced reprogramming 
eﬃciency (Dang, 1999; Nakagawa et al., 2008). While most approaches used viral 
delivery for the ectopic expression of the reprogramming factors, stable 
reprogramming by direct delivery of proteins fused with a cell-penetrating peptide 
has also been described, and alleviates the risk of mutagenesis (Kim et al., 2009a).
Another of the four reprogramming transcription factors, Oct4, has been shown to 
be key in maintaining embryonic stem cell identity, and is able to ectopically induce 
pluripotency in adult neural stem cells on its own (Kim et al., 2009b). Since 
combinatorial interactions of transcription factors are a common feature in the 
establishment and maintenance of cell type (Ravasi et al., 2010), insight into Oct4’s 
physical interaction partners should illuminate how the pluripotent state is 
established and maintained. In this study, my collaborators identified a considerably 
expanded set of Oct4-binding proteins in mouse embryonic stem cells. By 
integrating functional annotation with data on gene expression, transcriptional 
regulation, known protein-protein interactions, mutant phenotypes, disease and 
cancer, I here present a comprehensive analysis of the Oct4 interactome as 
determined through aﬃnity purification and mass spectrometry.
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•  Insertion of FTAP-tagged Oct4 via RMCE at Prmt locus in AB2.2 murine ES cells
•  Determined expression level at approximately 20-30% of endogenous Oct4
•  Immunoprecipitation of Oct4 and online nano-LC tandem mass spectrometry
Affinity 
purification & 
MS-MS
•  Identified 92 Oct4-associated proteins
•  Cross-verified list with literature for confirmed Oct4-interacting proteins
•  Determined most probable human orthologs and quantified conservation
Initial 
characterization
•  Analysed protein domain architectures using PFAM
•  Annotated genes using Gene Ontology, PANTHER, KEGG, REACTOME and MGI 
Mammalian Phenotype data
Functions
•  Constructed transcriptional regulatory network using published chromatin  
 immunoprecipitation data for transcription factors central in stem cell identity
•  Compared expression in ES cells and more differentiated cell types from multiple 
 studies and identified stem cell specific genes
Regulation
•  Determined overlap with the OMIM human hereditary disease database
•  Determined overlap with the Cancer Gene Census for cancer-causative genes
•  Analysed misexpression of Oct4-associated proteins using the Oncomine cancer 
 gene expression database
Disease and 
cancer
Identification and characterisation of Oct4-
associated proteins
Figure 4.1: An overview of the workflow undertaken to characterise the Oct4 interactome.
4.2. Methods
4.2.1. Identification of Oct4 interactors
My collaborators identified Oct4-interacting proteins in mouse embryonic stem cells 
through an aﬃnity purification and mass spectrometry approach. Using 
recombination-mediated cassette exchange (RMCE), my collaborators introduced 
an FTAP-tagged copy of Oct4 into murine AB2.2 embryonic stem cells at the Prmt 
locus (Pardo et al., 2010). The tagged copy was expressed at a low level in parallel 
with endogenous Oct4 (approximately 20–30% of the endogenous protein’s 
concentration). By using an FTAP-tag specific antibody, the tagged Oct4 was then 
immunoprecipitated in conjunction with interacting proteins. Three separate single-
step purifications were performed. Tandem mass spectrometry (MS/MS) in 
conjunction with nano-liquid chromatography (nano-LC)  was then used to identify 
the extracted proteins, and proteins appearing in all three Oct4-FTAP purifications 
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but not in controls were retained. The data are deposited in the Proteomics 
Identifications Database (PRIDE)  under the accession numbers 12005 through 
12010 (Vizcaíno et al., 2009). Using a data integration approach, I then analysed this 
high-confidence set of 92 Oct4 interactors.
4.2.2. Integrating known protein-protein interactions
To study the interactions among the Oct4 interactors and identify well-described 
protein complexes, experimental protein-protein interactions were obtained from the 
STRING database (Jensen et al., 2009). “Knowledge-based” interactions imported 
from other major databases were also included. The resulting network was 
visualised using Cytoscape 2.6.3 (Cline et al., 2007).
4.2.3. Expression at various diﬀerentiation stages
For the analysis of expression at diﬀerent stages of diﬀerentiation, data were 
obtained for 43 mouse samples in StemBase (Sandie et al., 2009), originating from 
16 studies with Aﬀymetrix MOE430A microarray chips, as used in an Oct4 
expression profiling study covering murine ESCs, embryonal carcinoma cell lines, 
and several early diﬀerentiated lineages (Campbell et al., 2007). Expression data 
were available for 70 of the 92 Oct4-associated proteins. Where multiple probes 
were available, the arithmetic mean expression was used. Student’s t-test was used 
for identifying genes diﬀerentially expressed in ESCs as compared to more 
diﬀerentiated cell types, and the Bonferroni correction was used for multiple testing. 
Expression values were log2-transformed and colour-coded as a gradient from blue 
(more than 1.5 times the standard deviation below the global microarray mean)  via 
black (microarray mean)  to yellow (more than 1.5 times the standard deviation above 
the mean). Average-linkage hierarchical clustering using using Genesis 1.7.6 (Sturn 
et al., 2002) was performed to arrive at the final layout.
4.2.4. Transcriptional regulation
ChIP-on-chip data were obtained for Oct4 and eight other transcription factors (Kim 
et al., 2008). The significance of the number of Oct4-associated proteins regulated 
by these factors was assessed against 1000 random sets of 92 genes. The protein 
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interaction network was generated with Cytoscape 2.6.3 (Cline et al., 2007), with a 
spring-embedded layout.
4.2.5. Sequence identity between mouse and human
Orthologous human proteins were identified with the g:Profiler orthology search tool 
(Reimand et al., 2007). Where g:Profiler was unable to provide an ortholog, NCBI 
BLASTP was used to find the best-matching human protein (Altschul et al., 1990). 
The one-to-one orthologous pairs were globally aligned with the Needleman-
Wunsch algorithm (Needleman and Wunsch, 1970). For assessment of the degree of 
conservation between the Oct4-associated proteins and their orthologs, sequence 
identities of all mouse-to-human ortholog pairs sequence lengths comparable to the 
Oct4-associated proteins in ENSEMBL release 57 were compared via a Mann-
Whitney U test.
4.2.6. Developmental, disease and cancer phenotypes
Mammalian Phenotype Ontology annotations were obtained from the Mouse 
Genome Informatics project (Blake et al., 2009), human disease associations were 
obtained from OMIM (Hamosh et al., 2005), and known cancer-causing mutations in 
genes were obtained from the Cancer Gene Census (Futreal et al., 2004). Student’s 
t-test was used to assess whether the observed numbers of Oct4 interactors with 
lethal phenotypes or disease, and cancer associations diﬀer significantly from those 
found in 1000 random sets of 92 genes.
4.2.7. Misexpression in cancer types
Data on significantly misexpressed human orthologs of the Oct4 interactors were 
obtained from the Oncomine database (Rhodes et al., 2007). To correct for multiple 
testing and expression noise, genes were considered misexpressed only if 
Oncomine reported a p-value below 10-10. This resulted in a manageable number of 
significant misexpression events. The network figure was generated using 
Cytoscape 2.8.2 (Cline et al., 2007), using a force-directed layout.
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4.2.8. Functional enrichment according to PANTHER annotation
The PANTHER functional annotation resource was used to identify annotation terms 
which were significantly overrepresented among the Oct4 interactors compared to a 
genome-wide background in the mouse (Thomas et al., 2003).
4.2.9. Overrepresented domains
Protein domains were identified with Pfam 24.0, and genome-wide and nuclear 
frequencies were calculated from domain annotations and experimentally 
determined subcellular localisation information in UniProtKB/Swiss-Prot release 
15.15 (UniProt Consortium, 2010). Fisher’s exact test was used to statistically 
assess the diﬀerences in domain occurrence.
4.3. Results
By integrating our list of Oct4-associated proteins obtained through aﬃnity 
purification and mass spectrometry with additional information, we hope to gain 
knowledge on the relative importance of the candidate proteins in stem cell identity 
and function. This information is then envisioned to be used to prioritise the most 
promising Oct4 interactors for further studies.
4.3.1. Identification of Oct4 interactors
Using a tandem aﬃnity purification approach followed by LC–MS/MS (liquid 
chromatography coupled to tandem mass spectrometry) in triplicate, my 
collaborators at the Sanger Institute were able to identify 92 Oct4-interacting 
proteins which were part of a diverse set of functional categories and complexes 
(Table 4.1). Sox2 and Nanog, two of the best-characterised Oct4 interactors 
(Reményi et al., 2003), were identified in only some of the three replicate 
experiments, and are therefore not included in this list. Overall, Oct4 associated with 
a varied set of proteins, including components of chromatin remodelling complexes, 
transcription factors and enzymes involved in histone and DNA methylation.
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Table 4.1: Oct4-associated proteins classified into protein complexes and functional 
categories. Gene names and sequence accessions for the IPI database are given, and the 
number of unique peptides in each of the three replicate experiments is shown. MW: molecular 
weight (Da).
Gene name Accession Description MW Exp I Exp II Exp III
Bait
Oct4 (Pou5f1) IPI00117218 POU domain, class 5, transcription factor 1 38705.35 20 19 21
NuRD complex
Chd4 IPI00396802 Chromodomain-helicase-DNA-binding protein 4 219096.34 21 40 33
Gatad2a IPI00625995 p66 alpha isoform a 67762.39 13 11 16
Gatad2b IPI00128615 Isoform 1 of Transcriptional repressor p66-beta 65712.08 13 7 16
Mbd3 IPI00131067 Isoform 1 of Methyl-CpG-binding domain protein 3 32168 4 6 4
Mta1 IPI00624969 Mta1 protein 80019.75 13 14 16
Mta2 IPI00128230 Metastasis-associated protein MTA2 75723.93 25 17 21
Mta3 IPI00125745 Isoform 1 of Metastasis-associated protein MTA3 67719.08 10 9 7
Hdac1 IPI00114232 Histone deacetylase 1 55609.93 11 12 11
Spalt-like transcriptional repressors
Sall1 IPI00342267 Sal-like 1 141745.1 11 17 18
Sall3 IPI00123404 Isoform 1 of Sal-like protein 3 140610.62 5 5 6
Sall4 IPI00475164 Isoform 1 of Sal-like protein 4 114711.29 35 29 28
BAF complex
Smarca4 IPI00875789 SWI/SNF related, matrix associated, actin dependent regulator 
of chromatin, subfamily a, member 4, isoform CRA_b
181913.68 3 5 1
Smarcc1 IPI00125662 Isoform 1 of SWI/SNF complex subunit SMARCC1 123326.28 7 3 4
Actl6a IPI00323660 Actin-like protein 6A 47930.54 4 1 1
FACT complex
Ssrp1 IPI00407571 Isoform 2 of FACT complex subunit SSRP1 81766.73 36 12 32
Supt16h IPI00120344 FACT complex subunit SPT16 120319.5 64 34 56
LSD1 complex
Aof2 IPI00648295 Amine oxidase (Flavin containing) domain 2 95113.5 9 6 7
Rcor2 IPI00226581 REST corepressor 2 58042.89 5 6 2
ISWI chromatin remodelling complex
Smarca5 IPI00396739 SWI/SNF-related matrix-associated actin-dependent regulator 
of chromatin subfamily A member 5
122291.43 5 7 2
INO80 chromatin-remodeling complex
Ino80 IPI00378561 Isoform 1 of Putative DNA helicase INO80 complex homolog 1 177265.25 5 6 1
Nfrkb IPI00274469 Nuclear factor related to kappa-B-binding protein 139134.5 22 11 4
Actl6a IPI00323660 Actin-like protein 6A 47930.54 4 1 1
Histone chaperone complex
Asf1a IPI00132452 Histone chaperone ASF1A 23099.19 3 1 3
Cabin1 IPI00380107 Calcineurin binding protein 1 245584.2 8 18 7
Hira IPI00123694 Isoform Long of Protein HIRA 113235.4 10 7 10
Ubn2 IPI00854896 Isoform 4 of Uncharacterized protein KIAA2030 142523.51 17 19 11
Transcription factors
Arid3b IPI00277032 Isoform 1 of AT-rich interactive domain-containing protein 3B 61091.99 9 8 3
Atf2 IPI00110172 Isoform 1 of Cyclic AMP-dependent transcription factor ATF-2 52550.73 4 5 5
Creb1 IPI00119924 Isoform 1 of cAMP response element-binding protein 36879.65 3 3 3
Ctbp1 IPI00128155 Isoform 1 of C-terminal-binding protein 1 48170.7 9 4 3
Ctbp2 IPI00856974 Isoform 2 of C-terminal-binding protein 2 107801.19 10 3 4
Klf4 IPI00120384 Kruppel-like factor 4 52531.81 1 1 2
Mitf IPI00125758 Isoform A of Microphthalmia-associated transcription factor 59160.39 2 3 1
Nfyc IPI00108204 Nuclear transcription factor Y subunit gamma 37230.86 7 3 1
Sp1 IPI00323887 Isoform 1 of Transcription factor Sp1 81309.84 5 4 6
Tcfe3 IPI00380308 Isoform 1 of Transcription factor E3 61555.7 9 5 7
Tcfeb IPI00314502 Transcription factor EB 52638.18 2 3 2
Zbtb10 IPI00223276 APUJÄUNLYHUK);)KVTHPUJVU[HPUPUNPZVMVYT 118071.48 9 5 12
Zbtb2 IPI00652356 Putative uncharacterized protein 58189.61 1 1 1
Zbtb43 IPI00230530 APUJÄUNLYWYV[LPU )PZVMVYTH 57551.37 2 1 3
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Gene name Accession Description MW Exp I Exp II Exp III
Transcription factors
Zfhx3 IPI00475055 AT motif binding factor 1 410697.11 3 36 1
Zfp217 IPI00758403 APUJÄUNLYWYV[LPU 115181.65 11 10 4
Zfp219 IPI00469594 APUJÄUNLYWYV[LPU PZVMVYT*9(FH 78831.33 4 6 7
Zfp513 IPI00830836 0ZVMVYTVMAPUJÄUNLYWYV[LPU 59968.12 1 2 1
Zic2 IPI00127145 APUJÄUNLYWYV[LPUA0* 55546.36 1 1 1
AZJHUI IPI00755380 :PTPSHY[V.LULTVKLS  58667.99 4 6 7
Regulation of transcription
Acin1 IPI00121136 0ZVMVYTVM(WVW[V[PJJOYVTH[PUJVUKLUZH[PVUPUK\JLYPU[OL
U\JSL\Z
151000.03 12 2 13
Brwd1 IPI00121655 0ZVMVYT(VM)YVTVKVTHPUHUK>+YLWLH[JVU[HPUPUNWYV[LPU
1
262057.12 1 2 2
Hcfc1 IPI00828490 /VZ[JLSSMHJ[VY* 216798.82 19 8 12
0ÄI IPI00126725 0U[LYMLYVUHJ[P]HISLWYV[LPU 50727.44 4 6 3
Phf17 IPI00453799 0ZVMVYTVM7YV[LPU1HKL 95434.25 4 2 4
9M_ IPI00406298 +5(IPUKPUNWYV[LPU9-? 76998.5 8 1 1
General transcription
Ttf2 IPI00112371 ;YHUZJYPW[PVU[LYTPUH[PVUMHJ[VY 126706.43 5 2 2
Recombination/repair
Lig3 IPI00124272 0ZVMVYT(SWOHVM+5(SPNHZL 114656.59 5 6 1
4ZO IPI00310173 4\[:OVTVSVN 152813.37 10 4 5
Parp1 IPI00139168 7\[H[P]L\UJOHYHJ[LYPaLKWYV[LPU 113491.6 24 17 33
Top2a IPI00122223 +5([VWVPZVTLYHZLHSWOH 173567.4 30 44 12
?YJJ IPI00118139 +5(YLWHPYWYV[LPU?9** 69270.68 6 3 1
?YJJ IPI00321154 (;7KLWLUKLU[+5(OLSPJHZLZ\I\UP[ 83802.29 6 5 13
?YJJ IPI00132424 (;7KLWLUKLU[+5(OLSPJHZLZ\I\UP[ 69726.04 12 5 12
Replication
9WH IPI00124520 9LWSPJH[PVUWYV[LPU(R+H+5(IPUKPUNZ\I\UP[ 69620.87 2 3 2
9WH IPI00132128 9LWSPJH[PVUWYV[LPU(R+HZ\I\UP[ 13688.99 1 1 1
Helicases
*OK IPI00107999 *OYVTVKVTHPUOLSPJHZL+5(IPUKPUNWYV[LPU 197601.13 8 9 7
*OK IPI00675483 *OYVTVKVTHPUOLSPJHZL+5(IPUKPUNWYV[LPU 234196.54 5 6 6
*OK IPI00875673 JOYVTVKVTHPUOLSPJHZL+5(IPUKPUNWYV[LPUPZVMVYT 224027.21 10 9 11
+O_ IPI00339468 0ZVMVYTVM(;7KLWLUKLU[95(OLSPJHZL( 150907.1 15 15 31
/LSSZ IPI00121431 0ZVMVYTVM3`TWOVJ`[LZWLJPÄJOLSPJHZL 95806.47 3 1 1
Histones
/PZ[OL IPI00282848 /PZ[VULJS\Z[LY/JPZVMVYT 20348.12 8 9 4
/PZ[OI IPI00407339 /PZ[VUL/ 11360.38 11 13 6
/PZ[OII IPI00229539 /PZ[VULJS\Z[LY/II 17248.15 9 7 4
Heterogeneous nuclear ribonucleoproteins
Hnrnpab IPI00277066 /L[LYVNLULV\ZU\JSLHYYPIVU\JSLVWYV[LPU()PZVMVYT 36302.44 3 2 2
Hnrnpl IPI00620362 /L[LYVNLULV\ZU\JSLHYYPIVU\JSLVWYV[LPU3 64550.49 10 4 8
/UYUW\ IPI00458583 7\[H[P]L\UJOHYHJ[LYPaLKWYV[LPU 88661.02 8 2 12
Histone ubiquitination (E3 ubiquitin ligase complex)
*\SI IPI00224689 *\SSPU) 111314 7 3 9
+KI IPI00316740 +5(KHTHNLIPUKPUNWYV[LPU 128026.73 7 5 16
Enzymes
*HK IPI00380280 *HYIHTV`SWOVZWOH[LZ`U[OL[HZLHZWHY[H[L
[YHUZJHYIHT`SHZLHUKKPO`KYVVYV[HZL
245649.59 4 18 11
+UT[H IPI00131694 0ZVMVYTVM+5(J`[VZPULTL[O`S[YHUZMLYHZL( 103203.53 4 4 7
+UT[S IPI00109459 +5(J`[VZPULTL[O`S[YHUZMLYHZLSPRL 49159.08 7 3 7
4`Z[ IPI00228457 0ZVMVYTVM/PZ[VULHJL[`S[YHUZMLYHZL4@:; 67588.54 4 2 3
Ogt IPI00420870 0ZVMVYTVM<+75HJL[`SNS\JVZHTPULWLW[PKL5
HJL[`SNS\JVZHTPU`S[YHUZMLYHZLR+HZ\I\UP[
118131.41 14 4 10
P4ha1 IPI00399959 0ZVMVYTVM7YVS`SO`KYV_`SHZLZ\I\UP[HSWOH 61132.82 14 5 5
Ppp2r1a IPI00310091 :LYPUL[OYLVUPULWYV[LPUWOVZWOH[HZL(R+HYLN\SH[VY`
Z\I\UP[(HSWOHPZVMVYT
66079.23 3 4 1
Trim24 IPI00227778 0ZVMVYT:OVY[VM;YHUZJYPW[PVUPU[LYTLKPHY`MHJ[VYHSWOH 114824.79 3 4 6
Trim33 IPI00409904 0ZVMVYT(SWOHVM,\IPX\P[PUWYV[LPUSPNHZL;904 125931.28 2 2 2
Karyopherins
Kpna2 IPI00124973 0TWVY[PUZ\I\UP[HSWOH 58234.28 7 7 2
Kpna3 IPI00230429 0TWVY[PUZ\I\UP[HSWOH 58193 2 1 2
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Gene name Accession Description MW Exp I Exp II Exp III
Chaperones
Dnaja1 IPI00132208 DnaJ homolog subfamily A member 1 45580.73 6 1 5
Proteasome
Psmb6 IPI00119239 Proteasome subunit beta type-6 25590.57 2 2 1
Nuclear assembly/organisation
Emd IPI00114401 Emerin 29417.38 2 1 1
Matr3 IPI00453826 Matrin-3 95085.04 14 6 11
Miscellaneous
Amotl2 IPI00263333 Isoform 1 of Angiomotin-like protein 2 85454.32 1 4 2
Cubn IPI00889898 Cubilin 407679.63 3 7 2
Nudc IPI00132942 Nuclear migration protein nudC 38334.29 2 2 2
4.3.2. Integrating known protein-protein interactions
Many of the Oct4-associated proteins provide links to interesting cellular systems. 
These include DNA repair proteins, components of the NuRD and BAF chromatin 
remodelling complexes, components of mRNP granules (compact cytoplasmic 
assemblies of translationally inactive mRNAs of uncertain function) (Erickson and 
Lykke-Andersen, 2011), enzymes involved in de novo DNA methylation and a 
particularly large set of transcription factors and chromatin remodellers (Fig. 4.1). 
These transcriptional regulators may be downstream eﬀectors in Oct4 signalling, 
mediating the large-scale chromatin changes observed in embryonic stem cells 
(Rasmussen, 2003; Azuara et al., 2006; Meshorer and Misteli, 2006).
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components
Figure 4.1: Oct4 interacts with a varied set of proteins. Network of protein-protein interactions 
within the Oct4 dataset. Blue borders are proteins downregulated upon ES cell diﬀerentiation. 
Orange fill indicates proteins whose absence results in embryonic lethality in the mouse.
4.3.3. Expression changes in diﬀerentiated cells
Of the Oct4 interactors, we find that one third are significantly downregulated in 
more diﬀerentiated cell types as compared to ES cells (Fig. 4.2). The pattern shown 
by most of these genes, including Oct4, is of a strong switch-like decrease in 
expression in more diﬀerentiated cell types.
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Figure 4.2: One third of the genes are significantly downregulated in diﬀerentiation. Expression 
of Oct4-associated genes in embryonic stem cells and diﬀerentiated cell types, based on 
microarray data. Expression values were log2-transformed and colour-coded as a gradient 
from blue (more than 1.5 times the standard deviation below the global microarray mean) via 
black (microarray mean) to yellow (more than 1.5 times the standard deviation above the 
mean). Columns correspond to experimental samples, arranged as follows: embryonal 
carcinoma P19  (EC), ES cells (ES), diﬀerentiating embryonic stem cells (DES), adult stem cells 
(AS), diﬀerentiated adult stem cells (DAS), mixed cells (M), and diﬀerentiated cells (D). Genes 
whose expression is significantly up- or downregulated in diﬀerentiation are marked “+” or “-” 
respectively. Diﬀerential regulation was assessed using Student’s t-test with the Bonferroni 
correction for multiple testing. Average-linkage hierarchical clustering was performed to arrive 
at the final layout.
4.3.4. Regulation by stem cell transcription factors
Approximately half of the Oct4-associated proteins are transcriptionally regulated by 
key transcription factors participating in stem cell regulatory networks (Fig. 4.3, Fig. 
115
4.4). For this analysis, published promoter binding data from chromatin 
immunoprecipitation experiments was obtained for Dax1 (Nr0b1), Klf4, Myc, Nac1 
(Btbd14b, Nacc1), Nanog, Rex1 (Zfp42), Zfp281 and Sox2. All nine are thought to be 
central in the maintenance of embryonic stem cell identity (Kim et al., 2008). 48 of 
the 92 interactor promoters (as well as Oct4’s own) are bound by at least one of 
these factors. Oct4 as a transcription factor has 10 regulatory targets among its 
interactors, including its own promoter.
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Figure 4.3: Regulation of Oct4 interactors by key stem cell transcription factors. This matrix 
shows promoter binding based on co-immunoprecipitation of Oct4 and 8 other transcription 
factors thought to be important in stem cell identity. Stem cell transcription factors correspond 
to columns while their target genes among the Oct4 interactors correspond to rows.
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In a network representation of the same data (Figure 4.4), it becomes especially 
apparent that while Nanog, Nac1, Dax1 and Sox2 share many targets with Oct4 
itself, c-Myc (Myc)  has several exclusive targets, including the DNA repair proteins 
Xrcc1 and Xrcc6.
Gene
TF Transcription factor
Target gene (promoter) Gene
Oct4
Oct4 target gene
Oct4 transcription factor
Figure 4.4: Regulation of Oct4 interactors by key stem cell transcription factors, presented as a 
network. The stem cell transcription factors are shown in dark grey, while their target genes 
among the Oct4-associated proteins are shown in light grey. Oct4 and its regulatory targets are 
highlighted in blue.
4.3.5. Sequence identity between mouse and human
The Oct4-associated proteins display significantly sequence conservation between 
mouse and human one-to-one orthologs (Fig. 4.5). The diﬀerence is significant at p 
= 1.3-20 (Mann-Whitney U test). Aside from a small number of outliers, this suggests 
that the identified Oct4-associated proteins are part of highly conserved systems 
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which are likely to be similarly important and similar in function in humans and other 
mammals.
0 20 40 60 80 100
genome-wide
Oct4-associated
Percent sequence identity
(mouse-human orthologs)
Figure 4.5: Oct4-associated proteins are significantly more conserved between human and 
mouse. Box plots with Tukey whiskers, showing sequence identity percentages as determined 
by global sequence alignment between the identified Oct4-associated proteins and their 
human one-to-one orthologs. Genome-wide sequence identities for all mouse-to-human one-
to-one ortholog pairs contained in Ensembl Compara are shown for comparison.
4.3.6. Developmental, disease and cancer phenotypes
Knockout phenotype information in mice was available for 50 of the 92 Oct4-
associated proteins, including Oct4 itself (Fig. 4.6). All 50 genes were annotated with 
non-normal phenotypes in at least one study. 42 out of the 50 Oct4 interactors 
which have been studied to date are essential for early mouse development, and 
mutations in these result in either pre-, peri- or postnatal lethality. In humans, a 
number of the one-to-one orthologs are associated with cancer and inherited 
developmental disorders (Table 4.2).
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Figure 4.6: Phenotypic analysis. List of phenotypes caused by spontaneous, induced, and/or 
genetically-engineered mutations in the genes encoding the Oct4-associated proteins as 
retrieved from the MGI resource. The number of genes with a particular phenotype is given.
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Table 4.2: Human hereditary disease associations for the human orthologs of Oct4-interacting 
proteins, obtained from the OMIM database.
Gene Disorder type Disorder
CREB1
CUBN
CUL4B
EMD
MATR3
MITF
MSH6
SALL1
SALL4
TFE3
TRIM24
TRIM33
ZFHX3
ZIC2
Cancer Histiocytoma, angiomatoid fibrous, somatic
Hematological Megaloblastic anemia-1, Finnish type
Multiple Mental retardation syndrome, X-linked, Cabezas typeMental retardation-hypotonic facies syndrome, X-linked, 2
Muscular Emery-Dreifuss muscular dystrophy
Muscular Myopathy, distal 2
Multiple
Tietz syndrome
Waardenburg syndrome, type IIA
Waardenburg syndrome/ocular albinism, digenic
Cancer
Colorectal cancer, hereditary nonpolyposis, type 5
Endometrial cancer, familial
Mismatch repair cancer syndrome
Multiple Townes-Brocks branchiootorenal-like syndromeTownes-Brocks syndrome
Multiple Duane-radial ray syndromeIVIC syndrome
Cancer Renal cell carcinoma, papillary, 1
Cancer Thyroid carcinoma, papillary
Cancer Thyroid carcinoma, papillary
Cancer Prostate cancer, susceptibility to
Developmental Holoprosencephaly-5
Table 4.3: Cancer-causative genes among the human orthologs of the Oct4-interacting 
proteins, according to the Cancer Gene Census project.
Gene Mutation Tissue Cancer type
CREB1
MITF
MSH6
POU5F1
SMARCA4
TFE3
TFEB
TRIM24
TRIM33
translocation mesenchymal clear cell sarcoma, angiomatoid fibrous histiocytoma
amplification epithelial melanoma
missense, 
nonsense, 
frameshift, 
splice site
epithelial
colorectal (somatic)
colorectal, endometrial, ovarian (germline)
non-polyposis colorectal cancer (hereditary)
translocation mesenchymal sarcoma
frameshift, 
nonsense, 
missense
epithelial NSCLC (non-small cell lung carcinoma)
translocation epithelial papillary renal, alveolar soft part sarcoma, renal
translocation epithelialmesenchymal renal, childhood epithelioid
translocation blood APL (acute promyelocytic leukemia)
translocation epithelial papillary thyroid
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4.3.7. Misexpression in cancer types
We determined significant over- and underexpression of the Oct4 interactors in 
various types of cancer using the Oncomine resource (Rhodes et al., 2007). Msh6, a 
mismatch repair gene implicated in hereditary predisposition to endometrial cancer 
(Table 4.3) (Ostergaard et al., 2005; Amberger et al., 2009), was here found 
significantly underexpressed in ovarian adenocarcinoma (Fig. 4.7). Two additional 
genes, Trim24 and Trim33, have been implicated in childhood papillary thyroid 
carcinoma (Klugbauer and Rabes, 1999). Here, we found Trim24 to be 
overexpressed in glioblastoma in addition to bladder and liver carcinomata, while 
Trim33 was underexpressed in glioblastoma and diﬀuse large B-cell lymphoma. Tfe3 
(Tcfe3) has been implicated in papillary renal cell carcinoma (Sidhar et al., 1996; 
Weterman et al., 1996), and was here found to be underexpressed in acute B-cell 
lymphoblastic childhood leukemia. Oct4-associated genes were always found 
consistently up- or downregulated where multiple studies were available in a specific 
cancer category (~11% of genes). This may lend additional confidence to the cancer 
misregulation events we observed.
121
gene up-regulated in cancer
Physical interactor of Oct4
(or Oct4 itself: see Seminoma)
Oncomine cancer group
gene down-regulated in cancer
p < 10-10 p < 10-16
Figure 4.7: Gene misexpression network for the identified Oct4 interactors in a comprehensive 
set of cancer types. Nodes represent a gene or cancer type, while edges (connections) 
represent significant misexpression. Edge thickness indicates the misexpression p-value 
(ranging from p < 10-10 to p < 10-16).
4.3.8. Functional enrichment according to PANTHER annotation
The Oct4 interactors were enriched in components of the Wnt signalling pathway 
(Table 4.4), which is known to be important in the achievement and maintenance of 
stem cell identity (Wend et al., 2010). Additionally, 65% of genes were annotated as 
nucleic acid-binding, and 33% as transcription factors. This supports the view that 
the Oct4 interactors could often be downstream transcriptional regulators.
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Table 4.4: Functional category analysis for enriched PANTHER terms among Oct4-associated 
proteins. An analysis for Pathway (PW), Biological Process (BP) and Molecular Function (MF) 
enrichment was carried out using the mouse genome as the background dataset.
Category Term % of Genes Count Expected p-Value
PW Wnt signaling pathway 8.60% 8 1.3 7.2E-03
BP Nucleoside, nucleotide and nucleic acid metabolism 73.12% 68 12.0 9.0E-39
BP mRNA transcription 48.39% 45 7.1 1.2E-23
BP mRNA transcription regulation 36.56% 34 5.2 7.0E-17
BP DNA metabolism 13.98% 13 1.0 5.3E-09
BP Chromatin packaging and remodeling 11.83% 11 0.8 1.2E-07
BP DNA repair 8.60% 8 0.5 6.1E-06
BP DNA recombination 4.30% 4 0.1 2.4E-03
BP Other mRNA transcription 3.23% 3 0.1 6.3E-03
MF Nucleic acid binding 64.52% 60 11.3 9.0E-31
MF Transcription factor 33.33% 31 7.3 5.3E-11
MF Zinc finger transcription factor 17.20% 16 3.3 2.8E-05
MF Helicase 12.90% 12 0.5 6.5E-11
MF DNA helicase 11.83% 11 0.2 3.3E-13
MF Chromatin/chromatin-binding protein 11.83% 11 0.5 8.7E-10
MF Histone 5.38% 5 0.4 5.5E-03
MF DNA methyltransferase 3.23% 3 0.1 3.7E-03
4.3.9. Overrepresented domains
Protein domains can give information on functionality, and certain domains are 
associated with specific contexts, such as chromatin remodelling and gene 
regulation. Table 4.5 shows an analysis of domain overrepresentation among the 
Oct4 interactors, relative to the proteome-wide and the nuclear background 
frequencies.
123
Table 4.5: Pfam domain occurrence, function and overrepresentation. The number of 
occurrences of a certain domain within the Oct4 interacting set is given, as well as the number 
of distinct proteins bearing the domain. Domain functions were obtained from Pfam 
annotations. Fold enrichment was calculated comparing the domain composition of Oct4 
partners to both the nuclear subset and complete set of UniProtKB/Swiss-Prot proteins with 
subcellular localisation information. This estimates domain overrepresentation in the Oct4-
associated group. Only domains significantly enriched are shown.
Pfam domain Domain description
Oct4 
interactors 
with this 
domain
cf. nuclear 
proteins 
(UniProtKB/
Swiss-Prot)
cf. all proteins 
(UniProtKB/
Swiss-Prot)
expected p-Value expected p-Value
Helicase_C Helicase conserved C-terminal domain 10 1.7 2.2E-05 0.5 3.3E-10
SNF2_N SNF2 family N-terminal domain 9 0.5 3.4E-08 0.1 1.1E-13
zf-C2H2 Zinc finger, C2H2 type 8 8.3 1.000 1.4 9.8E-05
PHD PHD-finger 6 1.1 0.002 0.4 2.9E-06
ELM2 ELM2 domain 4 0.1 2.5E-05 0.1 1.0E-06
GATA GATA zinc finger 4 0.4 0.002 0.1 2.1E-06
Chromo chromo' (CHRromatin Organisation 
MOdifier) domain
4 0.6 0.005 0.1 6.2E-06
Bromodomain Bromodomain 4 0.5 0.004 0.2 2.9E-05
CHDCT2 CHDCT2 (NUC038) domain 3 0.0 1.1E-04 0.0 3.3E-07
DUF1086 Domain of Unknown Function (DUF1086) 3 0.0 1.1E-04 0.0 3.3E-07
DUF1087 Domain of Unknown Function (DUF1087) 3 0.0 1.1E-04 0.0 3.3E-07
CHDNT CHDNT (NUC034) domain 3 0.0 1.1E-04 0.0 3.3E-07
DUF3371 Domain of unknown function (DUF3371) 3 0.1 0.000 0.0 6.4E-06
BAH BAH domain 3 0.1 0.001 0.1 5.1E-05
SAP SAP domain 3 0.4 0.014 0.1 1.7E-04
Ku Ku70/Ku80 beta-barrel domain 2 0.0 0.002 0.0 4.8E-05
Ku_N Ku70/Ku80 N-terminal alpha/beta domain 2 0.0 0.002 0.0 4.8E-05
Ku_C Ku70/Ku80 C-terminal arm 2 0.0 0.002 0.0 4.8E-05
zf-PARP Poly(ADP-ribose) polymerase and DNA-
Ligase Zn-finger region
2 0.0 0.002 0.0 4.8E-05
2-Hacid_dh_C D-isomer specific 2-hydroxyacid 
dehydrogenase, NAD binding domain
2 0.0 0.002 0.0 2.8E-04
2-Hacid_dh D-isomer specific 2-hydroxyacid 
dehydrogenase, catalytic domain
2 0.0 0.002 0.0 2.8E-04
4.4. Discussion
The expression of specific sets of regulatory transcription factors is used by the cell 
to control diﬀerentiation (Macarthur et al., 2009). Oct4 is an essential transcription 
factor which is central to stem cell identity and has been used in the generation of 
induced pluripotent stem cells from fibroblasts (Takahashi and Yamanaka, 2006). In 
this study, we aimed to understand the regulatory eﬀects of Oct4 in collaboration 
with Dr. Jyoti Choudhary’s group at the Wellcome Trust Sanger Institute. My 
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collaborators identified physical interactors of Oct4, and this group of proteins 
represented an important system for analysis using similar methods as in Chapter 3. 
We performed an in-depth analysis of the Oct4 protein-protein interaction network 
based on conservation, transcriptional regulation, expression data and phenotypic 
data, including implication in human disease.
By integrating these types of information, we found that Oct4 associated with a 
varied set of 92 proteins, including regulators of gene expression and modulators of 
Oct4 function. Half of its physical interaction partners are transcriptionally regulated 
by Oct4 itself or by other stem cell transcription factors (Figure 4.3), and one third 
display a significant down-regulation in expression upon cell diﬀerentiation (Figure 
4.2), supporting their functionality in the maintenance of pluripotency. The majority 
of the Oct4-associated proteins studied to date show early lethal phenotypes when 
mutated in mice (Figure 4.6), highlighting their importance in development or in basal 
functions such as DNA repair. A significant fraction of the human orthologs is also 
associated with inherited disorders (Table 4.2) or causatively mutated in certain 
cancers (Table 4.3). 
Oct4 interacts with several basal transcriptional regulators, such as Ttf2, as well as 
with proteins involved in DNA replication, recombination and repair, which displayed 
high expression throughout the ES cells and more diﬀerentiated cell types (Fig. 4.2). 
The alternative pattern shown by one third of the interactors and by Oct4 itself is of 
a strong switch-like decrease in expression in more diﬀerentiated cell types. This 
specific expression in embryonic stem cells supporting their functionality in the 
maintenance of pluripotency, supporting their functionality in the maintenance of 
pluripotency. Among the physical interactors of Oct4, P4ha1 was the only gene 
which showed increased expression in diﬀerentiating cell types, mammospheres 
and myospheres compared to ES cells. This expression pattern be explained by its 
function in the post-translational modification of collagen by proline hydroxylation. 
Its physical interaction with Oct4 in ES cells may perhaps point to additional 
hydroxylation substrates, whose modification might functionally relate to 
pluripotency.
Interestingly, in addition to P4ha1, several of the other physical interactors of Oct4 
we identified were also writers, readers, erasers or adaptor proteins involved in PTM 
signalling through lysine acetylation, methylation, phosphorylation, ubiquitination 
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and O-glycosylation (UniProt Consortium, 2012). Specifically, Brwd1 is a 
bromodomain lysine acetylation reader protein which interacts with SMARCA4, one 
of the most highly ranked lysine acetylation-related proteins we identified (Table 3.2). 
Kat7 is a histone acetyltransferase, while Hdac1 is a histone deacetylase. Kdm1a is 
a histone demethylase acting on H3K4 and H3K9. Ppp2r1a is a phosphatase 
adaptor protein, mediating specificity of the catalytic subunit of protein phosphatase 
2A. Chd1 and Chd4 are histone lysine methylation reader proteins for H3K4 di- and 
trimethylation. Trim33 is an E3 ubiquitin ligase, while Ogt is an O-glycosylation writer 
enzyme, transferring N-acetylglucosamine (O-GlcNAc) to serines and threonines and 
histones and other proteins. Intriguingly, Oct4 itself is modified by O-GlcNAc in 
addition to phosphorylation and sumoylation (Wagner and Cooney, 2009; Webster et 
al., 2009), which suggests that Ogt might be involved in modulating its activity. Ogt 
is in turn transcriptionally regulated by Oct4 and several other stem cell transcription 
factors (Fig. 4.3). Oct4 is also modified by phosphorylation and sumoylation (Wagner 
and Cooney, 2009). Together, these physical interactors of Oct4 may be involved in 
PTM-based signalling requiring the expression of Oct4, in line with the fact that 
several layers of regulation such as DNA methylation, chromatin remodelling and 
various transcription factors are involved in the establishment and maintenance of 
pluripotency (Hanna et al., 2010).
The presence of Sox2 and Nanog, two well-characterised Oct4 interactors, in only 
some of the experimental replicates could indicate a degree of transience and 
potentially point to additional regulation of these interactions. Our study of the Oct4 
interactome (Pardo et al., 2010) agreed with a separate independent study on a 
relatively small number of interactors (19 of the 54 identified in the independent 
study)  (van den Berg et al., 2010). The reason for the observed disparity in 
interacting proteins may be due to diﬀerences in cell lines, conditions, sample 
preparation, purification techniques or mass spectrometry equipment and data 
processing. Some interactions between proteins may also be non-specific, which 
further increases the level of experimental noise (Vermeulen et al., 2008). It therefore 
becomes important to integrate additional information to independently corroborate 
an initial list of co-purified proteins, as we have done in this study.
To summarise, the annotated Oct4 interactome presented here provides a resource 
which can guide further investigation of Oct4’s functional context with the aim to 
illuminate the regulation of pluripotency and diﬀerentiation. It may also aid in the 
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identification of additional factors which could help improve the eﬃciency and safety 
of the generation of induced pluripotent stem cells for use in regenerative medicine.
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5. Conclusions and implications
In this concluding chapter, I will highlight my most important findings and describe 
their potential implications, including the role of disruptions of post-translational 
signalling in human disease, and implications for the engineering of signalling 
systems in synthetic biology.
5.1. Key findings
5.1.1. Evolution of post-translationally modified residues
Significant selection pressure exists for all PTM types studied
Taken together, our results regarding the constraints on post-translationally modified 
residues at the species, population and individual levels constitute the finding that 
there is significant conservation for all six PTM types studied, in both structured and 
disordered regions of proteins. Between species, conservation at PTM sites was 
investigated using three alternative scoring methods, and was found to be most 
apparent in disordered regions even when using normalised scores. Using the 
original raw scores, the conservation scoring method rvET (a hybrid approach based 
on phylogeny and symbol entropy) reported significant conservation of all PTM 
types in both disordered and structured regions. Disordered sites of serine 
phosphorylation and N-glycosylation as well as structured sites of threonine 
phosphorylation were consistently reported as conserved by all methods, including 
normalised scores. Normalisation of the scores per protein generally appeared to 
decrease detection of PTM site conservation. The less frequent observation of PTM 
type conservation in structured regions at least when using normalised scores may 
be due to their higher intrinsic structural constraints, whereas in disordered regions 
the conservation of specific residues could be more apparent against their fast-
evolving background. At the population level, we found PTM sites to be significantly 
less variable than control residues, and significantly more prone to be aﬀected by 
disease mutations in individuals. Taken together, our results indicated significant 
constraints on both structured and disordered sites for all PTM types studied.
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Mimetic mutations hint at new signalling systems and may decrease the 
apparent conservation of PTM sites
Having quantitatively established that significant selection pressure exists on all six 
PTM types, independent of structural characteristics, we investigated the specifics 
of residue evolution. By investigating the conservation profiles of PTM sites, we 
found that while many modified residues appear to have originated before the 
divergence of the mammalian lineage, a notable fraction of serine and threonine 
phosphorylation sites appeared to be primate-specific. An analysis of substitutions 
at PTM sites uncovered evidence of significant mimetic and avoiding mutations at 
PTM sites, which respectively resemble either the modified or the unmodified state 
of the residue. Based on the significant overrepresentation of negatively charged 
amino acid substitutions at lysine acetylation sites observed using some scoring 
methods, we hypothesised that acylation reactions using negatively charged groups, 
such as succinylation and malonylation, could alternatively be taking place at these 
positions, at a frequency suﬃcient to result in an evolutionary signal. We were also 
able to confirm a previously reported enrichment in phosphomimetic glutamate 
substitutions at disordered serine phosphorylation sites (Kurmangaliyev et al., 2011), 
as well as a similar enrichment of aspartate substitutions for both disordered serine 
structured tyrosine phosphorylation sites. An example of avoiding mutations was 
found in the substitution of glutamine for asparagine at disordered N-glycosylation 
sites using some scoring methods, which is structurally highly similar but does not 
undergo N-glycosylation. Taken together, we consider these mutations to contribute 
to a decrease in the degree of conservation observed at PTM sites, despite their 
functionality.
5.1.2. The human lysine acetylation system
Evolutionary plasticity of a PTM-based signalling system
Our analysis of the enzymes and reader proteins which make up the human lysine 
acetylation signalling system highlighted its strong conservation across a set of 
mostly vertebrate species, on par with known essential genes. As a group, the 
reader (bromodomain) and writer (acetyltransferase) proteins appeared the least well 
conserved, indicating that they may be the more evolvable components of the 
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system compared to the deacetylases. Several other interesting aspects were found 
in the course of the analyses. As in the phosphorylation and ubiquitination systems, 
the proportion of erasing enzymes was small compared to the reader and writer 
categories. This may either indicate that erasers tend to primarily maintain an 
equilibrium of acetylation and deacetylation at a large number of substrate sites, 
while the writers might carry out primary signalling at a more limited set of sites, or it 
may indicate that a fraction of acetylated lysines remain permanently modified. The 
conservation profiles also highlighted a limited number of genes which were 
conserved in nearly all species studied, as well as evidence of lineage-specific 
family expansions presumably by gene duplication. Similar expansions have been 
described in the lysine methylation system (Aravind et al., 2011). We also developed 
a scoring method to prioritise proteins likely to be of particular importance in lysine 
acetylation signalling. This method rewarded candidate proteins with high sequence 
conservation among vertebrates, a large number of known protein-protein 
interactions, co-expression with many other lysine acetylation-related proteins and 
expression in a large number of cell types. The resulting ranking showed that based 
on their localisation, most proteins which fulfil these criteria appear to be associated 
at least partially with nuclear functions, which may support an ancestral role for 
lysine acetylation in gene regulation via histone modification which was followed by 
functional diversification. This is further supported by the set of genes which we 
identified as conserved in nearly all species studied, which includes histone 
deacetylases HDAC1–3 and the elongator complex protein ELP3, a histone 
acetyltransferase, among others.
A generalised framework for the study of PTM signalling systems
Beginning with an initial list of proteins of interest in three functional classes, the 
analyses performed here build on publicly available information sources which cover 
most of the human proteome. Our study therefore demonstrates the application of a 
generalised, transferrable framework for the analysis of human signalling systems. 
We envision that this analysis framework could prove useful in identifying the central 
components, and therefore the physiological functionality, of newly described 
signalling systems such as lysine succinylation, once the biochemical 
characterisation of relevant protein domains has progressed slightly further (Lin et 
al., 2012).
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5.1.3. The interaction network of Oct4
Identification of novel Oct4 interactors
We experimentally identified a set of 92 proteins which were co-purified with Oct4, 
thereby expanding the number of known Oct4 interactors at least three-fold (Pardo 
et al., 2010). Half of these interaction partners were transcriptionally regulated by 
Oct4 or by other stem cell transcription factors, and one third displayed significant 
down-regulation in expression upon ES cell diﬀerentiation, supporting their 
functionality in the maintenance of pluripotency. Many also showed lethal 
phenotypes when mutated in mice, or association with genetic disease and cancer 
in humans, highlighting their essentiality in development, transcriptional regulation 
and in basal functions such as DNA repair.
Oct4 is regulated via O-glycosylation by Ogt
Several of the physical interactors of Oct4 we identified are writers, readers, erasers 
and adaptor proteins involved in PTM signalling, which may have specific signalling 
roles when Oct4 is expressed. Both our own study of the Oct4 interactome and an 
independent study identified an interaction between Oct4 and Ogt, an N-
acetylglucosamine (O-GlcNAc) transferase (Pardo et al., 2010; van den Berg et al., 
2010). It had previously been found that Oct4 is modified by O-GlcNAc, and that its 
modification is important in zebrafish development (Webster et al., 2009). More 
recently, it has been found that O-glycosylation by Ogt causes Oct4 to upregulate 
several target genes with importance in embryonic stem cell identity, and that this 
modification is dynamically counteracted by an O-glycosylase, Oga (Jang et al., 
2012). In diﬀerentiation, the interaction between Ogt and Oct4 is rapidly lost along 
with expression of the target genes (Jang et al., 2012). According to our findings, 
Ogt is not significantly down-regulated upon diﬀerentiation, suggesting that its 
decrease in activity on Oct4 might be mediated by another signalling mechanism 
(Fig. 4.2).
5.2. Future directions
Our studies of the lysine acetylation signalling system and of the Oct4 interactome 
illustrate the value of data integration approaches for identifying important 
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components in biological systems, beginning from a list of candidates. This 
information can now be used to prioritise promising functional aspects and 
individual proteins for further study, as in the example of Ogt. Ultimately, I hope the 
results presented will prove useful in identifying new pharmacological targets in 
diseases such as cancer.
5.2.1. Investigating the signalling functions of newly discovered PTMs
Extracting biological meaning from large-scale datasets is a non-trivial ongoing 
challenge. The key appears to be the emergent knowledge that results from 
integrating multiple sets of related, complementary and mutually enhancing 
information. Today, more than 300 types of post-translational modification are 
known to occur physiologically in the cell (Witze et al., 2007). Meanwhile, 
unexplained spectra are still routinely being observed in mass spectrometry studies, 
potentially pointing to as yet unidentified modifications (Bischoﬀ and Schlüter, 2012). 
Serine and threonine acetylation have only recently been discovered (Mittal et al., 
2006; Mukherjee et al., 2006), as have aspartate and glutamate methylation (Sprung 
et al., 2008), followed by lysine succinylation, malonylation, crotonylation and 
various other types of acylation (Zhang et al., 2010c; Du et al., 2011; Tan et al., 2011; 
Lin et al., 2012; Xie et al., 2012). Several of these have been shown to be reversible 
and to diﬀer in their occurrence between cell lines, lending them promise in dynamic 
signalling roles. An in-depth analysis of the already intensely studied histone 
proteins recently found 67 previously undescribed modification sites, including 
lysine formylation, tyrosine hydroxylation and lysine crotonylation sites (Tan et al., 
2011). It was further shown that lysine crotonylation appears to be a transcriptionally 
activating signal, and that it is evolutionarily conserved in several species including 
yeast, mouse and human.
A large number of additional and atypical histone modifications have recently been 
discovered by in-depth mass spectrometry studies, and their functional elucidation 
is far from complete (Muers, 2011; Tan et al., 2011; Tweedie-Cullen et al., 2012). The 
fact that these modifications are still being discovered in a regulatory system as 
intensively studied as chromatin, along with indications of their dynamic regulation 
and functionality, suggests that atypical PTMs also remain undiscovered in other 
important signalling systems. For instance, serine and threonine acetylation of a 
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MAPK kinase by a pathogenic bacterium, Yersinia pestis, have been described, and 
these interfered with phosphorylation of the same residues (Mittal et al., 2006; 
Mukherjee et al., 2006). Additional reports of serine and threonine acetylation have 
been made on kinases in yeast (Zhang et al., 2010a). It remains to be investigated 
whether acetylation of serine and threonine phosphorylation sites could be a more 
widespread endogenous mechanism of regulating phosphorylation sites through 
cross-talk with acetylation. Extensive competition for substrate residues has also 
been documented between ubiquitination and lysine acetylation, where acetylation 
could extend protein half-life by preventing polyubiquitination, among other eﬀects 
(Grönroos et al., 2002; Jin et al., 2004; Caron et al., 2005; Danielsen et al., 2010; 
Wagner et al., 2011). The direct competition of multiple PTM types for individual 
residues further adds to the number of combinatorial states of PTM sites in a 
protein, and is likely to be an important area for future research on cellular 
information processing and decision making.
The presence of moonlighting enzymes that are able to modify proteins in addition 
to other canonical role further hints that our current picture of PTM signalling is still 
incomplete (Bansal et al., 2008; Baghel et al., 2011). At least in prokaryotes, not all 
acetylation events appear to require acetyl-CoA, since alternative enzymes which 
use acetoxycoumarins as acetyl group donors have been shown to exist (Bansal et 
al., 2008).
In plants, insects and mammals, there have been reports that proteins, calcium 
signals, vesicles and entire organelles can be exchanged between cells, either 
through plasmodesmata or tunnelling nanotubes (Rustom et al., 2004; Gallagher and 
Benfey, 2005; Chauveau et al., 2010). It is tempting to speculate that post-
translational signalling systems might sometimes extend directly between adjacent 
cells, potentially through the exchange of donor cofactors such as acetyl-CoA, or 
through modified proteins or peptides, which might be passed along these channels 
as intercellular signals. Similar systems exist for the propagation of RNAi-based 
antiviral defence activation in plants (Garcia-Ruiz et al., 2010; Uddin and Kim, 2011), 
and in the form of neuropeptides and small peptide hormones in animals (Husson et 
al., 2005; Reiher et al., 2011).
These discoveries, combined with the results on PTM site conservation and mimetic 
mutations presented here, point to a large component of cellular signalling that still 
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remains to be explored, and which may have implications in human disease. It 
therefore appears clear that there is scope for new discoveries in the analysis of 
post-translational signalling systems. As illustrated by a very recent study of the 
genome-reduced parasitic bacterium Mycoplasma pneumoniae, extensive bi-
directional cross-talk exists between lysine acetylation and phosphorylation even in 
simple organisms (van Noort et al., 2012). This also points to the fact that PTM 
systems should not only be studied in isolation if their functions are to be elucidated. 
In addition to post-translational modifications, modifications at the RNA level might 
also serve crucial functions (Kim et al., 2010). Like proteins, DNA and RNA have also 
been found to be enzymatically modified, with regulatory eﬀects on transcription, 
RNA editing and the subcellular localisation of specific tRNAs (Kaneko et al., 2003; 
Iyer et al., 2009). One common example is DNA methylation in CpG islands, which 
has a repressive eﬀect on transcription (Iyer et al., 2009). Another example is the 
hydroxymethylation of cytosine by the TET enzyme, which may have an epigenetic 
role in ES cells (Tahiliani et al., 2009). The complexities of mammalian translational 
processes, including alternative translation initiation sites, are still far from 
understood (Ingolia et al., 2011). The same is true for alternative splicing and 
alternative transcription, which contribute to diversity at the molecular level, 
between cell types, and between organismal phenotypes (Gan et al., 2011; 
McManus and Graveley, 2011; Pal et al., 2011; Barrie et al., 2012). By integrating 
these layers of signalling into models, we may increasingly be able to explain 
aspects which may currently be considered biological noise, but may in fact arise 
from complexity. However, certain types of biological noise may also be adaptive at 
the population level, as it can function to generate phenotypic diversity (Veening et 
al., 2008; Fraser and Kaern, 2009; Chalancon et al., 2012). At the single cell level, 
expression noise of stem cell transcription factors has been described to contribute 
to the maintenance of pluripotency in ES cells (Trott et al., 2012).
5.2.2. Promising experimental methods
The ability to synthesise proteins with defined modifications through the 
incorporation of stop codon-encoded unnatural amino acids should prove invaluable 
to the study of the eﬀects of individual PTMs (Liu et al., 2010b; Chin, 2011). By 
expanding the genetic code, site-specific encoding of PTMs such as ubiquitination, 
phosphorylation and others has been achieved in E. coli, S. cerevisiae, C. elegans 
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and Drosophila (Hancock et al., 2010; Neumann et al., 2010; Greiss and Chin, 2011; 
Virdee et al., 2011; Bianco et al., 2012; Chin, 2012; Davis and Chin, 2012). 
Additionally, the ability to generate phosphorylated peptides based on the presence 
of a leader sequence by using engineered class II lantipeptide synthetases in E. coli 
is promising (Thibodeaux and van der Donk, 2012). Another method which should 
prove extremely useful for the precisely targeted perturbation of PTM signalling is 
the use of genetically encoded photocaged residues. The caging groups on these 
residues can block their function until removed by light. Photocontrol of light-
switchable serine and tyrosine kinases (Gautier et al., 2011; Arbely et al., 2012), of 
protein-protein interactions (Levskaya et al., 2009) and of protein localisation to the 
nucleus (Gautier et al., 2010) have been demonstrated. 
Applying mass spectrometry to intact proteins followed by controlled fragmentation 
within the instrument (“top-down” mass spectrometry) oﬀers an interesting 
alternative to the more conventional “bottom-up” fragmentation–identification 
approaches which are most widely used and generally oﬀer higher rates of protein 
identification (Bogdanov and Smith, 2005; Yates et al., 2009). However, using intact 
proteins opens up the investigation of diﬀerent protein “modforms”, i.e. the 
combinatorial states of multiple PTMs within the same protein (Siuti and Kelleher, 
2007; Tweedie-Cullen et al., 2012). This type of analysis has already been 
demonstrated for individual histones (Tweedie-Cullen et al., 2012), and appears 
promising for the future combinatorial study of protein modifications, which have 
been described as akin to a “molecular barcode” in terms of information content 
(Benayoun and Veitia, 2009).
5.2.3. Limitations to be addressed
A subject that remains to be studied experimentally in detail is the plasticity of PTM 
sites between individuals and between related species. To a degree, this has been 
attempted in this dissertation, but our analyses also illustrated that experimental 
coverage of PTM sites remains very low outside of the standard model organisms 
(Fig. 2.4). A significant potential aspect of divergence between species therefore 
remains unexplored at present. To further highlight this, it has been shown that 
glycosylation involving sialic acids has uniquely diverged in humans, with medical 
implications, amid other reports illustrating that significant signalling diﬀerences 
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exist even between species as closely related as humans and chimpanzees (Varki 
and Altheide, 2005; Varki and Nelson, 2007; Varki et al., 2008; Varki, 2010; Varki et 
al., 2011). Glycan divergence on cell surfaces, possibly driven by pathogens, has 
been described as a possible important contributor to the speciation process itself 
(Varki, 2006). Integrating species-, cell type- and condition-specific knowledge on 
PTM signalling networks with protein-protein interaction networks is therefore a 
promising approach to achieve greater clarity in the understanding of signalling by 
PTMs (Minguez et al., 2012).
The precise concentration of the transcription factor Oct4 is key in regulating an 
embryonic stem cell’s decision between diﬀerentiation and pluripotency (Okita and 
Yamanaka, 2010). In diﬀerentiation, the directionality of Oct4 expression change 
aﬀects the type of diﬀerentiation: an increased expression level leads to ES cell 
diﬀerentiation into trophectoderm, while a decreased level leads to diﬀerentiation 
into mesoderm or endoderm. Similarly, it is likely that the fraction of proteins which 
are modified (PTM site occupancy), as well as the concentrations of writer, reader 
and eraser proteins, could be important in post-translational signalling. In yeast, it 
has been described that sites of low occupancy are less well conserved (Levy et al., 
2012). Large-scale studies on human cells would be useful to address this, and 
SILAC has been demonstrated as a quantification method for fractional occupancy 
of phosphorylation (Olsen et al., 2010). SILAC has also been used for measurement 
of the proteome-wide modification state changes induced upon perturbation of 
either a class of PTM enzymes (Pan et al., 2009), and of a single PTM enzyme (Hilger 
et al., 2009). In future, quantitative methods for the analysis of dynamic systems 
may then prove useful in analysing large-scale PTM signalling networks, especially 
those where a correlation exists with a donor molecule such as acetyl-CoA (Kim and 
Motter, 2009; Motter, 2010; Nishikawa and Motter, 2010).
Our study of PTM site evolution had two limitations which are non-trivial to address 
at present. The first relates to alternative splicing, which is very common in 
mammals. 92–94% of human genes undergo alternative splicing, and 86% of these 
display a minor isoform frequency of 15% or more (Wang et al., 2008). In this study, 
we avoided this additional level of complexity by using the canonical, usually longest 
transcript as recorded in the UniProtKB/Swiss-Prot database. This was done since 
the transfer of modification site annotation to alternative isoforms could not be done 
with confidence. In future, it would be interesting to investigate whether alternatively 
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spliced exons display an increase in the number of PTM sites they encode. Tissue-
specific exons have been found to contain an enrichment of linear motifs and to 
have important roles in rewiring interaction networks (Buljan et al., 2012; Davis et al., 
2012; Ellis et al., 2012; Weatheritt and Gibson, 2012; Weatheritt et al., 2012). The 
inclusion or exclusion of a PTM site through alternative splicing could therefore 
represent an eﬀective mechanism for the modulation of signalling.
Secondly, eﬀorts have been undertaken to dissect the dynamic nature of PTM 
signalling networks (Price et al., 2010), and to establish quantitative links between 
the concentrations of modifying and erasing enzymes, and the concentrations of 
individual modified forms (“modforms”) of proteins (Thomson and Gunawardena, 
2009). However, due to the limitations that accompanied the collection of known 
PTM sites from a large number of separate studies, experiments and conditions, we 
have had to consider PTM sites as mostly static and mutually independent for the 
purposes of this dissertation. Hopefully, large-scale information on the conditions, 
tissues, and combinations in which specific PTMs occur together will become 
available in future, which would allow a global elucidation of combinatorial PTM 
signalling.
5.2.4. Engineering signalling systems in synthetic biology
In future, the design of complex post-translational signalling circuits for information 
processing is envisioned in synthetic biology, which is becoming increasingly 
standardised and eﬃcient (Anderson et al., 2010). The introduction of new signalling 
circuits might be done especially easily by transgenically introducing systems which 
may be endogenously absent (Lim, 2010). Eventually, these methods might allow a 
ground-up reconstruction of biological systems from parts whose characteristics we 
understand (Hockenberry and Jewett, 2012), which may finally put biology on an 
even footing with the approaches used in chemistry and physics: reductionism 
followed by engineering (Bashor et al., 2010). Ultimately, this may be the only 
approach which can fully allow us to understand how the beautiful complexity of 
biological systems arises from their smallest parts.
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SUMMARY
The transcription factorOct4 is key inembryonic stem
cell identity and reprogramming. Insight into its part-
ners should illuminate how the pluripotent state is
established and regulated. Here, we identify a con-
siderably expanded set of Oct4-binding proteins in
mouse embryonic stem cells. We find that Oct4 asso-
ciates with a varied set of proteins including regula-
tors of gene expression andmodulators of Oct4 func-
tion.Half of itspartners are transcriptionally regulated
by Oct4 itself or other stem cell transcription factors,
whereas one-third display a significant change in
expression upon cell differentiation. The majority of
Oct4-associated proteins studied to date show an
early lethal phenotype when mutated. A fraction of
the human orthologs is associated with inherited
developmental disorders or causative of cancer.
The Oct4 interactome provides a resource for dis-
secting mechanisms of Oct4 function, enlightening
the basis of pluripotency and development, and iden-
tifying potential additional reprogramming factors.
INTRODUCTION
Two characteristics define embryonic stem cells (ESCs), self-
renewal ability and pluripotency. Recently, ectopic expression
of combinations of transcription factors (Oct4, Nanog, Sox2,
c-Myc, Esrrb, and Klf4) has been shown to reprogram mouse
and human fibroblasts into a pluripotent state (Kaji et al., 2009;
Okita et al., 2007; Takahashi et al., 2007; Takahashi and Yama-
naka, 2006; Woltjen et al., 2009; Yu et al., 2007). The induced
pluripotent stem cells (iPSCs) are very similar to ESCs and retain
the ability to self-renew and differentiate into the three germ
layers and thus promise great therapeutic potential in regenera-
tivemedicine (Amabile andMeissner, 2009;Maherali et al., 2007;
Wernig et al., 2007). Despite the recent flurry of studies, our
understanding of the molecular mechanisms and players that
drive ESC self-renewal and differentiation is still limited.
The POU transcription factor Oct4, also termed Pou5f1, is a
central player in ESC self-renewal and differentiation into
specific lineages. Levels of Oct4 must be tightly regulated to
maintain the ESC status. A decrease in Oct4 levels by 50%
induces differentiation toward the trophectoderm lineage,
whereas a 50% increase causes differentiation into mesoderm
and endoderm (Niwa et al., 2000; Shimozaki et al., 2003). Oct4
plays an essential role in early development given that loss of
Oct4 in the mouse embryo causes the failure of the inner cell
mass to develop (Nichols et al., 1998).
Oct4 regulates transcriptional programs to maintain ESC plu-
ripotency primarily in collaboration with transcription factors
Sox2 and Nanog (Boyer et al., 2005; Chew et al., 2005; Pan
et al., 2006). Several genome-wide analyses of regulatory targets
of key pluripotency factors has led to the identification of sets of
jointly regulated or bound targets, highlighting a complex tran-
scriptional circuitry responsible for ESC maintenance (Babaie
et al., 2007; Boyer et al., 2005; Ivanova et al., 2006; Kim et al.,
2008; Loh et al., 2006;Matoba et al., 2006). Also recently, various
other factors have been functionally linked to Oct4 and Nanog,
after identification of their binding partners by affinity purification
and mass spectrometry (Wang et al., 2006, Liang et al., 2008).
These studies have revealed a compact regulatory module
responsible for ESC pluripotency (Orkin et al., 2008).
To further elucidate the ESC transcriptional network, we have
carried out an unbiased and extensive study of Oct4-associated
proteins, using an affinity purification and mass spectrometry
approach. In contrast with a previous similar study (Wang et al.,
2006), epitope-tagged Oct4 was expressed under the control of
Oct4’s endogenous promoter to keep the natural transcriptional
regulation. The epitope tagging strategy circumvents the need
for specific antibodies and facilitates a generic purification pro-
cedure that results in cleaner and higher yield samples than
traditional immunoprecipitation experiments. Our data signifi-
cantly expands the current repertoire of Oct4-associated pro-
teins, thereby shedding light on the complex regulatory circuitries
of ESCs. The Oct4 interactome provides a useful resource to
investigate the mechanisms of Oct4 function and regulation
and to explore the basic principles underlying stem cell biology.
RESULTS
Efficient FTAP Tagging of Oct4 by Recombineering
and Single-Copy BAC Transgenesis
To investigate the molecular network around Oct4/Pou5f1,
we used an epitope-tagging affinity purification strategy.
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We modified the SPA tag (Zeghouf et al., 2004) containing
the 33 FLAG epitope and a calmodulin binding peptide (CBP)
separated by a TEV cleavage site, by adding an extra TEV site
to improve cleavage efficiency (Figure S1A available online).
The FTAP was fused at the C terminus of the Oct4 coding region
by recombineering into a BAC clone containing full-length Oct4.
This was then integrated into the Hprt locus of ESCs by recom-
binase-mediated cassette exchange (RMCE) (Prosser et al.,
2008). The whole procedure is depicted in Figure S1B. Expres-
sion levels of the Oct4-FTAP fusion protein were 30% that of
endogenousOct4 expressed from two alleles (Figure S1C), close
to what should be expected given that it is expressed from an
extra copy of the gene and avoiding interference with the ESC
phenotype, as shown by the expression of ESC markers by the
transgenic clone (Figure S1C).
Identification of Oct4-Associated Proteins
The tandem affinity tag allows single- and double-affinity purifi-
cations. We first performed three independent one-step purifi-
Figure 1. Analysis of Oct4-Interacting
Proteins
(A) Typical Oct4-FTAP and control purifications.
Molecular weight markers (kDa) are shown.
(B) Western blots confirming some of the interact-
ing proteins identified by mass spectrometry. C,
Western blot showing co-immunoprecipitation of
endogenous Parp1 with Oct4 in the presence
(B+) or absence (B-) of benzonase. In denotes
whole cell extract. D, Workflow tracing the sys-
tems analyses of the Oct4 interactome. E,
Network of protein-protein interactions within the
Oct4 dataset. Blue circles are proteins downregu-
lated upon ES cell differentiation. Red fill indicates
proteins whose absence results in embryonic
lethality in the mouse. See also Figure S1.
cations on whole-cell extracts from
both Oct4-FTAP-expressing and control
unmodified cells (Figure 1A). Eluates
were separated by gel electrophoresis,
and whole lanes were excised into
several regions, digested, and analyzed
by nano-liquid chromatrography/tandem
mass spectrometry (LC-MS/MS). MS
results files from each lane were merged
and searched against IPI with Mascot.
The data is available in the PRIDE data-
base (Martens et al., 2005) (www.ebi.ac.
uk/pride). The data was converted with
the PRIDE Converter (Barsnes et al.,
2009) (http://code.google.com/p/pride-
converter). The criteria for peptide and
protein identification are detailed in
Experimental Procedures. Mass spec-
trometry analysis resulted in the identifi-
cation of 92 proteins (excluding Oct4
itself) that were present in all Oct4-FTAP
purifications, but not in controls (Table 1).
The identification of some of the interact-
ing proteins was confirmed by Western blotting (Figure 1B).
These data considerably expand the list of published Oct4
binding partners and represent a major extension of the sets
reported in two similar studies (Liang et al., 2008; Wang et al.,
2006). We detected 13 previously identified Oct4 interacting
proteins in our study (Table S6). These included Sall4, Arid3b,
Zfp219, and Sp1 (Wang et al., 2006), Kpna2 (Li et al., 2008),
Parp1 (Gao et al., 2009), and NuRD complex members Hdac1,
Mta1/2, and Gatad2a/b (Liang et al., 2008; Wang et al., 2006).
Furthermore, we also identified Sox2 and Nanog, two of the
best characterized Oct4 binding partners (Ambrosetti et al.,
1997; Chew et al., 2005; Liang et al., 2008; Wang et al., 2006),
and Zfp281, Requiem/Dpf2, Yy1, RYBP, Dax1, Esrrb, and
Arid3a, recently shown to physically interact with Oct4 (Donohoe
et al., 2009; Sun et al., 2009; van den Berg et al., 2008; Wang
et al., 2006; Wang et al., 2008) in one or two (Arid3a and Esrrb)
purifications, but because of our strict criteria of result reproduc-
ibility, we did not include them in the final data set. We also iden-
tified proteins reported to be linked to Oct4 through association
Cell Stem Cell
An Expanded Oct4 Interaction Network
Cell Stem Cell 6, 382–395, April 2, 2010 ª2010 Elsevier Inc. 383
Table 1. Oct4-Associated Proteins Classified into Protein Complexes and/or Functional Categories
Complex/
Protein Class
Gene
Name Accession Description MW Exp I Exp II Exp III
Bait Pou5f1 IPI00117218 POU domain, class 5, transcription factor 1 38705.35 20 19 21
NuRD Complex
Chd4 IPI00396802 chromodomain-helicase-DNA-binding protein 4 219096.34 21 40 33
Gatad2a IPI00625995 p66 alpha isoform a 67762.39 13 11 16
Gatad2b IPI00128615 isoform 1 of transcriptional repressor p66-beta 65712.08 13 7 16
Mbd3 IPI00131067 isoform 1 of methyl-CpG-binding domain protein 3 32168 4 6 4
Mta1 IPI00624969 Mta1 protein 80019.75 13 14 16
Mta2 IPI00128230 metastasis-associated protein MTA2 75723.93 25 17 21
Mta3 IPI00125745 isoform 1 of metastasis-associated protein MTA3 67719.08 10 9 7
Hdac1 IPI00114232 histone deacetylase 1 55609.93 11 12 11
Spalt-like Transcriptional Repressors
Sall1 IPI00342267 Sal-like 1 141745.1 11 17 18
Sall3 IPI00123404 isoform 1 of Sal-like protein 3 140610.62 5 5 6
Sall4 IPI00475164 isoform 1 of Sal-like protein 4 114711.29 35 29 28
BAF Complex
Smarca4 IPI00875789 SWI/SNF related, matrix associated, actin
dependent regulator of chromatin, subfamily a,
member 4, isoform CRA_b
181913.68 3 5 1
Smarcc1 IPI00125662 isoform 1 of SWI/SNF complex subunit SMARCC1 123326.28 7 3 4
Actl6a IPI00323660 actin-like protein 6A 47930.54 4 1 1
FACT Complex
Ssrp1 IPI00407571 isoform 2 of FACT complex subunit SSRP1 81766.73 36 12 32
Supt16h IPI00120344 FACT complex subunit SPT16 120319.5 64 34 56
LSD1 Complex
Aof2 IPI00648295 amine oxidase (Flavin containing) domain 2 95113.5 9 6 7
Rcor2 IPI00226581 REST corepressor 2 58042.89 5 6 2
ISWI
Chromatin
Remodeling
Complex
Smarca5 IPI00396739 SWI/SNF-related matrix-associated
actin-dependent regulator of chromatin
subfamily A member 5
122291.43 5 7 2
INO80 Chromatin-Remodeling Complex
Ino80 IPI00378561 isoform 1 of putative DNA helicase
INO80 complex homolog 1
177265.25 5 6 1
Nfrkb IPI00274469 nuclear factor related to kappa-B-binding protein 139134.5 22 11 4
Actl6a IPI00323660 actin-like protein 6A 47930.54 4 1 1
Histone Chaperone Complex
Asf1a IPI00132452 histone chaperone ASF1A 23099.19 3 1 3
Cabin1 IPI00380107 calcineurin binding protein 1 245584.2 8 18 7
Hira IPI00123694 isoform long of protein HIRA 113235.4 10 7 10
Ubn2 IPI00854896 isoform 4 of uncharacterized protein KIAA2030 142523.51 17 19 11
Transcription Factors
Arid3b IPI00277032 isoform 1 of AT-rich interactive
domain-containing protein 3B
61091.99 9 8 3
Atf2 IPI00110172 isoform 1 of cyclic AMP-dependent
transcription factor ATF-2
52550.73 4 5 5
Creb1 IPI00119924 isoform 1 of cAMP response
element-binding protein
36879.65 3 3 3
Ctbp1 IPI00128155 isoform 1 of C-terminal-binding protein 1 48170.7 9 4 3
Ctbp2 IPI00856974 isoform 2 of C-terminal-binding protein 2 107801.19 10 3 4
Klf4 IPI00120384 Kruppel-like factor 4 52531.81 1 1 2
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Table 1. Continued
Complex/
Protein Class
Gene
Name Accession Description MW Exp I Exp II Exp III
Mitf IPI00125758 isoform A of microphthalmia-associated
transcription factor
59160.39 2 3 1
Nfyc IPI00108204 nuclear transcription factor Y subunit gamma 37230.86 7 3 1
Sp1 IPI00323887 isoform 1 of transcription factor Sp1 81309.84 5 4 6
Tcfe3 IPI00380308 isoform 1 of transcription factor E3 61555.7 9 5 7
Tcfeb IPI00314502 transcription factor EB 52638.18 2 3 2
Zbtb10 IPI00223276 zinc finger and BTB domain containing
10 isoform 1
118071.48 9 5 12
Zbtb2 IPI00652356 putative uncharacterized protein 58189.61 1 1 1
Zbtb43 IPI00230530 zinc finger protein 297B isoform a 57551.37 2 1 3
Zfhx3 IPI00475055 AT motif binding factor 1 410697.11 3 36 1
Zfp217 IPI00758403 zinc finger protein 217 115181.65 11 10 4
Zfp219 IPI00469594 zinc finger protein 219, isoform CRA_a 78831.33 4 6 7
Zfp513 IPI00830836 isoform 1 of Zinc finger protein 513 59968.12 1 2 1
Zic2 IPI00127145 zinc finger protein ZIC 2 55546.36 1 1 1
Zscan4b IPI00755380 similar to Gene model 397 58667.99 4 6 7
Regulation of Transcription
Acin1 IPI00121136 isoform 1 of apoptotic chromatin condensation
inducer in the nucleus
151000.03 12 2 13
Brwd1 IPI00121655 isoform A of bromodomain and WD
repeat-containing protein 1
262057.12 1 2 2
Hcfc1 IPI00828490 host cell factor C1 216798.82 19 8 12
Ifi202b IPI00126725 interferon-activable protein 202 50727.44 4 6 3
Phf17 IPI00453799 isoform 1 of Protein Jade-1 95434.25 4 2 4
Rfx2 IPI00406298 DNA-binding protein RFX2 76998.5 8 1 1
General
Transcription
Ttf2 IPI00112371 transcription termination factor 2 126706.43 5 2 2
Recombination/Repair
Lig3 IPI00124272 isoform Alpha of DNA ligase 3 114656.59 5 6 1
Msh6 IPI00310173 MutS homolog 6 152813.37 10 4 5
Parp1 IPI00139168 putative uncharacterized protein 113491.6 24 17 33
Top2a IPI00122223 DNA topoisomerase 2-alpha 173567.4 30 44 12
Xrcc1 IPI00118139 DNA repair protein XRCC1 69270.68 6 3 1
Xrcc5 IPI00321154 ATP-dependent DNA helicase 2 subunit 2 83802.29 6 5 13
Xrcc6 IPI00132424 ATP-dependent DNA helicase 2 subunit 1 69726.04 12 5 12
Replication
Rpa1 IPI00124520 replication protein A 70 kDa DNA-binding subunit 69620.87 2 3 2
Rpa3 IPI00132128 replication protein A 14 kDa subunit 13688.99 1 1 1
Helicases
Chd1 IPI00107999 chromodomain-helicase-DNA-binding protein 1 197601.13 8 9 7
Chd3 IPI00675483 chromodomain helicase DNA binding protein 3 234196.54 5 6 6
Chd5 IPI00875673 chromodomain helicase DNA
binding protein 5 isoform1
224027.21 10 9 11
Dhx9 IPI00339468 isoform 2 of ATP-dependent RNA helicase A 150907.1 15 15 31
Hells IPI00121431 isoform 1 of lymphocyte-specific helicase 95806.47 3 1 1
Histones
Hist1h3e IPI00282848 histone cluster 2, H3c1 isoform 2 20348.12 8 9 4
Hist1h4b IPI00407339 histone H4 11360.38 11 13 6
Hist3h2bb IPI00229539 histone cluster 3, H2bb 17248.15 9 7 4
(Continued on next page)
Cell Stem Cell
An Expanded Oct4 Interaction Network
Cell Stem Cell 6, 382–395, April 2, 2010 ª2010 Elsevier Inc. 385
with some of its interactors, namely Sall1 and Smarcc1 (Wang
et al., 2006). Eight previously identified Oct4-interacting proteins
were either not detected, namely EWS, NF45, Cdk1 (Wang et al.,
2006), and Zfp206 (Yu et al., 2009), or found also in controls,
such as beta-catenin (Takao et al., 2007), Hdac2 (Liang et al.,
2008), Ctcf (Donohoe et al., 2009), and Wwp2 (Xu et al., 2009;
Xu et al., 2004).
We next performed tandem affinity purification, although
yields were not high because of the low levels of tagged Oct4
and purification efficiency. We identified seven proteins of the
92, mainly members of NuRD, Sall proteins, and transcription
factors E3 and EB (Table S6). We believe these constitute the
highest-affinity interactors, given that they can endure a more
stringent purification. Although yielding small numbers of inter-
actors, this purification is still at the level of previous similar
studies (Liang et al., 2008; Wang et al., 2006).
For confirmation, we immunoprecipitated endogenous Oct4
from whole-cell extracts of untagged feeder-free E14 mouse
ESCs in duplicate and analyzed immunoprecipitates by mass
spectrometry. Forty-six proteins reproducibly overlapped with
the FTAP data set (Table S6). We detected all proteins identified
in a similar experiment (Liang et al., 2008). Not surprisingly,
proteins that were reproducibly copurified with endogenous
Oct4 tended to be more abundant in our single-affinity purifica-
tion data set.
To address whether the interactions detected were due to
coassembly of factors on chromatin, we then immunoprecipi-
tated Oct4 in the presence of DNase treatment with benzonase.
Western blotting showed that Parp1, a ubiquitous DNA-binding
protein, coimmunoprecipitates with Oct4 even in the absence
of DNA (Figure 1C). Preliminary purification experiments with
a differently tagged Oct4-FTAP cell line suggested that other
Table 1. Continued
Complex/
Protein Class
Gene
Name Accession Description MW Exp I Exp II Exp III
Heterogeneous Nuclear Ribonucleoproteins
Hnrnpab IPI00277066 heterogeneous nuclear ribonucleoprotein
A/B isoform 1
36302.44 3 2 2
Hnrnpl IPI00620362 heterogeneous nuclear ribonucleoprotein L 64550.49 10 4 8
Hnrnpu IPI00458583 putative uncharacterized protein 88661.02 8 2 12
Histone Ubiquitination (E3 Ubiquitin Ligase Complex)
Cul4b IPI00224689 Cullin 4B 111314 7 3 9
Ddb1 IPI00316740 DNA damage-binding protein 1 128026.73 7 5 16
Enzymes
Cad IPI00380280 carbamoyl-phosphate synthetase 2, aspartate
transcarbamylase, and dihydroorotase
245649.59 4 18 11
Dnmt3a IPI00131694 isoform 1 of DNA (cytosine-5)-methyltransferase 3A 103203.53 4 4 7
Dnmt3l IPI00109459 DNA (cytosine-5)-methyltransferase 3-like 49159.08 7 3 7
Myst2 IPI00228457 isoform 2 of histone acetyltransferase MYST2 67588.54 4 2 3
Ogt IPI00420870 isoform 1 of UDP-N-acetylglucosamine–peptide
N-acetylglucosaminyltransferase 110 kDa subunit
118131.41 14 4 10
P4ha1 IPI00399959 isoform 2 of prolyl 4-hydroxylase subunit alpha-1 61132.82 14 5 5
Ppp2r1a IPI00310091 Serine/threonine-protein phosphatase 2A 65 kDa
regulatory subunit A alpha isoform
66079.23 3 4 1
Trim24 IPI00227778 isoform short of transcription
intermediary factor 1-alpha
114824.79 3 4 6
Trim33 IPI00409904 isoform alpha of E3 ubiquitin-protein ligase TRIM33 125931.28 2 2 2
Karyopherins
Kpna2 IPI00124973 Importin subunit alpha-2 58234.28 7 7 2
Kpna3 IPI00230429 Importin subunit alpha-3 58193 2 1 2
Chaperones Dnaja1 IPI00132208 DnaJ homolog subfamily A member 1 45580.73 6 1 5
Proteasome Psmb6 IPI00119239 proteasome subunit beta type-6 25590.57 2 2 1
Nuclear Assembly/Organization
Emd IPI00114401 Emerin 29417.38 2 1 1
Matr3 IPI00453826 Matrin-3 95085.04 14 6 11
Miscellaneous
Amotl2 IPI00263333 isoform 1 of Angiomotin-like protein 2 85454.32 1 4 2
Cubn IPI00889898 Cubilin 407679.63 3 7 2
Nudc IPI00132942 nuclear migration protein nudC 38334.29 2 2 2
The number of unique peptides for three independent experiments is shown. MW, molecular weight. See also Table S6.
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DNA-binding proteins such as ligase 3 and topoisomerase 2a
also copurify with Oct4 in the absence of DNA (M.P. and S.P.
Shen, data not shown). This suggests that the interactions we
detect are not DNA mediated.
Summing up, over 50% of the Oct4-associated proteins (47
of 92) varying in abundance across our data set have been
confirmed by independent means, suggesting that the data set
we provide here is a bona fide set of Oct4 binding partners.
Functional Annotation Analysis of Oct4-Associated
Proteins
To uncover general trends in the functions of the Oct4-interact-
ing proteins, we carried out computational systems-level anal-
yses in a workflow depicted in Figure 1D. We first performed
a functional annotation analysis using DAVID 2008 (Dennis
et al., 2003) and the PANTHER database (Thomas et al., 2003).
We found an enrichment of GO terms such as nucleus, chromo-
some, and chromatin in the cellular component ontology; nucleic
acid binding, protein binding, transcription factor activity, in the
molecular function ontology; and transcription, regulation of
gene expression, and embryonic development in the biological
process ontology (Figure S2 and Table S2). This indicates that
GO terms associated to Oct4 are highly represented within the
list of Oct4-copurifying proteins, adding consistency to the
data set. Twenty proteins in the data set (21%) are annotated
with the GO term ‘‘transcription factor activity.’’ Oct4 has been
shown to associate with several transcription factors, and our
results agree with the notion that combinatorial binding among
pluripotency factors, which contributes to achieving specificity
in gene regulation, may be a frequent pattern in ESCs (Chambers
and Tomlinson, 2009).
We also analyzed the enrichment of proteins involved in
cellular pathways. DAVID analysis detected an enrichment of
proteins involved in the control of gene expression by vitamin
D nuclear hormone receptor, mainly members of the FACT and
SWI/SNF complexes. The data set also contains several proteins
involved in the nuclear part of the Wnt signaling pathway, as
revealed by PANTHER analysis. The Wnt pathway is involved
in stem cell maintenance (Anton et al., 2007; Sato et al., 2004),
possibly by modulating levels of pluripotency factors Oct4,
Nanog, and Sox2 (Kalmar et al., 2009).
We then analyzed the domain composition of Oct4-interacting
proteins and detected a significant abundance of DNA-binding
and chromatin-related domains (Tables S3 and S4). Highly
represented domains were DEAD/DEAH box helicase, SNF2-
related, PHD and zinc fingers, and chromo, bromo, and homeo-
box domains, all of which are either involved in ATP-dependent
chromatin remodeling or bind DNA and posttranslationally modi-
fied nucleosomes, thereby influencing gene expression.
The data set was manually classified into known protein com-
plexes and functional categories. As shown in Table 1 and sup-
ported by the GO and PANTHER analyses, Oct4 associates
mainly with transcriptional regulators, but also with a variety of
other chromatin binding proteins involved in DNA replication,
recombination, and repair, proteins involved in nuclear assembly
and/or organization, and diverse enzymes, some of which are
responsible for addition of posttranslational modifications.
To gain an overall view of the previously known interactions
among Oct4-associated proteins, we retrieved interaction data
from INTACT, HRPD, and MINT for the data set and represented
them as a protein interaction network (Figure 1E). The network
comprises 80 known interactions for 57 of the proteins including
Oct4. Repressor complexes NuRD and SWI/SNF and DNA
repair and de novo DNA methylation modules are apparent in
the network.
Transcriptional Regulation of Oct4-Associated Proteins
Many known Oct4 binding proteins are ESC-specific factors
(Wang et al., 2008). However, Oct4 has also been shown to
interact with more general modulators of transcription that
are expressed ubiquitously, such asmembers of the NuRD com-
plex (Liang et al., 2008; Orkin et al., 2008; Wang et al., 2006). We
investigated the patterns of expression of the Oct4-associated
data set in cells at different stages of differentiation, including
embryonic carcinoma, embryonic stem cells, embryoid bodies,
and various differentiated cell types, on the basis of transcrip-
tomics data (Campbell et al., 2007). Protein abundances were
fairly varied and most interactors maintained near constant
expression across the samples analyzed (Figure 2). This sug-
gests that Oct4 interacts mostly with proteins that are ubiqui-
tously expressed in both differentiated and undifferentiated
cells. After statistical analysis, 33 Oct4-interacting proteins were
found to be significantly less expressed in differentiated cells
compared to ESCs, in correlation with Oct4’s expression pattern
(Figure 2 and Table S6). Among these are the DNA methylation
regulatory factor Dnmt3l and the developmentally important
transcription factors Klf4, Sall1, and Sall4. We observed that
many complexes or interacting pairs in the interaction network
contained at least one member significantly downregulated
upon ESC differentiation (Figure 1E), possibly conferring an
ESC-specific role.
Regulation of gene expression involves complex dynamics
employing sequence-specific DNA binding proteins that form
the transcriptional regulatory network (Babu et al., 2004; Jothi
et al., 2009; Luscombe et al., 2004). Transcription factors often
operate in feedback loops, whereby the expression of a tran-
scriptional target modulates the function of the transcription
factor itself (Figure 3A). Pluripotency factors in ESCs are no
exception and show a high degree of transcriptional auto and
interregulation (Orkin et al., 2008). We next investigated whether
the promoters of the Oct4-associated gene set contain binding
sites for transcription factors that are central in the establishment
and maintenance of ESC identity. Promoter binding sites for
nine such transcription factors have previously been identified
by ChIP-on-chip (Kim et al., 2008). These include Oct4, Dax1,
Klf4, c-Myc, Nac1, Nanog, Rex1, Zfp281, and Sox2.
Nine of the 92Oct4-associated proteins were found to be tran-
scriptionally regulated by Oct4 itself in mouse ESCs, and 51% of
genes encoding Oct4 partners are targets of at least one key
ESC transcription factor (Figure S3). This concurs with findings
by others on a much smaller data set (Orkin et al., 2008; Wang
et al., 2006). To assess whether this is statistically significant,
we compared the results to 1000 randomly generated sets of
92 proteins. The expected percentage of promoter binding by
ESC transcription factors was only 28% (Z = 4.45, p < 1015),
indicating that it is a significant trait of the data set. Several genes
in the interaction set are common targets of multiple transcrip-
tion factors (20 of 92 are targets of at least three transcription
Cell Stem Cell
An Expanded Oct4 Interaction Network
Cell Stem Cell 6, 382–395, April 2, 2010 ª2010 Elsevier Inc. 387
factors), making it likely that they have central roles in pluripo-
tency and self-renewal. Ten of these are significantly downregu-
lated in differentiation, and all but two show a downregulation
trend (Table S6), in agreement with the hypothesis that genes
bound by multiple factors are active in ESCs and become
repressed as cells differentiate (Chambers and Tomlinson,
2009; Kim et al., 2008; Orkin et al., 2008). We constructed
a regulatory network by integrating promoter target data for
the nine stem cell transcription factors with the list of Oct4
binding proteins (Figure 3B). Several of the transcription factors
cluster together because of shared targets (e.g., Sox2, Nanog,
Nac1, and Dax1), whereas c-Myc and Klf4 exclusively target
certain groups of Oct4-interacting factors. This agrees with
the genome-wide trend of the c-Myc target set, which is
largely distinct from the rest of the pluripotency factors (Kim
et al., 2008).
Role of Oct4 Interactome inMouse Embryonic StemCell
Biology and Development
We next explored the consequences of loss of Oct4-interacting
proteins in ESCs or mouse development. Five Oct4-interacting
proteins have been identified as required for stem cell self-
renewal in large scale RNAi screens (Ding et al., 2009;
Hu et al., 2009). Literature searches ascribed a role in ESC
self-renewal or pluripotency to an additional nine Oct4-interact-
ing proteins (Table S6).
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Figure 2. Expression of Oct4-associated proteins in ESCs and Differentiated Cell Types Based on Microarray Data
Columns correspond to experimental samples, arranged as follows: embryonal carcinoma P19 (EC), ES cells (ES), differentiating embryonic stem cells (DES),
adult stem cells (AS), differentiated adult stem cells (DAS), mixed cells (M), and differentiated cells (D). Average-linkage hierarchical clustering was performed
to arrive at the final layout. Genes whose expression is significantly up or downregulated in differentiation are marked.
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Loss-of-function phenotypes inmice were available in theMGI
database for 49 Oct4-associated proteins. All 49 show diverse
phenotypes when absent or mutated (Figure 4 and Table S5).
Significantly, 83% (41 of 49) of the studied knockout alleles of
the interaction set showed embryonic and/or perinatal lethality,
with over 60% (30 of 49) being embryonic lethal (Figure 1E).
Similar analyses on random control data sets allowed us to
conclude that the result is significant (Z = 7.48, p < 1015).
In addition, 41% (20 of 49) showed an abnormal development
A
B
Figure 3. Transcriptional Regulation of
Oct4-Associated Proteins
(A) Scheme of transcription factor feedback regula-
tion.
(B) Regulatory network of targets of ESC transcrip-
tion factors among Oct4 partners. Stem cell tran-
scription factors and their target genes among
Oct4-associated proteins are shown in dark and
light gray, respectively. Oct4 and its regulatory
targets are highlighted in blue. See also Figure S3.
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Figure 4. Distribution of Phenotypes Caused by Mutations in the
Genes Encoding Oct4-Associated Proteins
Numbers are percentage of genes studied. Full data are shown in Table S5.
phenotype. These results indicate a high
level of requirement for components of
the Oct4 network in early mouse devel-
opment. Although feedback loops are
expected to add to the robustness of
a transcriptional regulatory network,
the high frequency with which mutation
of single Oct4 partners causes severe
early developmental phenotypes sug-
gests they are essential downstream reg-
ulatory hubs.
Involvement of Oct4-Interacting
Proteins in Human Disease
and Cancer
Given the extent of their part in mouse
development and the current excitement
about the cancer stem cell hypothesis,
we next explored a possible role of Oct4-
associated proteins in human disease.
Human orthologs were identified for all
Oct4-associated proteins and sequence identities determined
between mouse and human (Figure S4). All Oct4-associated
proteins were found to be highly conserved, with a median
sequence identity of 94%, compared to 77% genomic median.
This strong sequence conservation implies that the findings
reported here could be applied to human ESC biology.
We next investigated the involvement of the human orthologs
in human disease and development of cancer interrogating the
OMIM database and the Cancer Gene Census, which records
genes whose mutation has been causally linked to cancer.
Genes encoding 14 of 92 Oct4-associated proteins are impli-
cated in one or more hereditary diseases, mostly of develop-
mental nature, with six of them predisposing to certain types
of cancer (Table 2). Somatic mutations in eight Oct4-associated
proteins and Oct4 itself were found to be responsible for
different types of cancer, often through gene translocations,
presumably affecting their regulation (Table 3). Statistical anal-
ysis on random sets indicated that the observed numbers of
Oct4-interacting proteins linked to human disease (Z = 1.06,
p < 1015) and cancer (Z = 4.43, p < 1015) are significantly
higher than expected.
In light of the central role of Oct4 in pluripotency and the
cancer stem cell hypothesis, we investigated which of Oct4’s
physical interactors are misexpressed in cancer using the
Oncomine human cancer expression database. A large fraction
(60%) of the Oct4 interactors show misexpression in at least
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one cancer type, providing a degree of additional support to the
connection between stem cell identity and cancer.
DISCUSSION
The characterization of protein-protein interactions is a very effi-
cient strategy for understanding protein function and regulation.
The development of high-affinity tags, including the TAP (Rigaut
et al., 1999) and in vivo biotinylation tag (de Boer et al., 2003), in
combination with advances inmass spectrometry that now allow
protein identification with high sensitivity and accuracy, has
recently produced several protein interaction network reports.
However, most studies in the literature rely on cDNA overexpres-
sion driven by exogenous promoters or transgenic random
integration approaches.
We report here an epitope-tagging strategy for the purification
of protein complexes in mouse ESCs. We introduced the tag by
recombineering into a full-length Oct4-containing BAC and then
integrated this in a precise location in the mouse genome. This
approach has the advantage of maintaining the endogenous
promoter and therefore natural transcriptional regulation. The
technology is amenable to high-throughput delivery, as recently
demonstrated by random integration of tagged BAC transgenes
(Poser et al., 2008), and should greatly facilitate systematic
tagging of genes and analysis of protein complexes with roles
in development in different contexts, be it in stem cells, differen-
tiated cell types, or even mouse tissue (Ferna´ndez et al., 2009).
The affinity purification method described here is rapid, with
the goal of capturing weak or short-lived interactions. Previous
proteomic studies of Oct4 protein complexes have relied on
lengthy single or tandem purifications from nuclear extracts
with streptavidin capture (Wang et al., 2006) or anti-Oct4 anti-
bodies (Liang et al., 2008) and yielded small data sets, very
similar to our tandem purification data set. We identified all of
the partners reported by the Liang study except Hdac2, and
only five Oct4 partners found in the Wang study were not
detected in our data set, maybe because of our use of whole
extracts. Indeed, our approach has produced by far the most
extensive analysis of Oct4-associated proteins to date.
By using whole extracts, thereby not restricting the analysis
to the nuclear environment, our data set encompasses diverse
aspects of the life of Oct4, both nuclear and nonnuclear.
The broad data set puts Oct4 at the center of diverse cellular
processes that can have an impact on aspects of stem cell
biology (Figure 5), the most interesting of which are discussed
below.
Oct4 can both activate and repress transcriptional targets in
mouse and human ESCs (Babaie et al., 2007; Loh et al., 2006).
To date, Oct4 has been shown to be associated mainly with
Table 2. Genetic Disease Associations of Oct4-Interacting
Proteins
Gene Disorder Type Disorder
CREB1 cancer histiocytoma, angiomatoid fibrous, somatic
CUBN hematological megaloblastic anemia-1, Finnish type
CUL4B multiple mental retardation syndrome, X-linked,
Cabezas type
mental retardation-hypotonic facies
syndrome, X-linked, 2
EMD muscular Emery-Dreifuss muscular dystrophy
MATR3 muscular myopathy, distal 2
MITF multiple Tietz syndrome
Waardenburg syndrome, type IIA
Waardenburg syndrome/ocular albinism,
digenic
MSH6 cancer colorectal cancer, hereditary
nonpolyposis, type 5
endometrial cancer, familial
mismatch repair cancer syndrome
SALL1 multiple Townes-Brocks branchiootorenal-like
syndrome
Townes-Brocks syndrome
SALL4 multiple Duane-radial ray syndrome
IVIC syndrome
TFE3 cancer renal cell carcinoma, papillary, 1
TRIM24 cancer thyroid carcinoma, papillary
TRIM33 cancer thyroid carcinoma, papillary
ZFHX3 cancer prostate cancer, susceptibility to
ZIC2 developmental holoprosencephaly-5
See also Figure S4.
Table 3. Cancer-Causative Genes among the Oct4-Interacting Proteins
Gene Mutation Tissue Cancer Type
CREB1 translocation mesenchymal clear cell sarcoma, angiomatoid fibrous histiocytoma
MITF amplification epithelial melanoma
MSH6 Missense, nonsense, frameshift, splice site epithelial colorectal (somatic)
colorectal, endometrial, ovarian (germline)
non-polyposis colorectal cancer (hereditary)
POU5F1 translocation mesenchymal sarcoma
SMARCA4 frameshift, nonsense, missense epithelial NSCLC (non-small cell lung carcinoma)
TFE3 translocation epithelial papillary renal, alveolar soft part sarcoma, renal
TFEB translocation epithelial
mesenchymal
renal, childhood epithelioid
TRIM24 translocation blood APL (acute promyelocytic leukemia)
TRIM33 translocation epithelial papillary thyroid
See also Figure S4.
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members of repressor complexes NuRD and SWI/SNF (Liang
et al., 2008; Wang et al., 2006). We found both among our data
set of Oct4-copurifying proteins. NuRD, a histone deacetylase
complex, was the most prominent, further confirming this link.
Sall4, a well-known Oct4 partner, and other members of the
Spalt-like family of transcriptional cofactors have been shown
to associate to NuRD (Lauberth and Rauchman, 2006), raising
the possibility that they may bridge the interaction between
Oct4 and NuRD. This hypothesis is also supported by the similar
amounts in which they are detected in our experiments. We also
found several subunits of the SWI/SNF nucleosome-remodeler
complex, some of which have previously been linked to Nanog
(Liang et al., 2008), confirming the link to this chromatin remod-
eling complex.
Also amongOct4 binding proteins we found variousmolecules
involved in positive regulation of transcription, including several
activators and coactivators and chromatin-modifying enzymes
such as Myst2, a histone H4 acetyltransferase (Doyon et al.,
2006; Sterner and Berger, 2000). In addition, we detected Ttf2,
a component of the general transcription machinery, providing
evidence of a physical link between pluripotency factors and
basal transcription players. The Oct4 interactome included other
basal DNA-process-related factors such as proteins involved in
DNA replication, recombination, and repair. This could explain
why many of the Oct4-interacting proteins are ubiquitously
expressed in both differentiated and undifferentiated cells.
Our experiments suggest that the interaction is not DNA medi-
ated, given that copurification of DNA-binding proteins still
occurs upon DNA elimination by benzonase.
Importantly, we have uncovered enzymes with a potential
role in Oct4 regulation. Ogt is responsible for posttranslational
addition of O-linked N-acetylglucosamine (O-GlcNAc), a regula-
tory protein modification similar to phosphorylation possibly
working in concert with it (Kamemura and Hart, 2003). Oct4 is
modified by O-GlcNAc in human ESCs (Webster et al., 2009),
and Sp1, one of Oct4 partners, is too (Jackson and Tjian,
1988). A thorough analysis of O-GlcNAc modification in the
Oct4 interactome might yield important insight into dynamic
modulation of stem cell factors. Posttranslational modification
of transcription factors and cofactors is proving to be a critical
component of the regulation of gene transcription in general,
and important specifically in stem cell biology (Brill et al., 2009;
Van Hoof et al., 2009).
Half of Oct4-associated proteins seem to be directly regulated
by transcription factors with key roles in stem cell pluripotency
and/or reprogramming. This is also a characteristic of pluripo-
tency networks derived from smaller data sets from different
entry points (Orkin et al., 2008; Wang et al., 2006). This indicates
that even in the expanded and functionally diverse network,
this attribute still holds true, supporting a previously unsus-
pected role in stem cell biology for some of the proteins we iden-
tify here.
Expression of Oct4 decreases in a switch-like fashion as ESCs
differentiate into lineage-specific cell types, including progenitor
cells. Our analysis has uncovered 33 physical interactors of Oct4
that share this trend. Among these are several transcription
factors, such as the DNA methyltransferase 3-like regulatory
protein Dnmt3l, which stimulates genomic imprinting in germ
cells (Bourc’his et al., 2001; Gowher et al., 2005). This is consis-
tent with a recent report demonstrating that treatment with DNA
methyltransferase inhibitors can improve the efficiency of the
reprogramming process of differentiated cells (Mikkelsen et al.,
2008). Therefore, the 33 interactors upregulated in ESCs and
the transcription factors that regulate them might be interesting
candidates whose expression could be manipulated to facilitate
reprogramming.
We find that loss of function of most Oct4-associated genes
studied to date results in embryonic or perinatal lethality, sug-
gesting that many serve crucial functions in development.
Interestingly, most Oct4-binding proteins linked to a human
hereditary disorder (13 of 14), mostly developmental or cancer
predisposition, give rise to a related phenotype when absent
in the mouse. We find cancer-associated genes, either causal
or predisposing, to be transcriptional regulators involved in pro-
cesses relating to the cell cycle, differentiation, and DNA repair,
acting through chromatin remodeling, signaling, or transcription
factor activity. These results implicate the orthologs of Oct4-
interacting proteins in roles in human development and cancer,
and therefore the data presented here should be useful in eluci-
dating their part in human disease.
In summation, the extensive systems-level analyses
described here compiling data sets of currently available
genome-wide studies provide an integrated vision of the Oct4
interactome. Detailed investigation of this information should
facilitate the choice of candidate factors to test for roles in
ESC maintenance, differentiation, and reprogramming and pro-
vide great insight into the transcriptional regulation of ESC
biology.
EXPERIMENTAL PROCEDURES
Generation of FTAP-Tagged Oct4 ESCs
Full details are provided in Supplemental Experimental Procedures. In brief,
the FTAP epitope tag (33FLAG-23TEV-CBP) sequence was synthesized as
two DNA fragments by annealing overlapping complementary oligonucleotide
molecules with PCR. The two fragments were cloned into a modified version
of recombineering vector PL450 (Liu et al., 2003) for pCTR9 creation.
The correctness of the FTAP tag within pCTR9 was confirmed by sequencing.
Homology arms for recombineering were PCR amplified from the Oct4 con-
taining C57Black/6J derived BAC clone (RPCI 23-213M12) and cloned into
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the recombineering vector to create pCTS1 (Figure S1). The 50 homology arm
creates an in-frame fusion between the Oct4 C-terminal coding sequence and
the FTAP tag coding sequence, while deleting the stop codon. A fragment for
recombineering the FTAP tag sequence into the Oct4-containing BAC (RPCI
23-213M12) was generated by digesting clone pCTS1. Correct recombination
into E. coli DH10B containing BAC clone RPCI 23-213M12 was confirmed by
Southern analysis of BAC DNA with homology arm-specific DNA probes for all
six tagged BAC clones tested.
ESC cultures, electroporation, and mini-Southern-blot analysis of ESC
clones were as described previously (Ramı´rez-Solis et al., 1993). Integration
of single-copy BAC transgenes at the Hprt locus by recombinase-mediated
cassette exchange (RMCE) has been described previously (Prosser et al.,
2008). For RMCE integration of tagged Oct4 BAC insert into hprttm(rmce1)Brd
allele of CCI18#1.6G, cells were cotransfected with pCAGGS-Cre (Araki
et al., 1997) and the RPCI 23-213M12 BAC clone carrying an integrated
copy of the FTAP tag cassette and neomycin resistance gene. Double-resis-
tant colonies were isolated after successive selection with G418 (200 mg/ml)
and 6-TG (10 mM). Site-specific BAC integration was very efficient, as verified
by Southern analysis with Hprt flanking probes, with 19 of 23 double-resistant
colonies showing correct single-copy integration. For removal of the selection
cassette, the verified ESC clones were transfected with pCAGGS-Flpe (Schaft
et al., 2001) and then selected with FIAU (200 nM). FIAU-resistant subclones
were assessed for selection cassette deletion by Southern blotting. Absence
of a hybridizing 5 kb fragment indicated successful deletion of the selection
cassette. Transgenic clones were analyzed for expression of tagged Pou5f1
by Western blotting, demonstrating that 60% of clones expressed the Oct4-
FTAP fusion protein.
Affinity Purification
Murine ESCs expressing Oct4-FTAP or wild-type control cells (AB2.2) were
separated from feeders by trypsinization and incubation on gelatin-coated
plates for 60min.Whole-cell extracts were incubatedwith anti-FLAGM2Dynal
beads in buffer containing 150 mM NaCl and 0.1% NP-40 for 90 min at 4C.
Anti-FLAG Dynal beads were prepared by crosslinking M2 FLAG antibody
(Sigma) to Protein G-Dynal beads (Invitrogen) in accordance with themanufac-
turer’s instructions. Bound complexes were eluted with AcTEV protease (Invi-
trogen). For tandem affinity purification, the TEV eluate was incubated with
calmodulin resin (Stratagene) for 60 min at 4C. Elution was carried out by
Ca chelation with EGTA. TEV or EGTA eluates were concentrated in Vivaspin
500 PES centrifugal filters (Vivascience), reduced with 1 mM DTT, and alky-
lated with 2 mM iodoacetamide prior to sample fractionation by polyacryl-
amide gel electrophoresis with Novex NuPAGE Bis-Tris 4%–12% gels (Invitro-
gen). Gels were stained with colloidal Coomassie (Sigma) according to Rowley
(Rowley et al., 2000). Whole lanes were cut in 24 slices, destained completely,
and digested with trypsin (sequencing grade, Roche). Peptides were extracted
with 0.5% formic acid 50% acetonitrile and dried in a Speed Vac (Thermo).
Immunoprecipitation and Western Blotting
Oct4 complexes were immunoprecipitated with an Oct4 antibody (Santa Cruz)
coupled to Dynal-Protein G beads (Invitrogen). Immunoprecipitates were
eluted by boiling in 13 LDS loading buffer (Invitrogen) and separated by
LDS-PAGE (Invitrogen). Western blotting was carried out with antibodies
from Abcam (Parp1, Sall4, and Myst2), Bethyl Laboratories (Chd4), or Santa
Cruz (Oct4 and Hdac1).
Mass Spectrometry and Data Analysis
Peptides were redissolved in 0.5% formic acid and analyzed with online
nanoLC-MS/MS on a LTQ FT mass spectrometer (Thermo Fisher Scientific)
coupled with an Ultimate 3000 Nano/Capillary LC System (Dionex). Samples
were first loaded and desalted on a trap (0.3 mm id 3 5 mm) at 25 mL/min
with 0.1% formic acid for 5 min and then separated on an analytical column
(75 mm id 3 15 cm) (both PepMap C18, LC Packings) over a 30 min linear
gradient of 4%–32% CH3CN/0.1% formic acid at 300 nL/min. The LTQ FT
was operated in standard data-dependent acquisition. The survey scans
(m/z 400–2000) were acquired on the FT-ICR at a resolution of 100,000 at
m/z 400, and one microscan was acquired per spectrum. The three most
abundant multiply charged ions with a minimal intensity of 1000 counts were
subject to MS/MS in the linear ion trap at an isolation width of 3 Th. Dynamic
exclusion width was set at ± 10 ppm for 45 s. The automatic gain control target
value was regulated at 5E5 for FT and 1E4 for the ion trap, with maximum injec-
tion time at 1000 ms for FT and 200 ms for the ion trap, respectively.
The raw files were processed with BioWorks (Thermo). Database searches
were performed with Mascot v.2.1 (Matrix Science) against the mouse
IPI database (v. January 2009). The search parameters were: Trypsin/P with
two missed cleavages, 10 ppm mass tolerance for MS, 0.5 Da tolerance for
MS/MS, fixed modification Carbamidomethyl (C), and variable modifications
of Acetyl (Protein N-term), Deamidated (NQ), Dioxidation (M), Formyl
(N-term), Gln- > pyro-Glu (N-term Q), Methyl (E), and Oxidation (M). Decoy
database searches were performed at the same time as the real searches,
resulting in false discovery rates under 5%.
Only peptides with scores above 20 were used in the analysis. Protein iden-
tification required at least one high-confidence peptide (peptide score above
identity threshold, e % 0.05, length > 8 aas, precursor ion mass accuracy <
5 ppm where e R 0.005, peptide hit rank 1, and delta peptide score > 10).
There is increased risk of false discovery when a protein is identified by only
one peptide. Thus, all peptides identifying a protein without additional support
met the strict confidence requirements above and were manually verified.
Precursor ion mass accuracies of these peptides are shown in Table S1.
Mascot results were clustered to 95% protein homology to collapse highly
homologous sequences corresponding to the same gene, and all lists for
target and control purifications were compared in parallel. External contami-
nants (keratins, albumin, casein, and TEV protease) were excluded from the
list. In the final list of Oct4-associated proteins we report only proteins identi-
fied in all three replicates. We have chosen one representative of each protein
cluster, the one with the highest number of peptide matches, meaningful gene
symbol, and highest molecular weight.
Computational and Systems-Level Analysis
Orthologous human proteins were identified with the g:Profiler orthology
search tool (Reimand et al., 2007) or NCBI BLASTP and aligned with the Nee-
dleman-Wunsch algorithm. For assessment of the degree of conservation
between the Oct4-associated proteins and their orthologs, sequence identi-
ties of all mouse-to-human ortholog pairs of comparable sequence length in
ENSEMBL release 57 were compared via a Mann-Whitney U test.
Domains were identified with Pfam 24.0, and genome-wide frequencies
were calculated from domain annotations in UniProtKB/Swiss-Prot release
15.15 (Uniprot Consortium, 2010).
Mammalian Phenotype Ontology annotations were obtained from the
Mouse Genome Informatics project (Blake et al., 2009), human disease asso-
ciations were obtained from OMIM (Hamosh et al., 2005), and known cancer-
causing mutations in genes were obtained from the Cancer Gene Census
(Futreal et al., 2004). Student’s t test was used for assessing the significance
of the observed numbers of Oct4-associated genes with lethal phenotypes,
disease, and cancer associations against 1000 random sets of 92 genes, in
each case.
ChIP-on-chip data were obtained for Oct4 and eight other transcription
factors (Kim et al., 2008). The significance of the number of Oct4-associated
proteins regulated by these factors was assessed against 1000 random sets
of 92 genes. The protein interaction network was generated with Cytoscape
2.6.3 (Cline et al., 2007), with a spring-embedded layout.
For the analysis of expression at different stages of differentiation, data were
obtained for 43 mouse samples in StemBase (Sandie et al., 2009), originating
from 16 studies with AffymetrixMOE430Amicroarray chips, as used in anOct4
expression profiling study (Campbell et al., 2007) covering murine ESCs,
embryonal carcinoma cell lines, and several early differentiated lineages.
Expression data was available for 70 of the 92 Oct4-associated proteins.
Where multiple probes were available, expression was averaged. Student’s
t test was used for identifying genes differentially expressed in ESCs as
compared to more differentiated cell types (Bonferroni-corrected for multiple
testing). Expression values were log2-transformed and color-coded as a
gradient from blue (more than twice the standard deviation below the global
microarray mean) via black (microarray mean) to yellow (more than twice the
standard deviation above the mean). Average-linkage hierarchical clustering
was performed to arrive at the final layout.
Data on significantly misexpressed genes was curated from the Oncomine
human cancer expression database (Rhodes et al., 2007). Genes were
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considered mis-expressed below a p-value threshold of 1010 (Bonferroni-
corrected for multiple testing).
SUPPLEMENTAL INFORMATION
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